var title_f34_51_35632="Avascular necrosis hip MRI";
var content_f34_51_35632=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63334&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63334&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance image: Avascular necrosis of the hip (Legg-Calv&eacute;-Perthes disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T1-weighted coronal MR of the pelvis demonstrates lack of signal in the left capital femoral epiphysis compared with the right (arrow). Fragmentation is present. Note that the overlying synovial cartilage is maintained, as is the joint space.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the Department of Diagnostic Imaging, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35632=[""].join("\n");
var outline_f34_51_35632=null;
var title_f34_51_35633="Pickwickian syndrome";
var content_f34_51_35633=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pickwickian syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 232px; height: 362px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFqAOgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1f4Y+AfB938OvCdze+FdAuLm40m1mlll06FmdzChLElckknJJPXmunHw48EY58G+Gs/8AYLg/+Jo+E+f+FV+Deg/4k1n78eQldXQByg+HPgjv4M8Nj/uFwf8AxNL/AMK48D/9Cb4b/wDBXB/8TXVU2NQiKoLEAYyxyfzoA5f/AIVx4H/6E3w3/wCCuD/4mj/hXHgf/oTfDf8A4K4P/ia6qigDlf8AhXHgf/oTfDf/AIK4P/iaT/hW/gj/AKE7w3/4K4P/AImurooA5X/hXHgf/oTfDf8A4K4P/iaP+FceB/8AoTfDf/grg/8Aia6qigDlf+FceB/+hN8N/wDgrg/+Jo/4Vx4H/wChN8N/+CuD/wCJrqqKAOV/4Vx4H/6E3w3/AOCuD/4mj/hXHgf/AKE3w3/4K4P/AImuqooA5X/hXHgf/oTfDf8A4K4P/iaP+FceB/8AoTfDf/grg/8Aia6qigDlf+FceB/+hN8N/wDgrg/+Jo/4Vx4H/wChN8N/+CuD/wCJrqqDnjAFAHK/8K48D/8AQm+G/wDwVwf/ABNH/CuPA/8A0Jvhv/wVwf8AxNdVRQByv/CuPA//AEJvhv8A8FcH/wATR/wrjwP/ANCb4b/8FcH/AMTXVVX1G9ttNsLi9v5kgtLeNpZZXOFRQMkn8KAPMPiXp3w88DeHW1C48FeGri6lcRWtqNOgVpnPbOw4AGSTjgD6V4nJ4jsbiwvL0eBvC8Xkgtm00O3kt4RwFErOu7O49Rj0wK2teu/EHjfx7a+ILezuo4mfydCiaNQSMkqxV8gZ2l3OPlCise+l1LxRrqeDdAuRfRQ3bM8zpta8uQP3s8xycqp3bcj7oB64NAHV/C+9sfFmpfYW+FPhO8jiUeffQWEMEcZxkbgyNycYAH6Dp6tpHhf4d6nd3Nkng7w/BqNqAZ7OfSYFljB6H7pDKf7ykj3rX8FeGrHwL4YWxt2EkgzLPKcK08mOTjoOgAHavP8Ax34iuptc0mKxgubnWLS5NxC0FwIY7YuCkcU7HK4kzsC+oBOAaAO//wCFceB/+hN8N/8Agrg/+Jo/4Vx4H/6E3w3/AOCuD/4mrvgrxDF4n8PW+oxxtBMSYrm2f79vMpw8behBH5YPet2gDy/4m+AfB1n8NvFl1Z+E/D8FzBpN3JFLFp0KPG6wuQykLkEEAgiium+LH/JLPGX/AGBb3/0Q9FAB8J/+SWeDf+wLZf8AohK6quV+E/8AySzwb/2BbL/0QldVQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFGecd6KKACue8W+K7Pw6LaF0a61K7cJbWcTAO5/vEnhEHdzwK6GvINa1a2bxdrX9oXC6dfuxsrNHuPKe5twoDFedvLk43kc9KAPTNJ1P7bAs5eExsfL/d7srICcqQR+vf8RXiXxu8VN4h1m38K2Hz6TE3nXg80J9vZWwIUI5KK3LHuRgfdNeg6TYXS6Vr+jy3l1bPOou4LlQLd0Eg+baRuIwy8seRu+leS6Tp+meGNPvYNf1i1W0shOl5YXQJmvpkcrGsG4b/ACjnDEEZzgqAd1AEXiK+tvD3he10zSZEj1jVF+yBLW5Mslvb9S4zghpm2jJwdu30r1j4P+AYvCGg2lzqUUY1owFJCCMW6M24xAjhsHqxyffFeffA7w3e+LfEt3418WW7PIro1s+PLRpV4BVR1RAABngH15r2PxJrEFuZbe4Ey28aGSdo1JOwDJxtySMZBGM+xFAHKfE7xLeafpkGp6aymWG48qOCRSY3VxtLSZ4XAOVbIwfUEivnLXtQm1O5nnlYp50hkuAsjHznyQJXBON23C/KAOOPWu0+J+q6rd/Z7GeQRLcbrtlDBtiA4gjIDcAKd/JyS2egFcBaQ3l/qMVra+Ql1IpWOOWQKHIzhcscbj2A6k8UAewfs6+KLqLXpvD1xLE9pMjSRhUG5ZQMnLdTlQeDnpX0PXy/8C7G71nXNMSLT4lOhXJuH1HcVaNHRle3ZcDcWYAjPK7T9D9QUAcr8WP+SWeMv+wLe/8Aoh6KPix/ySzxl/2Bb3/0Q9FAB8J/+SWeDf8AsC2X/ohK6quV+E//ACSzwb/2BbL/ANEJXVUAFFFFABRRRQAUUUUAFFFFABSMSBkKW9hS0UAFICcnIwOxz1paKACiiigAoooJwMnpQB5V8Ydc1iYjRPDjxRRxyW51O4a48k7JX2rCHByhYAszjkKOOTXlXi2wNxqmkeGvD11Hc+G72ZhH9mjSeRZBIVl/6abFJ+Uu3OCckc16zeaKviHTfE11f6hqenz6lC7FANsMdqoKKGDDyyzKNxJO4BuoFZ/w+8KeFbfxdY6h4cLwapFbrd3tmxZlhjmiIQAdFyeQATx6CgDflGpaL488L6fPJFJpMsEttHclQHYpFlYnJOSxwzAjggEEZ5qPxn8OdD8dQteXFpHa6qyBjcRqBJuxhG3dxgY5yCPQjjtPEOj2+t6cba5U7kdZoJFO14ZVOVdW6qQe/pkdCRXNeAteGsW0N8A0AupZIprWd9xtLlGKyxKx5GSu4KeoyeOlAFWxVfC3gu1sba2voYEASZoZPMkthn5pVG35gCMsAMjOSpya4H4ga2dVRdBv9Q022vZpllstT3OlpcRupIkJXOAAcdSpJHUcL7TdsjXZbaFKLucbgrEDI3E9MDg5HI6HGTj59+MU3hm2nuLrRtOt01EsgvLh1wqxyhsP5eSq7+SDgHOGHXJAOD0u2keOWK1tZLm4hXc4jTeEGduWYcAAkcnjpWz4RtdZ/tO70y20yyvrme8+yPa3DKJ7WRd2ZPXy9vmK2D34wcGqvgWZLGLVBpUl2fFMsXlaZEkLSowYgOcKMq4XkFvkxnIzjH0H8I/AFl4QsXvF8yW/u40DPLglEAHC8A4Jy3PONoPIoA6fwl4eh8Oaa8CTPdXc8hnuruRQHuJSAC7Y9gB+HOTknboooA5X4sf8ks8Zf9gW9/8ARD0UfFj/AJJZ4y/7At7/AOiHooAPhP8A8ks8G/8AYFsv/RCV1Vcr8J/+SWeDf+wLZf8AohK6qgAooooAKKKKACiiigAooooAKKKq3+oWlgm68uI4QVZlDH5mCqWbA6nABJx2FAFqisNfEUZjkuGsL2PT0hM/2uUIkbL7AtuzjnBA4qOHxIZoWuP7LvYLQLuWa52R7+cAKm4vk9gVGaAOgormH8TXm2OOLQ7l76QEi1Mq70H8JkIyEB4PJ4+vFLJfarJHbgvCt42WaC1wyLx0aVxyB6hVz7UAdNXH/EO7a5gt/DVpefZLzVw8bTK6q8UAH7xlyDk4OABzz2xkVo9GubzWrm3n8QayY1jVJVSfy1WQjcvlMgBzgEsG46VuaNoUMWlLb6kZtQJUoWv3WdymeAWxg+ufp6CgDh/Gen3p8Ja/YW8ces6XOsFjpml2YI8pcKgMkpOSu87mxz8oGetdj4K0AeG9JEV1dy6jqk7K17fOnzzyBQoJwOAFUADoAPeuhWJEhEUSiNAu1QgxtHtXK2WqSadr/wDwjUzzS3KWK3dnLIw3Xm0kShmPGcsnGM4OfoAdbXhfj641XwP4+1HW9COn3GlalGz32nSusS+fFDuMjbupKlWyvJ24Oc16/wCGtSOpaczSlBdwTPb3KK4fy5FPIyPbB+hFc1qfhXff32s6tanX7xrlZtP0/gQWjLGY1OGbGSDlnP4LwKAKL+JV1Xw/H/aemanZrd7RPJaPHOqZ2AkbCxwfNUAAFjnHY1yZ0HRtNvLS91bxjMgv0aLF7pSQxXKDcfKbzE2+XtIOw9dqlccV0UfhmDw14RuNI1W+VrzVVaS7msokt5JZf4VtUJCDYBkLgk4zgkmvF/F3gnUNCs5bpD/wkdjcDz4dVtpTmNRkt5kXclOSRwoBPHSgDtvAVv4Z0aWHXNJk1d7MyeaupXyw2kUIBKNCZX2gxty2xQ7YA5BFei6N42XWry5tfDeo2eq3lmsbz2rYxKrMAWjmU7cDPPynng4rjvhr8PNb/suKe88SQGMNG9vixS5eBdofETTAiPO/BATqM16l4a8JaN4cmubjTbNFvbolri6YAyyknJyQOOewAHTigDeooooA5X4sf8ks8Zf9gW9/9EPRR8WP+SWeMv8AsC3v/oh6KAD4T/8AJLPBv/YFsv8A0QldVXK/Cf8A5JZ4N/7Atl/6ISuqoAKKKKACiiigAooooAKKK8u+KvxMi0S3utG8O/6b4ifEG2M8WzuMLn1fJGFHcjOO4Bt+IfHdtb3uraXpZLX1jb75LyWFntIZiRshdl/jOckDoOT6Vwnh/T7fxXr9hrlvd3dzqtnN9j1eO6kdBDCyEmMIOGJI+8Dgr7VX07QJrTT9I8N3VzqJIt5NW1RpLgxPMrSfPH5SnJkBO4OTz5fQ5xW94K8QarNea9c3MUV1pGmwv9n1CCMudQkRMEysMfMFC8AAZJA6UAdE+qRaj4iv9Bt4DJDpiRT3V3Io8hZjyEbBwSigNs9SucAZOirCO1EcDy21nIxw+S1zdtnkrnkZ9e3sBXJ+HrOXS/C+lXl3LPvK3OpXJlBRLp5PmzLGilnKgjCgbuB6VqLrMGRLcWtyb242t+8leCfYc4O1lXy4sg8EgZyDk5oA1t8kCJEYntImc7LaP5pHI5JJz8x55JO0dzVpIXULFAibnK+Yr5bb/vbfvH05Vff1ybewimiFyZ7kvI2AP7QJjYqPl+4SZOvTGD6U14rueIx3j+dEzHyxfYt48e0EfzP9JCOtAE82owfYNSuvtCn94luYrHEro7OFyyoTtJ+XPPABNdiM4561w9xpF0dBv7OHV7iyDmL7LLCiWqQyB921FUcKTgHcWyDXWabefa4cSx+TdIB5sO4EofY9xkEA98GgC5XIeOvBcHiO4sNUgv7zS9b0zc1pe2zZKA43BkPDggEYPrXTo+20VpnRtwyWDfKc+h9P6V51e6hBp3jl7q48QatqM8Onm7uNMhiMkAtJGYLLBHGMllZQCx3MVJoA2LN9U8M+H9Q1HWL6PVL+RWmjja3is2YKpIViG27umSTwB04rc0LXIdR0SyumkiW7mt4pXgdtjozoG2lTyD9RXPw26/EC31Nda0i8tNElgNrbrdN5UsqyIN8gUcqOgBJz16dK5/WPC+vRRxR38/h+SOEi206+eGdrmJiuxWIT7zFccE4yM+1AG7JpN1qfi86hf3gS3s55Et7ccJl41USjOcyrhlH1PTv5/wDGLxJPo0lnYaXJb6ZZ6jpsj3Eq2yTSCbawCbBhlkcFlDnjluvbufGlzBpkEU9+10bDTrcyLBvERnmPBfeWBchdzEDJ5z1PPkvja/1W6sdJkufDl5pc41OK3lu7u7G8SKpNu+xDuyULgHBxwMk0Ae/+BdJbRPCmnWUssstwI/MnkmbLvK53OSf95jW9WF4K1j+2vDttcSIIrqPNvcw+b5jRSodrKx65yM884IzW7QAUUUUAcr8WP+SWeMv+wLe/+iHoo+LH/JLPGX/YFvf/AEQ9FAB8J/8Aklng3/sC2X/ohK6quV+E/wDySzwb/wBgWy/9EJXVUAFFFFABRRRQAVV1a/g0rS7u/uyRb2sTTSEDJ2qMnA7njpS6jfW2m2Ut3fSrDbxDLMcnvgAAckkkAAckkAc1zuopdeKLX7Dd2E9jp0m15BLIvmTYwwjKqSVHQtznjHegDMk1e91e6e0n1iy0e5kSMw6aj7LrLqrAu7YyRn7qDGRgsRmoL/w14c8ONpr22mWNrPAW2XU52+Y5bBVnALb2yWUgE5UgYqj4hu7B4rTxTqM1tHa3MtvC0dwqO0cKySKdrehMm8sOcLXH+GRH4gn1C10X7Rf6rZSSXNhdNJIn2RjIVjVpGJEkaId4DeuAOpoAu6jfm+ub7QfC9hpN74l1GRjezXFncx/Z7fbhWkkk+bzQG4/OtTwX8PYtP06206e81PUNNguFu5IJI1iiurhQMMvO7ygBjYwIYjP16HwzZDw9p39n6vr011HLMZXv70C1e5Yn/V7iwJx1yowRgZ7HV1DUjdRvbQu0ClyouIllkcEc58tE2spxjlsEHv0oArvFpem6sJ7y8a1v3hZYkN08k0gfgbQ4wSCOAAcd+Kp2LT6POllDNf6hdSM0kl0zyTM4H3ScYReMDnC8cA1eih1G2kZX167mlaMmJINIUBF6gE7Tg/UjPoKp3s1zehZJbXxhErbeIVhCsSQSdhJK8jv07UARS3dk8+7UI5vtpOCskbMwbA6M8Q4wTnBCj3q7bauphlt9LtnvZ4vlT7IUQIvUhpSAgx3K5/OtF7Wd5ESS0uZrWVSkkVzKpGSc7mCq2fzwPSs+XT7A7mmj1KcuQ2+3lM6qoOAAoOAvsEzgUATzXN0ryx29pZXlwmd9urMzY7ASPxnqeVA461zsniO5h1S7stSubywuIX+0FhHBFcXKJz5SFgY3XHBwwfuMCuqsmtJ7IwRajb39tKGSFMR4yByo2gAEdMcH6c1zOr2mj3t2mh6trWqrJqlsxjszGWlVFUh0U7WcDv8APk9NrGgDrLK9t9QsoZ4o55reVVmESJgxq8R+XryOT93oTiq+lWNjoelWqLM0EcVqLeC9u4wJ403/ACRFmHOMgBSOcdzzXguk3Wq6PHpw0bU7lfs2pXEUU7Wjv9qTGNso+9GQFGIiMnO4YxXS6B8RtYa4nj8WXVlBbmJyy31sVMNxzsCogJYdjkAj070Ae+IFVQqABRwAOg9qo3n2iTVLOKOKUQKryvOsm1Qwwqoy9WzuY+g2/SvMr34hWaxWN1r+nySxPHsjvdHvTLDMSu4jy1IdQSOjr+Ncbf8Ai++8XX83h/wppclvYXDrPMy3TRXMqqo3FpmOFG0Y78DjPSgDpfGXi29j1e/uTa6ZHHFHJHolxKy3EgeL78oTnaHY7ARzlBnjJrgfDXirSbSwjfxDdXOr3TX0d5qlvqMfnkY+WOWAYwWC4DBuwyoBAp/w9g0axuJdU+2v9l09ome5iuDGkEMrNE6ngbyAVO4dfqaytKt57y50mxtdNbxFa2U7m2jitDELqHcu/wCY4+XgcsSB+lAHu/hfwnp2l3b+IdAlu9OF3iaawgm8y0uc/NvCkZ3MpyMEcn659Crwbw540m8IeJdO0HVbG+sdGWS4jt/tMqOwgeT90GCsQDG4ZMhjhSM54r3mgAooooA5X4sf8ks8Zf8AYFvf/RD0UfFj/klnjL/sC3v/AKIeigA+E/8AySzwb/2BbL/0QldVXK/Cf/klng3/ALAtl/6ISuqoAKKKKACiiuU8VXanVFjkluBa6ZZyancwRAbZwAVRHJ6jiQ7e5VfSgBmq3cGuXjtZMbmHSFe4+7mGS5UEKpOPm2cng8MV7ippb29WbVVgiinljaEwpN8oZHRVYZ69e5puneJdHuPDVprazLBpVzAuEcqgjZiPkPOA+WAxnsa5zQNG1GfX9U/tDWLnVNMZzHcrOiLG8inlEBX5Y4/lyc/Mxx2bIBwNh4cn8U6xpdnNvu/COis+n2/2BiTM6L82ckFeSoLnA+XHfNen/D7wnP4Z8PW2miS3NwxeS/lt5cPuJOwA7ctgcc46d63YreX7MqSxecwyGEe6OJRnIwOAeuSe9Ou7/S9Gt45L6WxsnnkCJ91PMc8BeeCTz36UAZ8Oh2FrNbXD2LQXsUm23u/NEly7N97JIOQRnPXjPFaSafqqWixvrsrTfPiY20QyT90MMDOPbGe9ZvhXR9Etle98NxwSKQYhcW1wZUwHOUXcxGQeuMfpXULvYEFlOOCCn/16AOf+xa7BAAusiS+ZlUPPApiKhsnCrtwSOOrYrDlj8RSzXFvea3BZ6nGTIsPlpc211BkkfJtWRcZAJBJB55Fdq4O7DQ7AeCVbjB9QRgn8DVHVbCK9XyLi3Se3DBwI3KvERyGAHII9VIPPQ0Ac4l3rlvdsINHgltYlDTrAGgkPy5DxOuUmUnjbhWGeRWtpGtNq0FjJbMvluR5v2hMsH7rvTAVxwNrAGtO5vWgsbiWO2kvTAhZ4oR+8JAyAAcAsfwPtniub0DWNO1y1m1u30u/svtdvsuFkikgmlZM/JswAxGCN2Qw6A4PABfi0zT9LM9zBJb2Nu7ma/hkwRvY8SHn5ZM/xD73HHQjlm8N6adcbV5o5NVlvJBBbagt6zzWci52xb1+6jY6jlWYggg5HSabZx393Yapb2suEQmO6nl+ZYmAPk7ASWIwQQ/3SCQT0rRnh/szzNQ0ewimSUtJcxQIqySerLjG5/YnnHrQBwereCrXUtaOtWV5Cbi/uo5JLe7kZ4UlWPYyoyEYkBAIJzyvpxWV4d0XxXoVhqlzHbSFzqSXEJupllmzvMcszgDn92TnHJ3Aj0r0PSdU0nX7aW6sizW02BPGSweArnKSRE5jfORkDPA9jWXYSXWp6XBBdx3Ftq1nGbqwup5FkM8YOMsyjHIwGU8kMO9AGXL4VsZ9WuzpVvdaZi78q5msL0WqzRON5JIU7jnGRwR0rlvEmk6Xpl9beFjFJY6Ib6NEgtJTPPflkBLPg5REPO49SQAMV6ItraQOtlo76baayVFxLD5jGD58ZAAOeSPlxjA6V5Ooi1z4iXOiWWkXKSG6jGqxgErK8QbcXfOVhL+WeBlhycnigDTs9OkXVNO1fWBbW2j2SnTrC1LSf6ZHvJRp96kR26bj8xz93uSue10jxBeareajp+nWkkFlaRLBFHHF5F1NkcMAxAt4QCoXI3EHI5rS1Y3thdLaxXUSzPH5zzPCfKTkBppD0OMhY4s8lckkAlbYvLZbZ7S1SeB1nInM7mJ3PJ3FxnG4rkE8FQRxnFAHlvxV8O6bo2mWuoWGjwXP9j3cF5JCF82NY2Yi4jeRjuZC+1ySPvA55zXtHhjVLTWNGgvdOlaW2k+6zqVYDsDnqQMDPOcda4Xx1bNfaHAbWCa61L7HdrIlxKtvvjePbIZTjGxfMVgB/dGPWt/4R37X/AMOdBaWF4ZorWOF0dSp+VQFbB/vLtf6MKAOwooooA5X4sf8AJLPGX/YFvf8A0Q9FHxY/5JZ4y/7At7/6IeigA+E//JLPBv8A2BbL/wBEJXVVyvwn/wCSWeDf+wLZf+iErqqACiiigBk0scETSSuqIvUk4ryq18TPb63cDxTaRL4b8Sfu47xS/lwOf3S28xPCOQpBxxuB9a7C5lfVvEVzAAn2fT2WKIkZIumjMhfB4O1THtz0LN6CuDuFbSPCmnX+r3eoahYtPBNJqlqvyRwBwUWSHldq98L/ALXWgB3hZrbw1bWfhfXUtYY7hZ7WW4jCxW8vy5VmLfMZV2mPJA3ZDc8AegeHbe0srNdNs9sU1rEkMkdurFY1x8iBj6A9c8kk96xWl0jxRJBPa3dtqtta6mvnOqJ5atFEzbyc4b76DcMj7uBxW2J4NYihk8y1ucnzFCo7KsfPPUZJ45OPpQBpvGiOmIbiZo1wuWJB+u4gE+9Yuv69punXdha61p0tvBds4S6miR4YmVc4ZgTtY9sjn9Ku2Ou2V1fy2OnyfaZrZhFOIIW8uI4zgv8AdHB6ZNVtbuvECaxCmj22lXliI9tzBcTNFIkjN8jhtpBXAORjPpQBq2CWc9tG9vDEkRXdGIxtyh5BxgY69KsHIYjGVzwCeffGcfnmnxiTylWXDOR8xH3Qf8KbhGyqrgbsHbxyPX/JoAiRnLMNrFRlsE5LDHTB5qlqt1aJa3bXMhWO2jMkwQHzI0AzuA69uo4PPBrQIP8ACPlGCPl579v/ANVcpqC39st3qU9/YW08F0FjmeEyr9jPSJ/4kJPLN6gdR0AMN7qO5v7DQ9Ttdbe3WOK607XrdGCbCoLs8gOY3OSpz2YHA5r0MvPbwq8f+lQ4zkEBgOxz0b/PWsu0vrKKwH2q5H2ZmKMAVeAlucK4HI5IAJB9q2I442VXt5MDsVbKkUAZUNvbrf3t3pfmR3uMz2u/asjYBG5TwGPTeOuOpxisLRNSgbXIZEL2lrNEtjHZzbkaOcMXeKQcgOFyUI4YE4JGDV+6XTm16IFiNStAXiCoxaJZOvlnGCrbeQc4IrCt9cj1fXP7H1OxDajcW7yw3FpkW9/AjcgNnMbocdSGRxwcHkA6O7Saw1a8vdMjludkaGexjTZ5nX94HI+aTBxjOCB69M/x7f3mhWsXiaxLyW9kyrqNqxyrWrEeY4XPEiDBHqAQetV7DxRHHqGlaTePcEXY3affXA2rdlTzC+cbJ1AwQR82CeOQG/E28v8AQdKuta0nb5CtGmpxvbibdbngsi5+8u7JzwVJz0GADyHxXCnhPxPqOo/b7e9g1hWuNMhtpmd1jPMTliOIg3B2no2BwTXYfD3VdV1LUb7Ubezs47qWz+zxXnkhZLi4UB3My5yQQuFk+6MY9qx9c1XT7vwjr9z4ZNjOum2SzW9uf+Xe0ugFubcqAOEKFhjpuUdsHpvBfhH/AIRSCbXbPWZ9Rl+yrb28bkGOYOq+XGwHI/etxjsRmgDr7a4nsLeSK00+VrsbJJUlmxCsjAGQCQ5wqDGWwcDAUEk1kan4h+y2VrqW5Z/7XuEs7byz+7EmHQBSwBKlhkAjBBpNS8TW1ne2tl4gubJblbdpHBZUiR1P7y4KsR+5Q/KmRuZs4H8VU/FslxrHg/w1q2ph1TTb5L27to4wWl8kPuOP4Rhd/HQcUAVLy7vX8aWd/A8GpeHLSO7tLgrN5XlzhW8wkfxgqgX0XB713Pw3mml8FaJ5zQzKthbgXET5Ep8sZOO2OnXnnpXjHi2wWXSm12cx6dcx6SRpc1qjpbyvLKJERFBwpZHMbb/vGQkV7noyx2VxDp1tax2VtFbKEtlOdgGBgAfKqjJGe5HHTNAG1RRRQByvxY/5JZ4y/wCwLe/+iHoo+LH/ACSzxl/2Bb3/ANEPRQAfCf8A5JZ4N/7Atl/6ISuqrlfhP/ySzwb/ANgWy/8ARCV1VABTJ5UghklmYJHGpdmPQADJNPrnNduZtSv30WxEgjRFmv5lQH92TxCpJADvjnOcL7spoAztNvJNM0m3uzpl9cz3dwL2WK3IkZGm3ZGSQCFBVcD+XNU/AOshfCFsn2S/ijtmNtcm8jVFgKlgwPPzYIAOM8n2ONfX76WK3gCyT6Y5/fh5IQ8IEZB2SkZ2ggKMjB54qhr92kVtFo+g6x/ZV7dX0++4eLeyHJkl2KwAY5kUDgj5u5FAGb4N8OaT4e8Xa/dWSxWsuoSGODTtwVY4EwHkRBzhpM9MDGB2rrGm8q5SCOxIiYgySMVhiA7kIclm4/u9O9Ynh/w/eLZm2tVXRLZV2STRyi4vpSeTulYFVOTk43c5wRXWWGl2did8ECeeR887DMjn1ZupNAENvcKzSrDPEwRgq7p+fXBUDjuMe1Z2naXqOna7eSR6osunXU/nm3ktMyIx6gShgNvTGQSMYro1VVJKqATySB1paAIoS2W8xBH8xAAOQ3v0pLmVLaNp5nYRL1wpOO3Qc1nm6lsryVdSnhEDkfZZWAXJP/LM5PLemOo7cGqdzYi5uVvXurmHyMObWxODjqVYryxJxx0/nQBhv4x08a5qkGrOtm+lXEMSW89wEZg65EqouS2cnjpgeuataVpXiex8R3Ti80y60S4umuxPKHN0qEcQj+EgcAHPA7Vq38NrDJJqx0L7VcqqvvSBDcsRyADxnGehIxU1lrEEyb5y1o8i7zBeR+S6rnAznjrQBqrbwqZSsUYMv+swo+f6+tZc1lJpsNzNosPmSgb1szIEjdu4BwdpI/DOPer0115ME7rFK5jPTH3s88H0/wAOa53WPE8un6rpW/TZZdKvn+zSXSDLWsp+6JV7KTxnpyDnkUAXk1CLUvKaJXhlyRGG+Vg2MtG6/wALDv8AgRkVzHjTT7iC3/tbwpatJrVvcx3UttEAPtKkhJCFJA3FQQ3fjB7GumvLL960seTdMpDKGx9oVTx/wNex/Pg8ZVhcJ4gsk1TQrqGWa3lkGApTFyh2sjg/dDD5WB6HaRyM0AZXiJ7DxJpU2na7DNDpmqWy3NjeRrmWKVRna2PuzRnBBHUAg9DnI1nUbqyvbPwx47vLcWGpCJZNShjAtZGQYa2dWzsZwFbOenoK6SytdUttdeS3S1n8M3Tm7SGTP2qzuuSyqo4K7gSVHILNXM/6P460HxPp19q9lqGnS3GLWSSEKdO+Vijsx5YiQFMnBwF9TQB5/BE3g7WPGXhy/jE1tLpVzBBMpQkxyAGOR8kdsAgc8ZAr0hfDKS/C200b7HctbWFxamQLJ5X2za6PJIrqC3lsTwcZwleR6BpGq6pq2mx+JrDVJ7a0ihlnEUJneG3b5kGV5IbBAHJA7cV9Bya/c+JtJu7PwZdx6ZrUGFlj1OzcPbA5AJjOOTjjqP5UAc74p0K10661XXvEWlWGvLFb20NrpVvaiQ2tsjfvGUEZ43MeB/Dj2FzR5c3sdneSR3Fvcz+UJDwjuE3QNgHG2S3+Q8fejx1NcITq3w71DQLbxJq2vNYTSTXOqXAZJoLmbBKpGSNwB5LK3XPFalreagPD2kyNFdLeTrBa2ZbYTNmTzrKQhTtQALKjegPNAGVqFveXOl+HtC16yl07T4dSdfJNw6M1jZoxeRscYx5JBBzkYFeoeGLwatrpu4lufLwzMzLhTjKox54JBc47Z6d68N8T6FGZden+03OuSRSTTaPd3FyZvMigmBvIHjztKhnYk99vHXFeyfDG6u9ZtdN1K4eMxtYRsY4idqyEbC7MOGYrGvy/wgn15APQ6KKKAOV+LH/JLPGX/YFvf/RD0UfFj/klnjL/ALAt7/6IeigA+E//ACSzwb/2BbL/ANEJXVVyvwn/AOSWeDf+wLZf+iErqWYKpZiAoGSTwAKAKurXMtpp081tCJ7gLiGIttDyE4VSewJI57Vy8upLocdlZ21hrOsSzO/nXVvEGSNmJZndnIXBY8YBwB2ArX1bTBrNzanUZPL0yB1nW3DFTNKvzKXPHCkZ29yAT0xWZ421h9E0i2m0i1a5uGurdiiN8yRySLGzhW+8cNtC+rD0oAv20tukE39pQWwS7+abyxujzsBIkPQHH8XQj8K5n4faMdW0XSda12D5kmm1C3S4cyvudiY5SzcjbGQFXoOpycYrWVlr+pfbppXsdA0m8tbq0FtJCC6sJGSJnycdJDwPRRyMV2lm8AWxs5I57kRosfmrCUgVlXrjpg9uo7UAaQukmIFtKjYYbsAuMfUdKmTc8ZEi7G5BCtn8jSTM0cRaOMyFf4FIBI9qFkLxh4+V57EHr0x69aAGy4MsRJwE3P8AkMf1qRcrwQSBwD69KjZxJBvAwGjJwwwRxTkXDtlsn+mTigDP8R6Jp+v6cLPVbKO9gWVJljkYqA6sCrZHIwea0l+VeF/IYzTh09KKAEAxnpk1DcW8d1G0U8ayoGDASKCuRyOPap6q/aTK5W1UOFOHkP3QfQf3j9PzoAo6jov2ix+z6ddXGlMHV1e1YDvkgqeMHpxSzRyeawdEUShkcN91z2yP4gefcd81fEbkZaRmY/w52AD2xzTbkSMqRiFZlZwr5bbsXBywPcjjpigDkdfvLqGWztWjltYHBNveAGRrSZeRv/vQkcFu2cNwchvnaJBo2r67bIxE2f7SexViqOsfzylOGOFweBkjB960tZb+zbqxSXUlK3W6A2bYD3L4O3y+QFP94/dPfFZUdhNa+J7HVLvULn7bcWptG0uywYJWjJZTI2OGALAk4HOOg5AM7VdRsHt7SbRNSunDWg1JLss0v2ZoYxhpR1/eoSjA8sR65I5T4i2sixeGPEsVmup3WtQraajZQQOq3aMokSQw9WMZGfm9s16RrqXlvdh7a6tTa6lbHTzay4+Sc58tl2j5lAZgwz0UEelY3h+Wbwna2ommfUdCuY0J1dZN7Wr8KUbdz5OQMH+HkH1oAg8H2F1p/je7haBoUuU8/wC3RuSksKFsQsuAiTBnBKrwEXA71W8daZq95ceG5EnOqQteiI6npy7LmCFlIdjtO0oDjkD5SFPWteO8utbtdS0TWIbe+tpJrjT7ieMlNrY3Rs4A+Ufw7hzkKehry/wjqmu+FPiBYTeLYb8TvGunupT5TF9xCgX5SNyqcj0zQB1Rub7xb8NfEmj63FaXWt6BcvbtLdOVT5MhLg46sFDMOgJANYOiXovbjwqtjcJHdWelzSalqttBv8hZ8LFGo7T4AUEjjPfJFdZ42ittF+IFteyJbPp+tWsllqf26YxRfuVV1fcP4ivy9P4aydFs5dF8A2ItLS4jutXY6hO9gyb43nD+SuxseYiqWbbngpmgDz3w5rlromtaRFc3+Le3utsguYlaK3DI8Dj5f9YCmw56M2Sa90+D2nw6X4bl0eM3TNo1/cWjSTBVMhDkhsL/AAsrI2D3PsK4Hw34TtPD8dhdaOI7y4S9Fjeee0RleKVAkkajp5iMc7ST0bOeldF8GLnz/EfiAHULzUZ0jihubp9nkzyxlow8e3t5axjJ5J3HnrQB63RRRQByvxY/5JZ4y/7At7/6Ieij4sf8ks8Zf9gW9/8ARD0UAHwn/wCSWeDf+wLZf+iEo1jxhY2usf2Xbwy314IfNeGMcAHOxeRgszLjB6d8UfCf/klng3/sC2X/AKIStjWtQ/sq2N0YGlXfFGEjxvkZ5FTA9xnOO/tQB53GfHXm2+pavqmkWF7fkC30dbJ7kgKpOwndkdSzsOMqozXSaIraSL2LxDq8utX9s8cytJZrE43htojC/eBIcAdip9M1D4htNV07U9VvPDkGlHU7yESvdX0zDyUXam3HZcZYdASpz61o6b4dtpvET+IrgmWeSHyYiWOHQ87mXpnso7D3Y0AReGrS9ur6+1LU7FYJbqYPslcsYRH8kaqM7SMbnyMfM564zW7cXdjbER3t/EkjkKBJOEJOeABkc59KuSAsCpUMjAhucH/P41U+wWCp81hAFBB5iU8joePT1oAtlN2w72+U5yD147+3NR/aAb02zI6nyxIrn7rckEA+owM/7w968+8W+GfGd14on1Twn4ngt7WWJENndFzGhAIJAXI5654INS6F4tvtSuf7Av7KXQfFdtGZoobn95b3iKcEo+csp9vmXrzg0AdfYxywTXdncXFzO8zPPHLIowqMcbFI/u/yIq5I42SNgjKDgjB5zVeV1v7eJ498U6kywq77CWUYIYDnHOCP/rUkF/HcRCdXWPazQSqzD93IDjB7cH88igDRpsjhEJOeeBjqTRE2+NW7kc8YqKZlEylyAqqWOeMds/zoAWzj8qBV43clsEkZ79alCgHIAzjHTtTWkVVUudu4gAHrk9qjvrhLSynuJQ5jijZ2CDLEAZwB3NADZb23juhbb1a6KGQRKRu255Y+g9zWHrmrT2Fss01wsEElyIkuVj/dQkkBBLnqjE7SwwASPrVnwrZ3AsXvtUtoYdRvsSzRoP8AVqB8kZPcqOCfXNJ410VfEfh+fR3nEK3ZUMxj3jarBiMfQUAYl1qNm09lput2BB1FpbLfLhwspXJt3kPPzp9xv4hjjI5xtJu7nw34g8i6lgi0GxWPT5VxtAifJt7g+hyDC+TywBxVT4olo/Cvm2U0HnrLEhjuBsnAjYNG6r182M98cqSaw/F19Z+IbrS9QvEdrW809nCwggxsPv7kB+cLIAwz60AegeE55GvNb0v7FGLTSZUOnzRRsVkjdd45b+NTlTg9hWHe+INKvfFV94WsNHudSikkzfeXcbYBG/zySYzy4fgqOua5Cx8QaqbvRxbq11cyWJh+zxTELLKhIDyrnn5W6VieFIpJb6We1kNtaxLiW8nLCONXODvZcEZIwP8A9ZoA9Sm1CTwZpuoap5dzqboi272ikB7lkm8iOUMeM7MByeOF6VW8W+ILePSJrm0uJf7d/s24uoNMuJQBGrKEmUk8HYyHAz1yBweOQjibUdUuLm4e4js9XtJbOxW4vTIoIYtvYj5lh3fMo5JK4Pthi/1fVtBuNOhit3lvb0W89rcbXu5ZmTazxgjMeNmCScLnHWgDu/H0I8WP8OtMvxGbu+b+0LwIdoESRKZCM5wclQM+hrpYdJim1HUri/tLK/mjk+0RP9mDHdgERo2cYCptI6gt6Hnh/AumXepaomu6sVjjtpnsjJ55VsRR48vbnbGibCSc8nPFekaHOH1O0dmuN97EZvmywPcZbgHAQAEDBGOtAFDwtpxhvYi277KttJdzXjWy27TSyOdrlR/EqmQZIB6Hoa0fhr4asfD+iNLaxOl7fMZ71pJvNZpsncGPTcCSDjjINXdN0yWGaUSImGunuF8sEDy2GArkkkvjr2wSK2dOhtYLOJLCOOO2I3oIxhfmO7P4kk/jQBYooooA5X4sf8ks8Zf9gW9/9EPRR8WP+SWeMv8AsC3v/oh6KAD4T/8AJLPBv/YFsv8A0Qla91pa3t1vvBE6RzxTQ4B3DYMgH3DFjn0OKyPhP/ySzwb/ANgWy/8ARCV1VAGBrEQuNasbZLcGaZH8+fYCv2ZSC0bZPVmKgf8AAiO9b9YejLJca/rV+7Axbo7OEY/hjBLHP+/I4/4AK3DwKACioXeV0/cKoOesmRx9Ov8AKiYXG0mExFuMBwRn15B/pQBI6KxyVVuO45rn/Fvh6DX7HyllaHVLZ/tNjdD71rKPusD3UkYYdwSPpvqzkyBkCgfdOc549KZLKnlrJ5iKvBy5wMUAcnpGof2wtjLqemTWWtIElltWxviOQpkjOfmTOFYDnGM44ze0e1s4NW1tTGym/ud+JTnzGWNc7R0xjBH19jiTVNLt302SYxvMQxuN1kuJjJxtePnAbgZ7NzngkU51fWbVYo5vst5FJG04ZR5sIxnjk4JB4POMke1AGjpFu9paCBrma5RTmOWZtzsp5+Y9+c/his+wv4rmXV5ZpE+x2dwVaXoMooJB/wB05/IVF4Z1+O7lk0y+kK6pbu6HfEYhcBT/AKxAfYgkDofwqvb6JCbGS3ZHjh1HU2vJYmG0tzv2kdslBkd+fWgDc013uV+0zLtLjdFGRhkjPTI7E9/y7VVlnnvfECWkMZFjaqJbiY5w0h+5GPXH3j/wH1qxLdx2djPdSsXbaZdi8sR/CAPyH1NVNLQxKumhy88f767lXKYZyWGPUk+/Tr1FAF/UdQjskcsjyMkTzbUGSVXGce/IAFMubk2elmeciAonmOZH3KmOSCx/LNZs1lYQXuo6yyXUk12i2ZVNzHAO35F6DJxz7ZrC+Lq2R+HmtWckk4jtLVZmSByG64jDeoJBJHfbQB57d6rout6UBd3V3LBFturrVY9PLzeeWO9BIeAoTaoAByPpVXw4VSGOfSodT1aGSaWzeOJ1hawMnAVS3Ds64JOCBjitP4f+Fb+ddLPjzYmlSIYLHT7s48xyCQDGOFP3iCct9K63xV4XOl3Gm634fijm1LTkS3sobiJvLSHIDR5GApPOHbJB+tAHCJ8OfER1hFtdLEOmjpJdXiSMuF6sU5yexFT6h4K8Y6Lonm6Vf+aLlE8+0tyoy+QERS3D/ezu4HBr168InE5lkWGNCj3EU6gKsZUgrnpnryCfaqWvRy3OktEl6tl5nlsjHKYC7Dj/AHSRj8eKAPGrLwhr2p3sEL2tppVvZwqRcWkgdJAhO5ogD88gyd2McjH15bWG0iBG/snVJdYuJAsw1KPMCLklmAH3nyP4uMEGvbfiZcW0WlSaNpQt7TVtQjWwsgsZV1WeRVkIwMAAFicc5ryL4n3Yu/iBPYWSqkGmRw6VbKybcbQM8DuWbA9gKANzwzp2u6XpUVhPFfKuuQSGzH2dTFDMyEKCW+4zrlSTxhs9RXsFhC9ldB49Pjtbe1gis4XlmP7tABv5PB28jP8AFtAHc1d03QjP4Q0zTNfeSaWKKLz9shXc64ONy4PBx0PYU6Xw9oUElh5tsCLPJt4ndnVScAEKSQSM8emTigDUt5vOWF7EI1s5ZnlbIJ/3RjnJ79MdKsQlyXBC7FOFIyPrxTUeZ5D+7CRg8Etyw+mOO3f8qkUsWYEcDofWgB1FFFAHK/Fj/klnjL/sC3v/AKIeij4sf8ks8Zf9gW9/9EPRQAfCf/klng3/ALAtl/6ISukvbmOzs57qc7YYY2kc+igZP8q5v4T/APJLPBv/AGBbL/0Qla3iKNrnThZpgm7lSBgTjMZOZB/37D0AS6DbSWmk28dw5e4IMsrEYy7ks3HYZY4q/RRQAVmanPp4PkXl/bwyO21FlkQHeRxgHv3HFJqR0+SULeTs2/8AdCJZGxnn+Fe/v2xWZNbadpVpFHpHh1r2QSnaqQquHHG9pJMf99ZJ+tADLDSdSsIftlhr95q7O/mSRXTRtHMvQiMqo2cZIwcZ68VY0G7sNY06eezs2bSrlvPWRzn7Q5+ZsKeQARjnHI4GOTW1nR5tasoJte1O50+3Qq8tnYzqkZ5+7JIVy46DjaOOlc94e8f+HLays4dMlEdm0slra6fb2cnmOyt1X/Z689OaAL/ifVln0i4ZLY/Y4oY7p59Rke1t4hkOqZX5/Mw6jaB2APPFZF/e6i8trtvb6BrGVC1nbMsUrRHCgBDksE3I+2TkgtmqEtrA1q15qnhjxLrV35nnW9gyOkFsWblUDMBkY3FjnkjBFQaZ4d8Xz6PPaaHo1n4d+0XEsk13qVx9quGV124XGT93AJJ69KAJr/x/qOh+IX03xrbq9jJJHNaatpQykKA7WZgckDOQw5xkjkYrt4/EcF94CvtZgu7afyLaaRZ4gSAVVgGK9VJHJHbNcva/CSW6u2ufEfirUtRM8UcV3DEiQR3AQjCsAD8ox0GCe5zVXUvDx+H0+dMsGfwzeT5vL6CZlvLANgFm4IlhGAcEfKM5z1oA7mze21XSLe6tb2C5guPswF3HJxKAwJC+mSOnvzVXw1q9vrF74oure5Hkx3a2KhyyhSiAE89Mszcj0FWoLy3OiyWVzbMsjTiwnjt12fM52+YMdFIO8H39aoPLF4S8PWOneGdGa+U3JtlU3A2hg+C0sjZO4n2JyKALviaV9Ksb3U1kLLp9vssbXkq05Uqu4DliSyqAemSe+RWfw3eeJV0u68WusIgENw+l2jnyjcLyTI/WRQei/dGP4utamnWl7emKTV4YoBBM0oijk3iSTJ2sTjoB0HqMnoK3aAMLUrPYkph0+OZ/tC3REhL+YRjLIequAPlHTjA9RBZ6hcQz30SyJdRTkz6fghDJldzRbjxuDZI9jz0qfxaLZrOzkuLqaFoL6B4lhYZll3gLGR3BzyPx7VFqel2+o2ep6ZIQiTShsxjaY9yjLAjo3U5/+vQBn2k95ML/AEu3tEcWdqqSvO4kHnbS6AKAdx5UtkgA4xmrXh+Kax8LW1/rCRLqq26vfSrKJi7KOQHOB1HQcDtXO+HtPuk1DXPFEWoNtvWeVbGfCKRH+6gdmzkAhGPvu9q4b4i+M7nxLYxeFvDGnynSbiCNxcxIzG6iUAssa4B8sEYLd9poAvPJqviD4g+ArfXpYNO1q0ilu7u1ilEpj+YOqsBwrsinPPQ+1WvgvZL4h8W+I/F1zETHLcuLdZV3Yy2VIb1VFUf8CrjPB9sbfRon8MO134w1GZvPmVDKbSzI2AOT9xmO3DDnHsDXu/grQ7TwR4OtNOMq7LZS00vYueSfU+g74AoA6V+VwRn2xmg/fJJ4AB5HA685qpb3jXRIhhlVOR5zptU+4BOSOh9CM81adUZsOM5B4PQj6dKAIBJcSXYURPFAhOXO0+ZxjHXIHf8AAdqs856DH1paKAAHOeCKKRRtH8z60tAHK/Fj/klnjL/sC3v/AKIeij4sf8ks8Zf9gW9/9EPRQAfCf/klng3/ALAtl/6IStFg0ni1nlx5VtYjy/rI535/CNMfjWd8J/8Aklng3/sC2X/ohKvyRBfF4Jz/AKXp7JwegjkH/wAe/SgDTF3GbhIQsm9uh2HHTPJ6DpVXWtUstMs/tGoPsty6oCQTvZjhVUDliSen1J4pdMkmuY4ZnVo4/wB4WjkQqwfdjv24br1yPSuSl0OHxh4im1C41K4uNOtJBBBAiGKNMH96pz/rN5C/N2XgdTQBrC3stMtb1bmcxaPFAtuzzzlFCr8pG7Axksc85JrkvEfiXxdMl62gx2Oh6dFAzWranbubi4ZRyNuQsS/K2C/X5eOa1NWsdO8V+KNJTV4ryXTrL/SbeOQ4trmVmbymKDqVEbkE8Ywf4qzviS2k+IINQ0ufWbSzW0lhutWBLM7WcJyVGOA29iAOuexoA4G3ijv9Lh1zWNRvfE01xvtbKOdtwu5ZRxDbw7gqtHg73PAw3pxu2efDklj4i1u/ur3UbdzYxSuyx2Kyuu2QxxquRDGAAXHLOPeolaKyM+ueJLR9MsbWAQQ2a5VtNtXB2W0Kqf8Aj7m+UuQcqhAyMitjVxbyeEtNg161uba58QXVtbTW0K5NshPyQKBxGAg28Z5JJwTQB2ugeKJ9a8NSa3DY+RBJIfssc77Wlj3BVb0G7JI/AVrac81ybOe8tJLa5kidnQzbvL5HyHHB+917YqrJpitZ2+m28SQWdskYWJGJwqEbVB4OPlx3rY8tI5lf5VG0RqoXpz/+r8qAEuLOGdWV/MCsgTCSMowPYGmw2ccS3Cu8ksczZKzOXABGNoB6D2q1SMMjpnkUAeazeHn8KeJpdWtp0ttHENvCk0sx22yK4Uwsp+8h3ZVs5U8dK7qzT7XFcJcW8sKR3TFFfC52tkMMdieefXmrOoWsd7ZT208UMsUqlWSZN6MPRlPUVWsYrfTLM2lrAtva2wyqB/8AlmecjuOc8H0oA0aoa3qUWlWBuJiAS6xICcAuxAUfmamu5GhsZZbfYSkTMm7lSQMj8Kz9Xkku9EjeCMSLJ5bSALuZUOMlBjlgOnegDFs7mzumWe5mjluNMMkl4VgdoPOAGGDMBlgOFIzwSB0rG1HV9WtfC+ni0FvN4k8S3HygOfKt0KZZ8/3Y4wOvc/hXRWOo79QgMzsMwm4mVpEJjjwdpwfmKMQSMcgqQa5i00CNfCF9qOrouoXM2nGGOyaQWsNtayNuMYZem7qzE5O0DjpQB4Xck3Fs1rfazNcQ2wFvEDMzLcKjEKF7EdSD71uaLqmtX2t3Nr4TguLprqzXToDcv5ktrbcZUMMKoznk4xn1rP8ADXhzxLf389rpVjc21xFETcPcEQrFDIOASwwMjgY5IGeMV7P4X8Nx+HNLudJ0MzW97cRRC9njnV2EpUqVB/gK54Pvk+tAG58OvDQ8HeGpLSYRSSsHluJ7foCBgRqfvEKAfxzWvL9ha/XVroQxzQkpC0hJO0j7w56ld2MDPOParWlRwQ2CJY20igOqOW6kjGWLH73fkZyc1au2MUbyWsEc9xtAVSQoxnjLY4A5P8qALSEFFIzgjIyCD+tVphcPfRquRamGQOwYAh8rtx36b6sRBliQP94AZ5zz9aCimRXI+ZQQD9cf4UANt4Vt4UiQsVXu7Fifck9akoooAKKKKAOV+LH/ACSzxl/2Bb3/ANEPRR8WP+SWeMv+wLe/+iHooAPhP/ySzwb/ANgWy/8ARCVeM32vxa8UDrmxsykvqGmZSvbHAhJ/4EKo/Cf/AJJZ4N/7Atl/6ISrXkA+Kr+aKZoxPbwW0gUdXUyv16ghD2/vD0oAsahM7wyXUc8kUEClYsf8tZCNoPuoLcA9Tz2BqUImnw2tnZjy7a3VEIAycEhVX8T1P+OauSRQR2gWYL5MQD/N0G05B/AgH8KrIYZrUTS7VEjJMXbC85BUE469B9P1AMe18myurNrqSW3SC3mu5v3oEYwsancozgLlgB22nGa4Wx8Gzap8PL3UE+y2WpeJbiPUdQnlUsYIC4kAjA/jUYbB6nOe2I/ig2q65r154c023SGx8i0N/dNP5RaISsWjjX+IHeAee2O9era5bedoN9bQwySb7d41hgkETP8AKRsVuiZ6Z7daAPCtPeXxH4isZ7WOe3gtizaMt3l2UE7ZNWnDcOxJwgPVj7E16VbaPG0eh7LqQwaXM1w+9fNlmdgyB3bqHbeTgDvjgVx+mQ6z/Ytlf3em/wDE91S44sRGohj2ACBXxylvEuWwByevzPXomnaf9j+zh55r+a0f59rBd8znMkrgcbuSQp4VSMYJFAG+q/ZolVFLbYycADLkAfrUk8QlVQSRtdW4Poc0RhgoUjAwf4iT145+lJCnkW8Uec7FVMk/hQBKTgdCfpQfaigigArK1iCGGeDVWJR7UFJCOjRNjcG9hgN7bfc1q1R15BJoeooy7la2kUr6gqeKAHW00Fws9rGW3RDawP8AdYcEexHSse/ic2F5a5uNv2WIx7JvJcMpI4fs2QtP8CpH/wAIToKiN4x9hiTa+dw+QZz+VWNTtETQNRhubdbqBI3aONz98BdwBPb5h19gaAOW0eWPUfEd3JJdTSwafucxy6cMHjkpNgbT6p1zntW/4evrTULi/tYp7m72Yaf7RblFPmDcMZABG3jA6bTmvLZ9O1HUIPGFi2rX9raX0enukmor5iGZgGfYy4P3Qq8DnHXivUPDd6l1rurQwXklwlqI4ZY3gMflSbBnJPLbhg5xx0zQBw+i61enw3Kumv5usPM9mjyN5nkRpK6pLcx9V2gbVAzuOOOMjZgjvF82x0v/AEVpWke4vJUJNuu8Lnduw0jbScEZ9eOvEaJKthpvijXri5itVutXupNOa7t3ZYod5DTygNl4gc47JnPWu68FQGwsZbuaO2tZLhUmaCzTGZZGZtxQk/vXyMZ6Dg4xQB2elrDaQx2ETvI1vGgYkHuMD2ycE4HT24p0USWEUMNnCWSSTn5yducksSck/wD6qrZCW+oy+czMkZUoD8sWFJwDjk85J57Vd8s7bZcndHz/AOOkc/nQBM0iK6ozqGbO1SeTjrihyQhKjLdqQ8srLzyQf1/rT8UAIudo3EFsckDAJpabHnYuc5wOvWnUAFFFFAHK/Fj/AJJZ4y/7At7/AOiHoo+LH/JLPGX/AGBb3/0Q9FAB8J/+SWeDf+wLZf8AohK2dPVTc6hIuT5l1nOOhWNFP/oJFY3wn/5JZ4N/7Atl/wCiErc0wjzL6POSlwQefVVYfowoAp6w81xqVvZCGJ7PyzJP5gDB2J2xpjPTO5icHhPetGcCXZCyiUEb2yODjBH5nH5Gsa4t1PjKS68xmkjsEjSHBC4aRyWJ7/dAHoCxrZhUfZVEyk712sSMEjnr6fTtnFAHCeLxdo93qM+nrfwWUdvDBblzH57vcRs8rEdApVCq9cq3Yg16DNEk0TxSjcjjDD1HpWNetZtNZabMYmuL2b7UIXb5isZD7sDqFIQegytbM8qQQySyttjjUsx9ABk0AefaWdQN5eXIhi+3Mfs7KW3xREfMse7/AJ5xA7pGH35G25GNtdBCBp0lrY2vnMiBzukO95HyC8rnuAW5A+8zADG2pdPaK7tNPu0EkEDIHWN0C/KBlWcdFwMtt65Iz92qchnvNUtrhovLt4i4WMEmWZuPLH+zgZY54G8dDnAB1SKEUAf/AK6bJyFHHLD9Of6U+kIyRx0OaAFoIB680UjbtrbQM9qAFqnrI3aPfLgHMEg5OP4TVymyIskbI4DIwIIPQigCjpbxy6ZbyqwEU0cbqFOVClQAAfSn6206aPfPZoz3KwOYlHUvtOB+dZnhyxfR/CNtYSXEs7WkBAlcAMVBO3p6AAfhWvMUuNNcgjy5Is5yfukev0oA8yt4DLqGo2q+dJPJpVvAqmZTM+wYykT4QKWJOSQxIJHFdd4cRo/Dkk2om7ge73NIbiZXliQLtOZE44Ckgj1rk765TTtI1HVJDc3tnFppto1kYuk+Wyg8tgPmO4KQf4eV71o+MreOHwbpnhhXubOfVFi0pBZwl2jQqDKQB0XaCpY/dzmgDG8N6QNO0DShfqItLtwkksQJaOYMS0KHJ+5GrKzH/lo5Hpiu3sd1vJqEsip5kflxjBQMFxnDbR8pJOSec5+XtVbU7AQ6csItSllYukVlD87fIiAKcKSSQc7c89z0q7IxSLULuaQMzPhDK3yR4UjaCACBk9s5zxhjQBLOkk9vq1pI7hpISFY4+UMCMKB6dPTOOvNa7A/aYz2CMP1WsLw/9rll1ITsVZbpQJlIPmKoXKhckKAcqQPfvk10JZQ4QsNxBIGeSB1/mPzoAilOyS3AAw0hHXp8rGpqjlGZIflJw+cjt8p5NSUAR2/EEYBzhQM1JUducx8DADMoH0JFSUAFFFFAHK/Fj/klnjL/ALAt7/6Ieij4sf8AJLPGX/YFvf8A0Q9FAB8J/wDklng3/sC2X/ohK14M2/iC5i58u7iE6/76YR/0MX61kfCf/klng3/sC2X/AKIStjVh5Vxp90MARziNz3KyDYB/32UP4UAVLssniobjJ5T2RJBwY/lfknvuw/4jdWkglEY8wEkgDknA5wAfX3PesXxFcR2Grx3t0sCQraOiT4ZpVJkjBXaPvAkxHv8AdI71sSDETQx7mWNfL+U5ZTt/op/UUAZ2mWNtd+IG8QFT9oe0+zQsX6QGQsCF/wBoqGz15x2reqnp4HmXJOzcsmzC9lABUfXB/PNXKAMq+cDz0yjYOXODgdCBgcnAwSO+QP4qqottHZ3l0SwMamOd1bc6KASyKR/Fk5JGcsTzkDFm/E3mzKsiiRsOjtjESDq2O+3k8g5YjsOL9nBDBaxRQriJANoPJH/1++fegCWJt8SNtZcgHa3Uex96cT+tFNb7y9Ovf6GgB1MnBMMgCljtOFBwT7Zp9FABRRRQBi26SvrOqpKV+z+Wioid9wJOR69fwp0Yuo/C0Udlt+2C2WKMsQArYxuOfTrj2psVwLlLu6heFmw7WziInbtyhOc/McjoMcYqDW9OP2C2htZpEntlLRbedxPyn5ejHDHAPAzQBQdrK3a0s79o5RPMlrFDcMJTOwG7cCQScKN4JPGSPaprTN94/upZEk2WNmsEMgOULuwaUD0OBGMelUtM1Wz0iy17UbyVLXS9FH2YK77zEkaBmAbPIJIAzzlSPStvwiqT6d/aaFm/tHbcglShKkAjIPTr+WKAIdXggk1iBP3WAGlkRmbcXYbV2j7pJweCc8Z9c1b+5MukQCIhp5Z0hxEhMgIP3FBGVwM5J5VdzdcVua4lt9jE92YlS3cSBpeinP5n6DqcDvWPeQy3gtbdIZlR2JnPmYcA8+XnBwCSN5Xp0BPAABq6PFBHHdGGFFV7gkvGAFkPAyADxjG36qT3q1JCW1GCf+FIpEP/AAIof/Zaj0uBIIpthVmeZmdlTaC3TgZ7AAfhVmUDzYW25O4jPoMH/AUAOcEsmBwGyfyNOoooAjhPzSr2V8dfUA/1qSmLnznGOMA59+f8BT6ACiiigDlfix/ySzxl/wBgW9/9EPRR8WP+SWeMv+wLe/8Aoh6KAD4T/wDJLPBv/YFsv/RCVvavam90u6t0x5kkZCE9mx8p/A4NYPwn/wCSWeDf+wLZf+iErqSAwIYAg8EHvQBh3cFvrR0q7e2R8gvGs8G5oW4YPg/dIKY+pFJfTSW2sWen6bGEE7m6upNhO1Aw9OrOSBknAVT7UnhW3Eum2FzNF5csETW8SBi2xN2Op6khFJ9MY9zQsdWtrptW1eWO6mhtLnZEYo2LEICm1UUZcl2kOOfvL7YANnRjcC/1lbmHYPtQaJlB2uhiQA59cg5rVrifhHfQ6j4XmugpW8kvJ2u8oy5kLZGAxJA2FBjOBjFdtQBVvkQ7NwBdmCqpHDnkjPqByfwp8RDJnkjHBOOQT/X/ADio79gqqdrAEEFxjIGR8o9SxwBSoS5BIG8HA7jdjk8dh0/MUAWRnJ9KWkUgqMdKWgAooooAKiun2W8jbgp2nBPY9qlrL1+VYlsBI4VJLuOM56NnOAfqcfjigB1pZQ2mhR23ljZHBtIxgnjJ/M81g6y89x8Q9Dt7Pyo3tbeS5u5HBJMLnYqL2yXGc+i1ueJbhrfSJfJkEdxKVhhJGfnYgDA79a5hdb0668XeJbT7MXvNFtoZHuWwQzFGZQvPUbjx6mgClBpsN+sHhm2topdGu3lvb7zt7nyA+EAJP3pJAz+gCtivRo0WNFSNQqKAFVRgADsKw/CWmta2b310pF/fBJJVPAiULhIgOwUce5LHvW6SBjJAzxQBzfjO7kiXTY4AnzXahpSAxjIUkBQTzI2QFGDycnim2sMC6lDbGF1fY0ck4ACrwD5KnOckHczJ1K8kcAR64ZPNtrhSUPmGb7YyjbaIYwp2g/ekIO0cHqeK0tN00me0vJo2tjCjJDaqRtiVsZzg4LHGc+5FAGncSBEZF4by2ZfQYx/iKWbHmQEso+fjJ6/KeBTZ0LM4GMtGVH+fxqSUgbWIBwwxk9M8f1oAVcGRyAcjA/r/AFp1RxDDynHVs/8AjoqSgCJcfapDnnYvH4tUtQr/AMfknB/1a8546tU1ABRRRQByvxY/5JZ4y/7At7/6Ieij4sf8ks8Zf9gW9/8ARD0UAHwn/wCSWeDf+wLZf+iErqq5X4T/APJLPBv/AGBbL/0QldVQBxWi3eqtoGvRRb4Lm3vb9YppIv8AVgSs0e1T9/KsCDnHHOelWdbsYf7L0bQLI31vb3DBFurSQxtEka7ySwIbLBSvHdsnpSSvPceMtY0OfZ/Z93py3W7P7wFt0Tqo9MKhz/jTYRear8RjKwaHT9GtmjXIZGuJZtvUEYZFCHBB6n2NAFLwbfpeeLrr+xiRoA06NY02gRh0mkUGLAwVI3ZPrjNd5XlPwl0+0svHHjWLR/tKaVaSxWkUM7s3luN5kCZJwu7J/GvVqAILwO0QESBnLDDHHyerc+gqKED935RJDrhCTnCDq31Jx+Y9KsXKh7d1aQxrj5mBxgd+e3FV4AJA7uAPNAJU/wAMfYH9T+J9KALa42jHTtS0gORk0tABRRRQAVznm/2v4uubOSNHstKjikOcg/aWO5SMHGFQA893ro64b4XajaaqviS/tWV2uNYmBI+9tVVVC3oCFyPrQBt+IZ4v7R0yCYP5cTSX0jADCrEvG70+Zhj6V5N8NdKj1jxlJq9hrNtdHUVe/wBZihCsgR3zBApPORj5+g4x3r0fxZEb0XhgnWaJ0WwlWNxiBS2+cv6Hy1HHXketc78C4Lue11vWr22EKajcq1oAqqFt1B2KoXoACBigD1KqeqTGBLdlxzOinIzgE4P86uVQ1GH7VvgErITE2GQAsjcYYe9AGLPFPeXOmxhQRHtaPJyLb92cu2eHfBIVcYH3jW7psMNpawwRZVQDtDtuY85JyeT61TjtI9OtdOt4WkxE6KWd9zMSpXLMeprRs1CwkDoHf/0I0AEoLXSKfuGN8jPuv/16lbIUBSRyOnPelI+bdySARimzSRxRl5mCoOpPQUAIiss0hOdrYI579D/IVJUDM5aHIx+8YED0w2P6VPQBEv8Ax9Sf7i9/dqlqGNla7mCnJVVVvY8nH5EVNQAUUUUAcr8WP+SWeMv+wLe/+iHoo+LH/JLPGX/YFvf/AEQ9FAB8J/8Aklng3/sC2X/ohK6quV+E/wDySzwb/wBgWy/9EJXVUAcpeW0kfxFt72O+skaSw+zLZy5WSUb2dnU+2F4x69OKtgpb61qd8iSyyTW8UYZXHlkqX2Rrk4LkuefdR2zWf4rv59P8WaF9jtrm8nuop4vIhMaZVdjkl2Ix0HfnpWZ4ptPGUmn29xpMek/24JmEUYYmOFGGGmO8jc652jggb+hoA534NSSaXrurW80N1dy30qy3uoGTMMM+B+4yfvyB3YMy8ZZa9lr5+8A6jrkmu+ItNufEdneSIryqsipIl1cKRuaMkA4AUjgehGMc/QNABVe23kZmUrI/zsN2dnov5enGc+tWKh5RggYs7ktk9h/9bgf5NAE1FFFABRRRQAyeaO3gkmndY4o1Lu7HAVQMkmuE+EPh5tA8L3c7LPE+oXEt4sMwDGJCTsBC9TtwSM961viRHLceF5LS3jEst1PDEsRkEYlHmKWQsem5Qw/GuH8H6B/a+sat4z1PXm1NT5kYs7eR4Ftth5jJDAbkAIz0PXPOaAOt1nTm8SWWprZXLWeqwRPbO8EmYpGZVOHTOTxxhhldxxnqZ/h/CsMWpkw21vcXE63E0VtI0kaM0ajAY9eFHYfSoYvE1pHq2kaIYL24bVYpJIrxVGxgq5wZFOCdnGVJPAz60fDWwXT015LaO1WwfUpHtngjCbkKr1wSCRjGeM9+c0AdlVKUONSUxgkNE4JwcK3yYyau0wqwDlCCScjd0HSgCG7QHaxVXyyja3Q4J/x/Sp0AAOM9T1+tKzBRk9KYoInkO5iCBwTwOvSgCT0pkuNoy20bhz+I4pY87TnPU9R71HcruCDco+bIz1P096AHBvli5zu7jkHj1oVyZ3TjCgH3yc//AFqjtgzW1qWZnYKCzHqfl6mlgB+0XLEn7wAH/AR/jQBMFAJIABY5OB1NLRRQAUUUUAcr8WP+SWeMv+wLe/8Aoh6KPix/ySzxl/2Bb3/0Q9FAB8J/+SWeDf8AsC2X/ohK6quV+E//ACSzwb/2BbL/ANEJXVUAc/4z065u9Phu9LMg1LT5PtEIjKq0owQ8QLAgb0LAZ6NtPavMLvxDdaPNp9zpeh6fe+F2QWVxqNxby3F7CrSHzI7jIDKxdjlTnk5PWvb65jXPDl7JezX/AIb1X+yb6bY04MAliuCmdpdcg5wdpYHJAUfwjAB55qHgjw1N4R1TW/DlpDp3nx74o9Qtn/0Ro2AKxjPyEkYAGeSNvHFey2svn2sM2xo/MQPscYK5GcEetcz4f8NXovl1XxXqC6nqycRJCrR2tsPWOIsRvOTlzzjgY5z1Y4FABUUURSWWR23M544xtUdB/M/ialooAKKKKACiiigDN8S6Umt6DfabIQouIiqvjOx+qt9QwB/CvMPhFocui6pqNtqur2V82oQ7ZLaJAzPIpKy+ZkZG3p12ndXsNeR+JPAHiX/hJZNR8J3GjaeWke5a8VXjupZGOSshwyuvpwB6jigDkdMdtG+JFmviDQrXQ0XzLayWCy8w7WO2Eh1+VmBAO/AbBINe96HYHTdMhtnaN5hlpZI4xGJJCcs20cDJJrjvDHh/xFeT2Nx4tltIfsUzXSxWKCPz5zkb5SCQwAPYKcnnI6+gUAFFFFADZDhR06gc/WmqMzuwB+6BntwT/jSXDFUXbGXy6jjtz1/DrT1QIuEA4GBQA6o5d+Y9n97njtTyCcckY5OO/tUdwyoqs4yN6gfUkAfzoAhtG82zsZPVVbk56oaktxia595B/wCgLQWxChxt2uFwvA+9j8qdCCJJyehcEf8AfK0AS0UUUAFFFFAHK/Fj/klnjL/sC3v/AKIeij4sf8ks8Zf9gW9/9EPRQAfCf/klng3/ALAtl/6ISuqrlfhP/wAks8G/9gWy/wDRCV1VABSMwBA6k9BS0UAFFFFAB60UVDcSspEceDK4O3IyBjHJ9hn1oAeWIfGQFAycqffv09KZ5zFhiF9nOWJA746dadFGync8jOxAB7D8BS+WPM8wklgMDk4A+n9aAER5Gb5o9q+pYZoBl3cqm3/ePp9KkpGYKMk4oABnHIAPtRznoMfWkRi2cqVHbPU06gBrlwvyKpb0JwP5UKXLHcqhexDZ/pTqKAGyB8fuyoPqwzThnHPWjvmkVQoAUYAoAAvJyxOTn6Up5FFIQDwQCOvNAEUkCtEqDcdrBhmRs8H1zmnSyiOLzMZXjPbgnrUnfNR3UXn28sRON6lc4zjI60AQbAltOp+YxyNJye+d4/nUWptMtteLDIqSyIqRNnBVm+UH88VaVdszggkOASe2Rwf6VT1O4tLW2ia8ljihEi7pJCAF2HcCSegyB+dAF2eYQ20swR5fLVm2RjczY7AdzxjFZ+lfb/tLHUJcvJH5jQrt2QZPyopAyeM5Y9SMgAcU60vYbeW1sJjtu5gzBQM7mADOfYAsOT3YDvS6fJdNe6g95HEoWVYYRCWbKABgzZAwfnOQOBjqaANKiiigDlfix/ySzxl/2Bb3/wBEPRR8WP8AklnjL/sC3v8A6IeigA+E/wDySzwb/wBgWy/9EJXVV+aNp4+8Y2drDa2fizxBBbQIscUUWpTKkaKMBVAbAAAAAFS/8LH8cf8AQ5eJP/BpP/8AFUAfpTRX5rf8LH8cf9Dl4k/8Gk//AMVR/wALH8cf9Dl4k/8ABpP/APFUAfpTRX5rf8LH8cf9Dl4k/wDBpP8A/FUf8LH8cf8AQ5eJP/BpP/8AFUAfpTTQiiQuAN5ABPcgZx/M/nX5sf8ACx/HH/Q5eJP/AAaT/wDxVH/Cx/HH/Q5eJP8AwaT/APxVAH6StBEZvNKL5uNu/wDiA9AewqQcCvzW/wCFj+OP+hy8Sf8Ag0n/APiqP+Fj+OP+hy8Sf+DSf/4qgD9KHUOpU5wfQkH9KakapggEnpkkk/ma/Nn/AIWP44/6HLxJ/wCDSf8A+Ko/4WP44/6HLxJ/4NJ//iqAP0por81v+Fj+OP8AocvEn/g0n/8AiqP+Fj+OP+hy8Sf+DSf/AOKoA/SmivzW/wCFj+OP+hy8Sf8Ag0n/APiqP+Fj+OP+hy8Sf+DSf/4qgD9KaK/Nb/hY/jj/AKHLxJ/4NJ//AIqj/hY/jj/ocvEn/g0n/wDiqAP0por81v8AhY/jj/ocvEn/AINJ/wD4qj/hY/jj/ocvEn/g0n/+KoA/SmivzW/4WP44/wChy8Sf+DSf/wCKo/4WP44/6HLxJ/4NJ/8A4qgD9Kaq3lot0k6ORtkhaLBXcBu68Hr249q/OD/hY/jj/ocvEn/g0n/+Ko/4WP44/wChy8Sf+DSf/wCKoA/Rx7VkvJJ7VIYnkA8xymfMOQOcYJwoIHPf2qzBH5e8nG53LE+vp+gA/Cvza/4WP44/6HLxJ/4NJ/8A4qj/AIWP44/6HLxJ/wCDSf8A+KoA/SmivzW/4WP44/6HLxJ/4NJ//iqP+Fj+OP8AocvEn/g0n/8AiqAPv/4sf8ks8Zf9gW9/9EPRX593fj7xjeWs1reeLPEE9tOjRyxS6lMySIwwVYFsEEEgg0UAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35633=[""].join("\n");
var outline_f34_51_35633=null;
var title_f34_51_35634="Patient information: High-fiber diet (The Basics)";
var content_f34_51_35634=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16251\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/31/39413\">",
"         Nutrition label",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/38/42598\">",
"          Foods with fiber",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\">",
"           Amount of fiber in different foods",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/62/23531\">",
"            Over-the-counter fiber supplements",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?20/59/21426\">",
"         Patient information: Constipation in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?11/35/11827\">",
"         Patient information: Diet and health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/50/38690\">",
"         Patient information: Fecal incontinence (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?40/15/41202\">",
"         Patient information: Hemorrhoids (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/14/7395\">",
"         Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?34/10/34977\">",
"         Patient information: Constipation in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/62/28642\">",
"         Patient information: Diet and health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?5/55/6006\">",
"         Patient information: Fecal incontinence (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/47/40689\">",
"         Patient information: Hemorrhoids (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?8/39/8817\">",
"         Patient information: High-fiber diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?30/32/31239\">",
"         Patient information: Type 2 diabetes mellitus and diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: High-fiber diet (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/high-fiber-diet-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H27978999\">",
"      <span class=\"h1\">",
"       What is fiber?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Fiber is a substance found in some fruits, vegetables, and grains. Most fiber passes through your body without being digested. But it can affect how you digest other foods, and it can also improve your bowel movements.",
"     </p>",
"     <p>",
"      There are two kinds of fiber. One kind is called &ldquo;soluble fiber&rdquo; and is found in fruits, oats, barley, beans, and peas. The other kind is called &ldquo;insoluble fiber,&rdquo; and is found in wheat, rye, and other grains.",
"     </p>",
"     <p>",
"      Both kinds of fiber that you eat are called &ldquo;dietary fiber.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27979006\">",
"      <span class=\"h1\">",
"       Why is fiber important to my health?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Fiber can help make your bowel movements softer and more regular. Adding fiber to your diet can help with problems including constipation, hemorrhoids, and diarrhea. Plus, it can help prevent &ldquo;accidents&rdquo; if you have trouble controlling your bowel movements.",
"     </p>",
"     <p>",
"      Getting enough fiber can also help lower your risk of heart disease, stroke, and type 2 diabetes. That&rsquo;s because fiber can help lower cholesterol and help control blood sugar.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27979013\">",
"      <span class=\"h1\">",
"       How much fiber do I need?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The recommended amount of fiber is 20 to 35 grams a day. The nutrition label on packaged foods can show you how much fiber you are getting in each serving (",
"      <a class=\"graphic graphic_figure graphicRef51585 \" href=\"mobipreview.htm?38/31/39413\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27979020\">",
"      <span class=\"h1\">",
"       How can I make sure I&rsquo;m getting enough fiber?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To make sure that you&rsquo;re getting enough fiber, eat plenty of the fruits, vegetables, and grains that contain fiber (",
"      <a class=\"graphic graphic_table graphicRef52349 \" href=\"mobipreview.htm?28/61/29661\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef79063 \" href=\"mobipreview.htm?41/38/42598\">",
"       figure 2",
"      </a>",
"      ). Many breakfast cereals also have a lot of fiber.",
"     </p>",
"     <p>",
"      If you can&rsquo;t get enough fiber from food, you can add wheat bran to the foods you do eat. Or you can get fiber supplements (",
"      <a class=\"graphic graphic_table graphicRef79264 \" href=\"mobipreview.htm?22/62/23531\">",
"       table 2",
"      </a>",
"      ). These often come in a powder and should be added to water or another liquid.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27979027\">",
"      <span class=\"h1\">",
"       What are the side effects of fiber?",
"      </span>",
"      &nbsp;&mdash;&nbsp;When you start eating more fiber, your belly might feel bloated, or you might have gas or cramps. You can avoid these side effects by adding fiber to your diet slowly.",
"     </p>",
"     <p>",
"      Some people feel worse when they eat more fiber or take fiber supplements. This is true for some people who have certain digestive problems, such as irritable bowel syndrome or diverticulosis. If you feel worse after adding more fiber to your diet, you can try decreasing the amount of fiber to see if that helps.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27979076\">",
"      <span class=\"h1\">",
"       More on this topic:",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/35/11827?source=see_link\">",
"       Patient information: Diet and health (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/59/21426?source=see_link\">",
"       Patient information: Constipation in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/15/41202?source=see_link\">",
"       Patient information: Hemorrhoids (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/50/38690?source=see_link\">",
"       Patient information: Fecal incontinence (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"       Patient information: High-fiber diet (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/62/28642?source=see_link\">",
"       Patient information: Diet and health (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/10/34977?source=see_link\">",
"       Patient information: Constipation in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/14/7395?source=see_link\">",
"       Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/47/40689?source=see_link\">",
"       Patient information: Hemorrhoids (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/55/6006?source=see_link\">",
"       Patient information: Fecal incontinence (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/32/31239?source=see_link\">",
"       Patient information: Type 2 diabetes mellitus and diet (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/51/35634?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16251 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-124.240.187.81-3C54767836-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35634=[""].join("\n");
var outline_f34_51_35634=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27978999\">",
"      What is fiber?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27979006\">",
"      Why is fiber important to my health?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27979013\">",
"      How much fiber do I need?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27979020\">",
"      How can I make sure I&rsquo;m getting enough fiber?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27979027\">",
"      What are the side effects of fiber?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27979076\">",
"      More on this topic:",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16251\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/31/39413\">",
"      Nutrition label",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/38/42598\">",
"       Foods with fiber",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\">",
"        Amount of fiber in different foods",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/62/23531\">",
"         Over-the-counter fiber supplements",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/14/7395?source=related_link\">",
"      Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/10/34977?source=related_link\">",
"      Patient information: Constipation in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/59/21426?source=related_link\">",
"      Patient information: Constipation in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/62/28642?source=related_link\">",
"      Patient information: Diet and health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/35/11827?source=related_link\">",
"      Patient information: Diet and health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/55/6006?source=related_link\">",
"      Patient information: Fecal incontinence (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/50/38690?source=related_link\">",
"      Patient information: Fecal incontinence (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/47/40689?source=related_link\">",
"      Patient information: Hemorrhoids (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/15/41202?source=related_link\">",
"      Patient information: Hemorrhoids (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=related_link\">",
"      Patient information: High-fiber diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/32/31239?source=related_link\">",
"      Patient information: Type 2 diabetes mellitus and diet (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35635="Dimercaprol: Patient drug information";
var content_f34_51_35635=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dimercaprol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/42/9893?source=see_link\">",
"     see \"Dimercaprol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/32/26115?source=see_link\">",
"     see \"Dimercaprol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F160824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      BAL in Oil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10205310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2749301",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arsenic, gold, lead, or mercury poisoning.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10205309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2749305",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dimercaprol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2749554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to peanuts, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10205313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10205314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pain and irritation where this drug goes into the body.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10205316\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10205312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10205317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10205318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15552 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-FD3AE0A3B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35635=[""].join("\n");
var outline_f34_51_35635=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160824\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205310\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205309\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205313\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205314\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205316\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205312\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205317\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10205318\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/42/9893?source=related_link\">",
"      Dimercaprol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/32/26115?source=related_link\">",
"      Dimercaprol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35636="Clemastine: Patient drug information";
var content_f34_51_35636=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clemastine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/62/7142?source=see_link\">",
"     see \"Clemastine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/13/25813?source=see_link\">",
"     see \"Clemastine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F152461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tavist&reg; Allergy [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hives.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling of the face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701821",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clemastine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024057\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696039",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is most useful if started before contact with the allergen. Take at least 1 to 3 hours before.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694356",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (syrup) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12227 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-BD889E7001-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35636=[""].join("\n");
var outline_f34_51_35636=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152461\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024055\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024054\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024059\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024060\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024062\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024057\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024058\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024063\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024064\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/62/7142?source=related_link\">",
"      Clemastine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/13/25813?source=related_link\">",
"      Clemastine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35637="Thioguanine: Pediatric drug information";
var content_f34_51_35637=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Thioguanine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?34/54/35685?source=see_link\">",
"    see \"Thioguanine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/33/3605?source=see_link\">",
"    see \"Thioguanine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F226912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tabloid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F226913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lanvis&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1050255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Antimetabolite (Purine Analog)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1050247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/54/35685?source=see_link\">",
"      see \"Thioguanine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral (refer to individual protocols):",
"     <b>",
"      Acute lymphoblastic leukemia (ALL); delayed intensification treatment phase (combination therapy):",
"     </b>",
"     Children &ge;1 year: 60 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily for 14 days (Lange, 2002; Nachman, 1998)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Children: No adjustment required (Aronoff, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Deterioration in transaminases, alkaline phosphatase or bilirubin, toxic hepatitis, biliary stasis, clinical jaundice, evidence of hepatic sinusoidal obstruction syndrome (veno-occlusive disease), or evidence of portal hypertension: Discontinue treatment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F226891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tabloid&reg;: 40 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F226876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1050259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Total daily dose can be given at one time.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1050250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 15&ordm;C to 25&ordm;C (59&ordm;F to 77&ordm;F) in a dry location.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1050258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Remission induction and remission consolidation treatment of acute nonlymphocytic leukemia (ANLL, AML) [FDA approved in pediatrics (age not specified) and adults]; has also been used for treatment of acute lymphoblastic leukemia (ALL)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F853383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Thioguanine may be confused with thiotepa",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       6-thioguanine and 6-TG are error-prone abbreviations (associated with sixfold overdoses of thioguanine)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Lanvis [Canada and multiple international markets] may be confused with Lantus brand name for insulin glargine [U.S., Canada, and multiple international markets]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F226954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Fluid retention, hyperuricemia (common)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, intestinal necrosis, intestinal perforation, nausea, splenomegaly, stomatitis, vomiting, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia (may be delayed), bleeding, granulocytopenia, leukopenia (common; may be delayed), marrow hypoplasia, pancytopenia, thrombocytopenia (common; may be delayed)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Ascites, esophageal varices, hepatic necrosis (centrilobular), hepatic sinusoidal obstruction syndrome (SOS; veno-occlusive disease), hepatitis, hepatomegaly [tender], hepatoportal sclerosis, hepatotoxicity, hyperbilirubinemia, jaundice, LFTs increased, nodular regenerative hyperplasia, peliosis hepatitis, periportal fibrosis, portal hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1050263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to thioguanine or any component; history of previous therapy resistance with thioguanine and in patients resistant to mercaptopurine (usual to find cross-resistance between thioguanine and mercaptopurine)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1050246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Thioguanine is potentially carcinogenic and teratogenic. Hyperuricemia occurs commonly with treatment; institute adequate hydration, urine alkalinization, and prophylactic allopurinol. Cross resistance with mercaptopurine generally occurs. Avoid vaccination with live vaccines during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1050245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Not recommended for maintenance therapy or long-term continuous treatment; thioguanine is potentially carcinogenic and teratogenic. Liver toxicity associated with vascular endothelial damage has been reported in patients receiving long-term thioguanine maintenance therapy; liver toxicity is particularly prevalent in children (up to 25%) receiving maintenance therapy for acute lymphoblastic leukemia and in males; liver toxicity usually presents as hepatic sinusoidal obstruction syndrome [SOS; formerly called veno-occlusive disease (VOD)] or portal hypertension; monitor liver function carefully for liver toxicity and discontinue in patients with evidence of hepatic SOS (eg, hyperbilirubinemia, hepatomegaly [tender], and weight gain due to ascites and fluid retention) or portal hypertension (eg, splenomegaly, thrombocytopenia, esophageal varices). Hepatotoxicity with or without transaminase elevations may occur. Pathologic findings of hepatotoxicity include hepatoportal sclerosis, nodular regenerative hyperplasia, peliosis hepatitis, and periportal fibrosis. Avoid ethanol; may increase the risk for hepatotoxicity. Myelosuppression (anemia, leukopenia, and/or thrombocytopenia) is a common dose-related toxicity (may be delayed); monitor for infection (due to leukopenia) or bleeding (due to thrombocytopenia); withhold treatment for abnormally significant drop in blood counts. Patients with genetic enzyme deficiency of thiopurine methyltransferase (TPMT) or who are receiving drugs which inhibit this enzyme (eg, mesalazine, olsalazine, sulfasalazine) may be highly sensitive to myelosuppressive effects and may require substantial dose reductions.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F226885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     5-ASA Derivatives: May decrease the metabolism of Thiopurine Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F226887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10329862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have demonstrated adverse effects. There are no adequate and well-controlled studies in pregnant women. May cause fetal harm if administered during pregnancy. Women of childbearing potential should avoid becoming pregnant during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1050254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential and platelet count, liver function tests (serum transaminases, alkaline phosphatase, bilirubin), hemoglobin, hematocrit, serum uric acid; testing for thiopurine methyltransferase (TPMT) deficiency is available; clinical signs of portal hypertension or hepatic sinusoidal obstruction syndrome (SOS; veno-occlusive disease)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1050244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Purine analog that is incorporated into DNA and RNA resulting in the inhibition of synthesis and utilization of purine nucleotides",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1050262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: 30% (range: 14% to 46%), variable and incomplete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Does not reach therapeutic concentrations in the CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Rapid and extensive hepatic metabolism by thiopurine methyltransferase (TPMT) to 2-amino-6-methylthioguanine (MTG; active) and inactive compounds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, terminal: 5-9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Metabolites excreted in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1050252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/33/3605?source=see_link\">",
"      see \"Thioguanine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maintain adequate hydration, unless otherwise instructed to restrict fluid intake. May cause nausea, vomiting, loss of appetite, weakness or lethargy, or mouth sores; increased susceptibility to infection; report signs or symptoms of infection (eg, fever, chills, sore throat, burning urination, fatigue); bleeding or easy bruising; dark urine, light-colored stool, or yellowing of skin or eyes; unresolved mouth sores, nausea, or vomiting; weight gain; or swelling of abdomen. Discontinue thioguanine immediately if jaundice occurs. Women of childbearing potential should be advised to avoid becoming pregnant.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1050264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Myelosuppressive effects:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     WBC: Moderate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Platelets: Moderate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset (days): 7-10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Nadir (days): 14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Recovery (days): 21",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Myelosuppressive effects may be delayed; continuation of treatment should be evaluated at first sign of decreased hematologic parameter.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F226895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent: Use appropriate precautions for handling and disposal.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 20 mg/mL oral suspension may be made with tablets, methylcellulose 1%, and simple syrup NF. Crush fifteen 40 mg tablets in a mortar and reduce to a fine powder. Add 10 mL methylcellulose 1% in incremental proportions and mix to a uniform paste. Transfer to a graduated cylinder, rinse mortar with simple syrup, and add quantity of simple syrup sufficient to make 30 mL. Label \"shake well\" and \"refrigerate\". Stable for 84 days refrigerated (preferred) or at room temperature.",
"    </p>",
"    <div class=\"reference\">",
"     Dressman JB and Poust RI, &ldquo;Stability of Allopurinol and Five Antineoplastics in Suspension,&rdquo;",
"     <i>",
"      Am J Hosp Pharm",
"     </i>",
"     , 1983, 40(4):616-8.",
"     <span class=\"pubmed-id\">",
"      6846371",
"     </span>",
"    </div>",
"    <div class=\"reference\">",
"     Nahata MC, Pai VB, and Hipple TF,",
"     <i>",
"      Pediatric Drug Formulations",
"     </i>",
"     , 5th ed, Cincinnati, OH: Harvey Whitney Books Co, 2004.",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians, 2007, 173.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Broxson EH, Dole M, Wong R, et al, &ldquo;Portal Hypertension Develops in a Subset of Children With Standard Risk Acute Lymphoblastic Leukemia Treated With Oral 6-Thioguanine During Maintenance Therapy,&rdquo;",
"      <i>",
"       Pediatr Blood Cancer",
"      </i>",
"      , 2005, 44(3):226-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/15503293 /pubmed\" id=\"15503293 \" target=\"_blank\">",
"        15503293",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Culbert SJ, Shuster JJ, Land VJ, et al, &ldquo;Remission Induction and Continuation Therapy in Children With Their First Relapse of Acute Lymphoid Leukemia: A Pediatric Oncology Group Study,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 1991, 67(1):37-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/1985721/pubmed\" id=\"1985721\" target=\"_blank\">",
"        1985721",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lange BJ, Bostrom BC, Cherlow JM, et al, \"Double-Delayed Intensification Improves Event-Free Survival for Children With Intermediate-Risk Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2002, 99(3):825-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/11806983/pubmed\" id=\"11806983\" target=\"_blank\">",
"        11806983",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nachman JB, Sather HN, Sensel MG, et al, \"Augmented Post-Induction Therapy for Children With High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(23):1663-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/9614257/pubmed\" id=\"9614257\" target=\"_blank\">",
"        9614257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steuber CP, Civin C, Krischer J, et al, &ldquo;A Comparison of Induction and Maintenance Therapy for Acute Nonlymphocytic Leukemia in Childhood: Results of a Pediatric Oncology Group Study,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1991, 9(2):247-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/1988573 /pubmed\" id=\"1988573 \" target=\"_blank\">",
"        1988573",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stork LC, Matloub Y, Broxson E, et al, \"Oral 6-Mercaptopurine Versus Oral 6-Thioguanine and Veno-occlusive Disease in Children With Standard-Risk Acute Lymphoblastic Leukemia: Report of the Children's Oncology Group CCG-1952 Clinical Trial,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2010, 115(14):2740-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/20124218/pubmed\" id=\"20124218\" target=\"_blank\">",
"        20124218",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vora A, Mitchell CD, Lennard L, et al, \"Toxicity and Efficacy of 6-Thioguanine Versus 6-Mercaptopurine in Childhood Lymphoblastic Leukaemia: A Randomised Trial,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2006, 368(9544):1339-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/51/35637/abstract-text/17046466/pubmed\" id=\"17046466\" target=\"_blank\">",
"        17046466",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12835 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-E13A3EE944-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35637=[""].join("\n");
var outline_f34_51_35637=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226912\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226913\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050255\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050247\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226891\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226876\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050259\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050250\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050258\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F853383\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226954\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050263\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050246\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050245\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300132\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226885\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226887\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10329862\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050254\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050244\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050262\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050252\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050264\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226895\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12835\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12835|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/54/35685?source=related_link\">",
"      Thioguanine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/33/3605?source=related_link\">",
"      Thioguanine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35638="Physiology of cholecystokinin";
var content_f34_51_35638=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physiology of cholecystokinin",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35638/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35638/contributors\">",
"     Rodger A Liddle, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35638/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35638/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35638/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35638/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/51/35638/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholecystokinin (CCK) is the major hormone responsible for gallbladder contraction and pancreatic enzyme secretion. CCK, like other gastrointestinal hormones, is produced in discrete endocrine cells that line the mucosa of the small intestine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/1\">",
"     1",
"    </a>",
"    ]. It is also found in the central nervous system and peripheral nerves innervating the intestine. In these locations, CCK probably functions as a neurotransmitter.",
"   </p>",
"   <p>",
"    The original discovery of CCK in 1928 was based upon the observation that a substance within intestinal extracts stimulated gallbladder contraction in dogs (hence the name cholecystokinin). In 1943, a similar extract (which has been called pancreozymin) was noted to stimulate pancreatic enzyme secretion. However, purification of the hormone and determination of its amino acid sequence showed that the actions on the gallbladder and pancreas were due to the same hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advances in protein biochemistry, molecular biology, and the development of specific CCK receptor antagonists have increased our understanding of the physiologic and potential pathophysiologic actions of CCK. In humans, physiologic properties of CCK include the ability to stimulate gallbladder contraction, increase pancreatic enzyme secretion, delay gastric emptying, potentiate insulin secretion, and regulate food intake (",
"    <a class=\"graphic graphic_table graphicRef68930 \" href=\"mobipreview.htm?1/2/1067\">",
"     table 1",
"    </a>",
"    ). In addition, CCK regulates bowel motility and has growth promoting effects on the pancreas in certain animals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MOLECULAR FORMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of molecular forms of cholecystokinin (CCK) have been identified in brain, intestine, and blood of experimental animals and humans. The original form of CCK purified was a tritriacontapeptide (CCK-33) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/5\">",
"     5",
"    </a>",
"    ]. CCK is produced from a single gene, and different molecular forms are the result of posttranslational processing. Molecular forms ranging in size from 4 to 83 amino acids have been identified in tissue and blood with the predominant molecular form being CCK-58, and less commonly CCK-8 and CCK-33. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22660?source=see_link\">",
"     \"Synthesis, secretion, and regulation of gastrointestinal peptides\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CCK possesses a five amino acid sequence at the carboxyl terminus that is identical to that of gastrin (",
"    <a class=\"graphic graphic_figure graphicRef55890 \" href=\"mobipreview.htm?3/34/3631\">",
"     figure 1",
"    </a>",
"    ). The carboxyl terminus confers the biologic activity of CCK; as a result, gastrin has weak CCK-like activity and CCK has weak gastrin-like activity. The amino acid sequence similarity has also made assays for CCK difficult, since antibodies specific for the biologically active end of the molecule often crossreact with gastrin, which circulates in the blood at concentrations 10 to 100 times greater than that of CCK [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25751?source=see_link\">",
"     \"Physiology of gastrin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DISTRIBUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholecystokinin (CCK)-containing cells are concentrated in the proximal small intestine and decrease in number toward the distal jejunum and ileum. CCK cells originate from stem cells in the intestinal crypts and migrate up the villus, where the apical surface is exposed to intestinal contents. CCK cells possess basal processes that extend to other cells in the mucosa and submucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/7\">",
"     7",
"    </a>",
"    ]. It is possible that through this mechanism CCK cells communicate with neighboring cells to exert paracrine actions.",
"   </p>",
"   <p>",
"    CCK is a member of the family of \"brain-gut\" peptides in which the same transmitter is found in the intestine and central nervous system. Although CCK is found in neurons throughout the brain, it is most highly concentrated in the cerebral cortex. CCK has been colocalized in neurons containing dopamine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/8\">",
"     8",
"    </a>",
"    ]. These neurons project to the limbic forebrain and ventromedial hypothalamus, which may be important for regulating food intake. It has been suggested that CCK has an important role in the regulation of satiety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CCK is also abundant in peripheral nerves of the gastrointestinal tract, which innervate the colon, ileum, and myenteric and submucosal plexus, and in the celiac plexus and vagus nerve. Although the exact physiologic actions of CCK in the nervous system are unknown, it most likely functions as a neurotransmitter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CCK RECEPTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Receptors for cholecystokinin (CCK) within the gastrointestinal tract have been identified in the pancreas, gallbladder, stomach, lower esophageal sphincter, ileum, and colon. CCK receptors are also abundant in brain and on some peripheral nerves.",
"   </p>",
"   <p>",
"    Two types of CCK receptors have been identified based upon receptor binding characteristics: CCK1 receptors (formerly known as CCK-A receptors) and CCK2 receptors (formerly known as CCK-B receptors). These receptors arise from separate genes but are both G-protein coupled, seven membrane-spanning proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/49/22293?source=see_link\">",
"     \"Peptide hormone signal transduction and regulation\"",
"    </a>",
"    .) The CCK2 receptor is identical to the gastrin receptor and is present in the stomach and brain. Thus, the receptor is often referred to as the",
"    <span class=\"nowrap\">",
"     CCK2/gastrin",
"    </span>",
"    receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The development of antagonists to the two CCK receptors has been useful for defining the biologic actions of CCK. Four types of CCK receptor antagonists have been used in pharmacologic and physiologic studies. These include cyclic nucleotide analogues (eg, dibutyryl cGMP), amino acid derivatives (eg, loxiglumide [CR-1409]), carboxyl terminal CCK analogues, and substituted benzodiazepines (eg, devazepide). CCK receptor antagonists inhibit CCK- and meal-stimulated gallbladder contraction and have effects on gastric emptying and satiety.",
"   </p>",
"   <p>",
"    In addition to the study of receptor function using pharmacologic interventions, a number of animal models lacking CCK receptors have been studied. In a rat strain in which the CCK1 receptor is disrupted, animals develop hyperglycemia, hyperinsulinemia and obesity, suggesting that normal CCK action is important for these metabolic processes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/12\">",
"     12",
"    </a>",
"    ]. In other studies, cloning of the CCK1 and 2 receptors has made it possible to delete these genes in experimental animals. CCK1 receptor deficient mice appear to maintain normal body weight, although satiety responses to exogenous CCK are impaired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/9\">",
"     9",
"    </a>",
"    ]. Deletion of the CCK2 (gastrin) receptor in mice resulted in decreased gastric acid production, elevated plasma gastrin levels, and reduced numbers of parietal and ECL cells in the stomach, indicating the importance of the CCK2 receptor in maintaining gastric morphology and acid secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     REGULATION OF SECRETION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with most gastrointestinal hormones, cholecystokinin (CCK) is secreted in response to ingestion of a meal, after which plasma concentrations increase approximately five- to ten-fold. Postprandial levels remain elevated for three to five hours while food empties from the stomach into the upper small intestine. The primary stimulants of CCK release are ingested fat and protein; carbohydrates have a less potent effect on secretion.",
"   </p>",
"   <p>",
"    The release of CCK is controlled by negative feedback regulation. This concept arose from studies demonstrating that inactivation or removal of proteolytic activity from the small intestine of rodents resulted in increased pancreatic exocrine secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/14\">",
"     14",
"    </a>",
"    ]. Similar findings have been made in other species, including humans, whereby pancreatic secretion is controlled in part by the presence or absence of pancreatic enzymes (eg, trypsin) in the intestine (",
"    <a class=\"graphic graphic_figure graphicRef80014 \" href=\"mobipreview.htm?7/14/7393\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This observation led to the discovery in animals of intestinal releasing factors that are secreted into the intestine and stimulate CCK secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. These releasing factors are inactivated by pancreatic enzymes in the intestine. However, they are able to stimulate CCK secretion when pancreatic secretion is reduced or with ingestion of a meal that temporarily binds trypsin and other digestive enzymes. Whether these releasing factors are present in humans remains unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     BIOLOGIC ACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholecystokinin (CCK) is the primary hormone responsible for gallbladder contraction. Coincident with stimulating gallbladder contraction, CCK also relaxes the sphincter of Oddi, which facilitates bile secretion into the intestine. Although CCK is a potent stimulant of pancreatic secretion in most species, the predominant CCK receptor type in the pancreas in humans is CCK2, which has a much higher affinity for gastrin than for CCK. As a result, CCK may have a limited role as a pancreatic secretagogue in humans. On the other hand, CCK receptors are present on the vagus nerve and appear to mediate the effects of CCK on pancreatic secretion by causing the release of acetylcholine locally in the pancreas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastric emptying is delayed by CCK, which may be one mechanism by which CCK can reduce food intake and induce satiety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/3\">",
"     3",
"    </a>",
"    ]. The effects of CCK on the stomach appear to occur with physiologic postprandial blood levels of the hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/20\">",
"     20",
"    </a>",
"    ]. Since CCK levels increase after ingestion of a meal, its effects on gallbladder contraction, pancreatic secretion, and gastric emptying serve to coordinate many digestive processes. Thus, CCK is a key regulator of the ingestion and digestion of a meal.",
"   </p>",
"   <p>",
"    CCK acts on vagal afferent nerve fibers and sends signals to the dorsal hindbrain to terminate meal size and increasing the intermeal interval [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/21\">",
"     21",
"    </a>",
"    ]. Administration of CCK antagonists to animals and humans increases food intake by increasing meal size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/22\">",
"     22",
"    </a>",
"    ]. Continuous administration of CCK to animals reduces food intake but this effect is lost after 24 hours. However, a long-acting CCK analog resistant to enzyme degradation produced sustained food reduction in non-human primates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large clinical trial was conducted evaluating the ability of an orally active CCK analog, GI191771X, to induce weight loss over a 24-week period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/24\">",
"     24",
"    </a>",
"    ]. Drug- and placebo-treated subjects were restricted to hypocaloric diets. Both drug- and placebo-treated subjects lost weight, but a greater weight loss was not observed in drug-treated subjects. Although the authors concluded that CCK does not have a role in long-term energy balance, this trial did not test the appetite suppressing effects of the CCK analog [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/25\">",
"     25",
"    </a>",
"    ]. Therefore, it remains to be determined if there is a therapeutic role for CCK agonists in the regulation of human food intake.",
"   </p>",
"   <p>",
"    CCK also increases transient lower esophageal sphincter relaxations (tLESRs), an effect mediated through the CCK1 receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/26\">",
"     26",
"    </a>",
"    ]. It remains uncertain whether CCK-stimulated tLESRs is hormonal or occurs through CCK neurons.",
"   </p>",
"   <p>",
"    Receptors for CCK have been identified on a number of tumors, including gastrointestinal, gallbladder, and lung cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. However, the effect of CCK on cancer growth is unknown.",
"   </p>",
"   <p>",
"    CCK enhances pain perception in models of inflammatory and neuropathic pain, although it is generally agreed that CCK does not cause pain under normal conditions. Through its ability to facilitate nociception CCK has \"anti-opioid\" properties. These effects occur through direct actions on specific peripheral neural pathways or neural centers such as the rostral ventromedial medulla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL USES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholecystokinin (CCK) has a number of roles in clinical medicine, most of which currently involve diagnostic testing. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Radiographic examinations of the gallbladder",
"     </li>",
"     <li>",
"      Measurement of pancreatic exocrine secretion",
"     </li>",
"     <li>",
"      Stimulation of bile and pancreatic juice for collection for cytology or other testing",
"     </li>",
"     <li>",
"      Sphincter of Oddi manometry (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/36/12874?source=see_link\">",
"       \"Clinical manifestations and diagnosis of sphincter of Oddi dysfunction\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapeutic uses of CCK are limited. In patients who are unable to eat (eg, parental alimentation), CCK injections can stimulate gallbladder contraction and reduce gallbladder sludge and gallstone formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Due to CCK's ability to reduce food intake and produce weight loss in animals, small molecule CCK agonists are currently being developed for treatment of obesity.",
"   </p>",
"   <p>",
"    Peptide hormones are being developed as radiopharmaceuticals to treat certain tumors. Radiolabeled",
"    <span class=\"nowrap\">",
"     cholecystokinin/gastrin",
"    </span>",
"    analogs are under investigation for treating small cell lung cancers, ovarian and colon cancers, and some gastroenteropancreatic cancers that express the CCK2 receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of studies in humans suggest a potential role for CCK receptor antagonists. However no drug is currently approved for clinical use:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Selective CCK1 receptor antagonists increase hunger in humans, indicating that endogenous CCK has a physiologic role in regulating appetite [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In animal models, CCK1 receptor blockade improved survival and reduced the severity of pancreatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/35\">",
"       35",
"      </a>",
"      ]. However, because the human pancreas expresses lower levels of CCK1 receptor mRNA, it is less clear that CCK antagonists will be beneficial in human disease. Nevertheless, preliminary reports suggest that loxiglumide may be clinically useful in the treatment of acute pancreatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The ability of a CCK receptor antagonist to increase appetite lends itself to the treatment of anorexia nervosa or anorexia associated with cancer or other diseases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antagonists selective for the CCK2 receptor (gastrin antagonists) appear to have potent anxiolytic activity and may be useful for treatment of anxiety or panic attacks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Gastrin antagonists have been shown to reduce acid secretion in humans and may be useful adjuncts to H2 blockers or",
"      <span class=\"nowrap\">",
"       H/K",
"      </span>",
"      proton pump inhibitors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/38\">",
"       38",
"      </a>",
"      ]. Trophic effects (such as occur on ECL cells) of hypergastrinemia would not occur with gastrin receptor blockade.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL ASSOCIATIONS",
"    </span>",
"   </p>",
"   <p>",
"    There are no known diseases of cholecystokinin (CCK) excess. Abnormally low CCK levels have been reported in patients with bulimia nervosa (but not purging alone), celiac disease, and in conditions that delay gastric emptying [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. The pathophysiologic role of CCK in these disorders is unknown.",
"   </p>",
"   <p>",
"    Genetic polymorphisms or reduced expression of the CCK1 receptor in the gallbladder have been reported in gallstone disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Reduced expression of the CCK1 receptor would be expected to impair the ability of CCK to stimulate gallbladder contraction and lead to bile stasis, which is a known predisposing factor in gallstone formation.",
"   </p>",
"   <p>",
"    Genetic polymorphisms have been found in the promoter region of the CCK1 receptor in some obese individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/44\">",
"     44",
"    </a>",
"    ]. It has been proposed that these polymorphisms alter CCK-induced satiety signals, contributing to abnormal weight control; however, the molecular mechanisms of these polymorphisms remain to be elucidated.",
"   </p>",
"   <p>",
"    Weight loss is associated with a reduction in circulating levels of CCK and other hormones involved in the homeostatic regulation of body weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35638/abstract/45\">",
"     45",
"    </a>",
"    ]. It is possible that these low levels encourage weight regain following weight reduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H130151371\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cholecystokinin (CCK) is a key regulator of the ingestion and digestion of a meal. CCK stimulates gallbladder contraction and relaxes the sphincter of Oddi, thereby facilitating bile secretion into the intestine. By delaying gastric emptying, it can reduce food intake and induce satiety. CCK also acts on vagal afferent nerve fibers and sends signals to the dorsal hindbrain to terminate meal size. CCK may have a limited role as a pancreatic secretagogue. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Biologic actions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CCK is produced from a single gene but different molecular forms result from posttranslational processing. CCK possesses a five amino acid sequence at the carboxyl terminus that is identical to that of gastrin (",
"      <a class=\"graphic graphic_figure graphicRef55890 \" href=\"mobipreview.htm?3/34/3631\">",
"       figure 1",
"      </a>",
"      ). The carboxyl terminus confers the biologic activity of CCK; as a result, gastrin has weak CCK-like activity and CCK has weak gastrin-like activity. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Molecular forms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CCK-containing cells are concentrated in the proximal small intestine and decrease in number toward the distal jejunum and ileum. CCK is highly concentrated in the cerebral cortex and is also found in peripheral nerves of the gastrointestinal tract. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Distribution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The release of CCK is controlled by negative feedback regulation. The primary stimulants of CCK release are ingested fat and protein; carbohydrates have a less potent effect on secretion. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Regulation of secretion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abnormally low CCK levels have been reported in patients with bulimia nervosa, celiac disease, and in conditions that delay gastric emptying. Reduced expression of the CCK1 receptor in the gallbladder has been reported in gallstone disease.",
"      <br/>",
"      <br/>",
"      It has been hypothesized that genetic polymorphisms in the promoter region of the CCK1 receptor as noted in patients with obesity may alter CCK-induced satiety signals, and contribute to abnormal weight control. Weight loss is associated with a reduction in circulating levels of CCK and other hormones involved in the homeostatic regulation of body weight. It is possible that these low levels encourage weight regain following weight reduction. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical associations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic uses of CCK include radiographic examinations of the gallbladder, measurement of pancreatic exocrine secretion, stimulation of bile and pancreatic juice for collection for cytology or other testing, and sphincter of Oddi manometry. Therapeutic uses of CCK are in development. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical uses'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/1\">",
"      Polak JM, Bloom SR, Rayford PL, et al. Identification of cholecystokinin-secreting cells. Lancet 1975; 2:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/2\">",
"      Jorpes E, Mutt V. Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand 1966; 66:196.",
"     </a>",
"    </li>",
"    <li>",
"     Mutt V. Secretin and cholecystokinin. In: Gastrointestinal Hormones, Mutt V (Ed), Academic Press, San Diego 1988. p.251.",
"    </li>",
"    <li>",
"     Liddle RA. Cholecystokinin. In: Gut Peptides: Biochemistry and Physiology, Walsh JH, Dockray GJ (Eds), Raven Press, New York 1994. p.175.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/5\">",
"      Mutt V, Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem 1968; 6:156.",
"     </a>",
"    </li>",
"    <li>",
"     Rehfeld JF. Cholecystokinin. In: Handbook of Physiology: The Gastrointestinal System, Vol II. Neural and Endocrine Biology, Makhlouf GM (Ed), Oxford University Press, New York 1989. p.337.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/7\">",
"      Chandra R, Samsa LA, Vigna SR, Liddle RA. Pseudopod-like basal cell processes in intestinal cholecystokinin cells. Cell Tissue Res 2010; 341:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/8\">",
"      Meyer DK, Protopapas Z. Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatum. Ann N Y Acad Sci 1985; 448:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/9\">",
"      Kopin AS, Mathes WF, McBride EW, et al. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 1999; 103:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/10\">",
"      Wank SA, Harkins R, Jensen RT, et al. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci U S A 1992; 89:3125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/11\">",
"      Kopin AS, Lee YM, McBride EW, et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci U S A 1992; 89:3605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/12\">",
"      Takiguchi S, Takata Y, Funakoshi A, et al. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 1997; 197:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/13\">",
"      Langhans N, Rindi G, Chiu M, et al. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 1997; 112:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/14\">",
"      Green GM, Lyman RL. Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats. Proc Soc Exp Biol Med 1972; 140:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/15\">",
"      Owyang C, Louie DS, Tatum D. Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 1986; 77:2042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/16\">",
"      Spannagel AW, Green GM, Guan D, et al. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci U S A 1996; 93:4415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/17\">",
"      Herzig KH, Sch&ouml;n I, Tatemoto K, et al. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc Natl Acad Sci U S A 1996; 93:7927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/18\">",
"      Liddle RA. Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol 1995; 269:G319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/19\">",
"      Owyang C, Logsdon CD. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology 2004; 127:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/20\">",
"      Liddle RA, Morita ET, Conrad CK, Williams JA. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986; 77:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/21\">",
"      Sayegh AI. The role of cholecystokinin receptors in the short-term control of food intake. Prog Mol Biol Transl Sci 2013; 114:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/22\">",
"      Moran TH, Ameglio PJ, Peyton HJ, et al. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol 1993; 265:R620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/23\">",
"      Moran TH, Sawyer TK, Seeb DH, et al. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue. Am J Clin Nutr 1992; 55:286S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/24\">",
"      Jordan J, Greenway FL, Leiter LA, et al. Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients. Clin Pharmacol Ther 2008; 83:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/25\">",
"      Roses AD. Stimulation of cholecystokinin-A receptors with Gl181771X: a failed clinical trial that did not test the pharmacogenetic hypothesis for reduction of food intake. Clin Pharmacol Ther 2009; 85:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/26\">",
"      Zerbib F, Bruley Des Varannes S, Scarpignato C, et al. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol 1998; 275:G1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/27\">",
"      Smith JP, Solomon TE, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 1990; 35:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/28\">",
"      Staley J, Jensen RT, Moody TW. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells. Peptides 1990; 11:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/29\">",
"      Rai R, Tewari M, Kumar M, et al. Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease. Hepatobiliary Pancreat Dis Int 2011; 10:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/30\">",
"      Heinricher MM, Neubert MJ. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J Neurophysiol 2004; 92:1982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/31\">",
"      Doty JE, Pitt HA, Porter-Fink V, Denbesten L. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg 1985; 201:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/32\">",
"      Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990; 170:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/33\">",
"      Khan IU, Beck-Sickinger AG. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. Anticancer Agents Med Chem 2008; 8:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/34\">",
"      Wolkowitz OM, Gertz B, Weingartner H, et al. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol Psychiatry 1990; 28:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/35\">",
"      Satake K, Kimura K, Saito T. Therapeutic effects of loxiglumide on experimental acute pancreatitis using various models. Digestion 1999; 60 Suppl 1:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/36\">",
"      Ochi K, Harada H, Satake K. Clinical evaluation of cholecystokinin-A- receptor antagonist (loxiglumide) for the treatment of acute pancreatitis. A preliminary clinical trial. Study Group of Loxiglumide in Japan. Digestion 1999; 60 Suppl 1:81.",
"     </a>",
"    </li>",
"    <li>",
"     Wang RY, Ashby CR Jr. actions of CCK in the central nervous system. In: CCK Antagonists in Gastroenterology, Adler G, Beglinger C (Eds), Springer-Verlag, Berlin-Heidelberg 1991. p.44.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/38\">",
"      Beltinger J, Hildebrand P, Drewe J, et al. Effects of spiroglumide, a gastrin receptor antagonist, on acid secretion in humans. Eur J Clin Invest 1999; 29:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/39\">",
"      Geracioti TD Jr, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988; 319:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/40\">",
"      Calam J, Ellis A, Dockray GJ. Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease. J Clin Invest 1982; 69:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/41\">",
"      Keel PK, Wolfe BE, Liddle RA, et al. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. Arch Gen Psychiatry 2007; 64:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/42\">",
"      Srivastava A, Pandey SN, Dixit M, et al. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J Gastroenterol Hepatol 2008; 23:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/43\">",
"      Miller LJ, Holicky EL, Ulrich CD, Wieben ED. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 1995; 109:1375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/44\">",
"      Miyasaka K, Takiguchi S, Funakoshi A. Cholecystokinin 1A receptor polymorphisms. Curr Top Med Chem 2007; 7:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35638/abstract/45\">",
"      Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011; 365:1597.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2558 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-CC23815824-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35638=[""].join("\n");
var outline_f34_51_35638=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H130151371\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MOLECULAR FORMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DISTRIBUTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CCK RECEPTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      REGULATION OF SECRETION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      BIOLOGIC ACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL USES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL ASSOCIATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H130151371\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2558\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2558|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/34/3631\" title=\"figure 1\">",
"      CCK and gastrin homology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/14/7393\" title=\"figure 2\">",
"      CCK releasing factor regulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2558|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/2/1067\" title=\"table 1\">",
"      Actions of cholecystokinin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/36/12874?source=related_link\">",
"      Clinical manifestations and diagnosis of sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/49/22293?source=related_link\">",
"      Peptide hormone signal transduction and regulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25751?source=related_link\">",
"      Physiology of gastrin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22660?source=related_link\">",
"      Synthesis, secretion, and regulation of gastrointestinal peptides",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35639="Stool color card used to screen infants for biliary atresia";
var content_f34_51_35639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stool color card used to screen infants for biliary atresia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 407px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This stool color card is used for early identification of acholic stools in infants in Taiwan. Parents are instructed to compare their infant's stool to the colors on the card during the first 30 days of life, and to inform their health care provider immediately if the stool resembles panels 1, 2, or 3. In a second edition, the labels \"abnormal\" and \"normal\" were omitted.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 2006; 117:1147. Copyright &copy; 2006 by the AAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35639=[""].join("\n");
var outline_f34_51_35639=null;
var title_f34_51_35640="Viral meningitis: Management, prognosis, and prevention in children";
var content_f34_51_35640=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Viral meningitis: Management, prognosis, and prevention in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Cecilia Di Pentima, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35640/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/51/35640/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management, prognosis, and prevention of viral meningitis in children will be discussed here. The epidemiology, pathogenesis, clinical manifestations, diagnosis, and differential diagnosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22809?source=see_link\">",
"     \"Viral meningitis: Epidemiology, pathogenesis, and etiology in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/21/10586?source=see_link\">",
"     \"Viral meningitis: Clinical features and diagnosis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW OF APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral meningitis may be suspected on the basis of epidemiologic data, clinical features, and initial cerebrospinal (CSF) studies, but clinical features cannot reliably differentiate viral from bacterial meningitis; the CSF profiles of bacterial and viral meningitis overlap considerably (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The diagnosis of viral meningitis requires negative CSF culture for routine bacterial pathogens and positive identification of a viral pathogen in the CSF or other patient samples. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/21/10586?source=see_link&amp;anchor=H19#H19\">",
"     \"Viral meningitis: Clinical features and diagnosis in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pending results of CSF cultures and virologic studies, the results of the initial evaluation can be used to make a provisional diagnosis of bacterial meningitis, viral meningitis, or unclear etiology (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"     table 1",
"    </a>",
"    ). The provisional diagnosis is one of several considerations in the initial management.",
"   </p>",
"   <p>",
"    Indications for hospitalization may include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ill-appearance or signs of encephalitis (eg, altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; hemiparesis; flaccid paralysis; paresthesias; seizures). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21769?source=see_link&amp;anchor=H2#H2\">",
"       \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Need for empiric antimicrobial therapy (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Empiric antibiotics'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Need for intravenous hydration or aggressive pain control (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Supportive care'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Immunocompromised host",
"     </li>",
"     <li>",
"      Age younger than one year",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Suspected bacterial meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with positive Gram stain, CSF white blood cell (WBC) count",
"    <span class=\"nowrap\">",
"     &gt;1000/microL",
"    </span>",
"    with a predominance of neutrophils (polymorphonuclear leukocytes, PMN), and CSF glucose concentration &lt;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    are likely to have bacterial meningitis. They should be hospitalized and treated accordingly (",
"    <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"mobipreview.htm?34/44/35521\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Immediate management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Suspected viral meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with CSF WBC count",
"    <span class=\"nowrap\">",
"     &lt;500/microL",
"    </span>",
"    with &gt;50 percent mononuclear cells, CSF protein &lt;80 to 100",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    normal CSF glucose, and negative Gram stain are likely to have viral meningitis (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"     table 1",
"    </a>",
"    ). Epidemiologic and clinical data that support the provisional diagnosis of viral meningitis include associated herpangina, enterovirus disease in the community in the summer or fall, and improvement in clinical illness after lumbar puncture (LP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Decisions regarding empiric antibiotic treatment versus observation of children with suspected viral meningitis while awaiting culture results are made on a case-by-case basis. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Empiric antibiotics'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Unclear etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology is unclear when the clinical and laboratory features of bacterial and viral infections overlap. We suggest that such children be treated with empiric therapy pending additional information (eg, results of culture, PCR, or repeat lumbar puncture). (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Empiric antibiotics'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Repeat LP",
"    </span>",
"    &nbsp;&mdash;&nbsp;When one of the features suggestive of bacterial meningitis is a predominance of neutrophils rather than mononuclear cells in the CSF differential, and assuming that CSF analysis for EV by PCR is negative, observing a patient with or without administration of antimicrobials and repeating the LP 6 to 24 hours after the initial procedure may help clarify the likely etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/4,5,7-9\">",
"     4,5,7-9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A shift to mononuclear predominance supports a viral process.",
"     </li>",
"     <li>",
"      Persistent PMN predominance supports a bacterial process. However, persistence of PMN also occurs with viral meningitis and should not be used as the only criterion to distinguish between bacterial and viral disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUPPORTIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supportive care for children with viral meningitis may include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rest in a quiet, dimly lit room",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/15/19705?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      for headache, pain, and fever;",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      should be avoided because of its association with Reye syndrome",
"     </li>",
"     <li>",
"      Intravenous fluid therapy if prolonged emesis has resulted in hypovolemia. Careful attention to fluid balance is an important aspect of supportive care. The need for fluid repletion must be balanced against the risk of inappropriate secretion of antidiuretic hormone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neonates and immunocompromised hosts may require aggressive supportive care for disseminated disease (eg, myocarditis, pericarditis, hepatitis, coagulopathy), particularly with enterovirus or herpes simplex virus (HSV) infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40713?source=see_link&amp;anchor=H3#H3\">",
"     \"Neonatal herpes simplex virus infection: Management and prevention\", section on 'Supportive measures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EMPIRIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While awaiting the results of bacterial cultures, empiric antimicrobial therapy should be provided to patients in whom bacterial meningitis is suspected or cannot be excluded. Empiric treatment for HSV, tuberculosis, and various other infections also may be warranted in patients who are severely ill or have clinical features suggestive of these infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Empiric antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with suspected bacterial meningitis or meningitis of unclear etiology should be hospitalized and treated with appropriate empiric therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The decision to treat children with suspected viral meningitis with empiric antibiotics while awaiting bacterial cultures is individualized based upon epidemiology and clinical factors. Important considerations include the season, age and clinical status of the child, exposure history, and findings of the initial evaluation. In view of the serious consequences of delayed treatment for bacterial meningitis, the threshold to initiate empiric antibiotic therapy should be relatively low.",
"   </p>",
"   <p>",
"    We recommend empiric antibiotic therapy while awaiting bacterial culture results in the following patients with suspected viral meningitis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those who are younger than three months of age (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/26/28074?source=see_link\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Those who are severely ill or immunocompromised",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Choice of agent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric antibiotics should be chosen to cover the most likely bacterial pathogens in the individual host. In severely ill patients, empiric therapy for unusual bacterial pathogens also may be warranted. Glucocorticoids, when administered initially to children who were ultimately diagnosed with aseptic meningitis, were not shown to produce detectable adverse outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/47/16121?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and outcome of bacterial meningitis in the neonate\", section on 'Empirical therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=see_link&amp;anchor=H15#H15\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric regimen'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/21/4442?source=see_link\">",
"     \"Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who improve symptomatically, empiric antibiotic therapy is usually discontinued when the bacterial culture is negative after 24 to 48 hours",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an alternative diagnosis is made (eg, by viral polymerase chain reaction [PCR]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/3\">",
"     3",
"    </a>",
"    ]. In patients with persistent symptoms, additional evaluation may be necessary. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Persistent symptoms'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Empiric antivirals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the clinical scenario and severity of illness, empiric treatment with antiviral therapy may be warranted for certain patients.",
"   </p>",
"   <p>",
"    We recommend empiric therapy with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    for children with CSF pleocytosis who have encephalitis, or focal findings on examination, imaging, or electroencephalography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/3\">",
"     3",
"    </a>",
"    ]. Acyclovir also may be warranted when HSV is a possible etiology in an immunocompromised patient. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Specific therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As of November 2012, there is a shortage of intravenous (IV)",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/11\">",
"     11",
"    </a>",
"    ]. Alternatives to IV acyclovir during the shortage are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=see_link&amp;anchor=H72507949#H72507949\">",
"     \"Acyclovir: An overview\", section on 'Acyclovir shortage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Decisions regarding the use of empiric",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    in infants with CSF pleocytosis who are younger than 28 days must be made on a case-by-case basis. Clinical features suggestive of HSV infection include mucocutaneous vesicles (",
"    <a class=\"graphic graphic_picture graphicRef75059 graphicRef56041 graphicRef78598 \" href=\"mobipreview.htm?26/55/27513\">",
"     picture 1A-C",
"    </a>",
"    ), seizures, lethargy, respiratory distress, thrombocytopenia, coagulopathy, blood oozing from intravascular catheter sites, hypothermia, sepsis-like illness, hepatomegaly, ascites, or elevated transaminases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/12-15\">",
"     12-15",
"    </a>",
"    ] . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/31/35321?source=see_link&amp;anchor=H4#H4\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Information about the relative prevalence of HSV and bacterial meningitis in neonates with CSF pleocytosis is provided by a retrospective review of 5817 neonates evaluated in the emergency department and admitted to a tertiary-care children's hospital over five years (2001-2005) (",
"    <a class=\"graphic graphic_table graphicRef57037 \" href=\"mobipreview.htm?0/59/956\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The findings are summarized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The overall prevalence of HSV infection was not statistically different than that of bacterial meningitis (0.2 and 0.4 percent, respectively).",
"     </li>",
"     <li>",
"      All 10 patients with confirmed HSV infection had clinical features suggestive of HSV (eg, rash, elevated liver transaminases, sepsis-like picture).",
"     </li>",
"     <li>",
"      In neonates with CSF pleocytosis, predominance of PMNs (&gt;50 percent) in the CSF was associated with bacterial meningitis, but predominance of mononuclear cells (&gt;50 percent) in the CSF was not associated with HSV. Nonetheless, a predominance of PMN in the CSF did not absolutely exclude the possibility of HSV (95% CI 0-5.4).",
"     </li>",
"     <li>",
"      Enteroviral meningitis was more likely than HSV in febrile neonates with CSF pleocytosis (20 cases versus 1 case, respectively, during enteroviral season and six cases versus one case during nonenteroviral season).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As illustrated by the editorials accompanying publication of this review, controversy exists regarding the empiric use of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    in neonates with CSF pleocytosis and no other manifestations suggestive of HSV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. On the one hand, acyclovir is an effective therapy for an uncommon, but potentially devastating, infection that may have a subtle presentation and occurs with approximately the same prevalence as bacterial meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/13,16\">",
"     13,16",
"    </a>",
"    ]. On the other hand, empiric acyclovir therapy may be associated with adverse effects or prolong hospitalization while awaiting results of viral cultures or HSV PCR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/14,17\">",
"     14,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40713?source=see_link&amp;anchor=H4#H4\">",
"     \"Neonatal herpes simplex virus infection: Management and prevention\", section on 'Acyclovir therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who are clinically improved, empiric",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    may be discontinued when HSV PCR and cultures are negative or an alternative diagnosis is made (eg, by enteroviral PCR). Viral isolates usually grow in tissue culture by four to eight days. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40265?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/31/35321?source=see_link&amp;anchor=H11#H11\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Evaluation and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with persistent symptoms, continuation of empiric",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    additional evaluation may be necessary. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Persistent symptoms'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SPECIFIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of viral meningitis are treated symptomatically. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Supportive care'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Selected antiviral agents have been tried against some of the viral pathogens.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enteroviruses &ndash; The treatment of EV infection is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41383?source=see_link&amp;anchor=H41570045#H41570045\">",
"       \"Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Herpesviruses &ndash; Although the outcome of HSV meningitis without encephalitis is usually excellent even without antiviral therapy,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"       acyclovir",
"      </a>",
"      can be used to hasten recovery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/3,18\">",
"       3,18",
"      </a>",
"      ]. Acyclovir is dosed as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For neonatal HSV, 60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day intravenously (IV) in three divided doses for 21 days (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40713?source=see_link&amp;anchor=H4#H4\">",
"       \"Neonatal herpes simplex virus infection: Management and prevention\", section on 'Acyclovir therapy'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For CNS infections in children aged 3 months to 11 years, 60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV, in three divided doses for a minimum of 14 to 21 days",
"     </li>",
"     <li>",
"      For CNS infections in children &ge;12 years old, 30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV, in three divided doses for a minimum of 14 to 21 days",
"      <br/>",
"      <br/>",
"      As of November 2012, there is a shortage of IV",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"       acyclovir",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/11\">",
"       11",
"      </a>",
"      ]. Alternatives to IV acyclovir during the shortage are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=see_link&amp;anchor=H72507949#H72507949\">",
"       \"Acyclovir: An overview\", section on 'Acyclovir shortage'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Treatment of meningitis associated with acute EBV infection is supportive. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=see_link&amp;anchor=H26#H26\">",
"       \"Clinical manifestations and treatment of Epstein-Barr virus infection\", section on 'Treatment and prevention'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Treatment of symptomatic CMV infection in children is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36664?source=see_link&amp;anchor=H19#H19\">",
"       \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arboviruses and LCMV &ndash; Most arboviral and LCMV infections of the CNS are treated symptomatically. Investigative therapies for WNV are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=see_link\">",
"       \"Arthropod-borne encephalitides\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/10/33958?source=see_link\">",
"       \"Treatment and prevention of West Nile virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Influenza &ndash; The treatment of influenza virus infections is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26746?source=see_link&amp;anchor=H20#H20\">",
"       \"Antiviral drugs for the prevention and treatment of seasonal influenza in children\", section on 'Antiviral therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PERSISTENT SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;When symptoms persist or worsen in patients with bacterial culture-negative aseptic meningitis, nonviral causes must be considered (",
"    <a class=\"graphic graphic_table graphicRef80651 \" href=\"mobipreview.htm?35/24/36237\">",
"     table 3",
"    </a>",
"    ). Additional evaluation may include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/5,19\">",
"     5,19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Repeat lumbar puncture with removal of 3 to 5 mL of CSF (if possible) for fungal and mycobacterial cultures.",
"     </li>",
"     <li>",
"      Imaging of the CNS and sinuses with MRI or CT to look for parameningeal infection and acute disseminated encephalomyelitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=see_link\">",
"       \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation for Lyme disease, ehrlichiosis, rickettsial infection. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/48/28425?source=see_link\">",
"       \"Diagnosis of Lyme disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/5/6234?source=see_link\">",
"       \"Human ehrlichiosis and anaplasmosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/51/14135?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation for parasitic infection. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/36/28232?source=see_link\">",
"       \"Clinical manifestations and diagnosis of cysticercosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15207?source=see_link\">",
"       \"Trichinellosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=see_link\">",
"       \"Toxoplasmosis in immunocompetent hosts\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with viral meningitis recover completely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/1,20,21\">",
"     1,20,21",
"    </a>",
"    ]. Some patients complain of fatigue, irritability, decreased concentration, muscle weakness and spasm, and incoordination for several weeks after the acute illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prognosis depends upon the age of the child and the etiologic agent. Enteroviral meningitis typically has a benign clinical course, which by definition lacks the neurologic abnormalities that characterize encephalitis or myelitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/22\">",
"     22",
"    </a>",
"    ]. The morbidity and mortality are not precisely known, as widespread disease occurs each year, and EV meningitis is not a reportable condition. For particularly susceptible neonatal or immune-compromised hosts, the rates of sequelae and mortality may be as high as 74 and 10 percent, respectively. When death occurs, it is usually due to hepatic failure (with echoviruses) or myocarditis (coxsackieviruses) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The duration of symptoms in children is usually less than one week; many report clinical improvement after lumbar puncture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/6,22\">",
"     6,22",
"    </a>",
"    ]. Adolescents and adults may have a prolonged convalescent stage, with symptoms persisting for several weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with EV meningitis generally recover without neurologic sequelae. Several studies have suggested possible long-term neurologic, cognitive, developmental, and language abnormalities in young children following EV meningitis; however, these observations have been inconsistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/21,26-28\">",
"     21,26-28",
"    </a>",
"    ]. EV71 CNS infection with cardiopulmonary involvement has been associated with neurologic sequelae, including delayed development and reduced cognitive function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The immune clearance of EV is dependent upon an appropriate antibody-mediated response. Individuals with hereditary or acquired defects in B lymphocyte function (eg, agammaglobulinemia, hypogammaglobulinemia, common variable immunodeficiency) may develop persistent, sometimes fatal, chronic meningitis or meningoencephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34585?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Infections in immunocompromised patients'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sequelae of Western equine encephalitis (WEE) viral infection are mainly associated with encephalitis. These include fatigue, irritability, headaches, and tremors that can last up to two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/31\">",
"     31",
"    </a>",
"    ]. The overall case fatality rate is 3 to 4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/31\">",
"     31",
"    </a>",
"    ]. Neonates and young infants are more severely affected. More than 50 percent of neonates develop severe motor damage or cognitive disabilities following WEE virus CNS infections. Older patients with meningitis have a good prognosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=see_link&amp;anchor=H11#H11\">",
"     \"Arthropod-borne encephalitides\", section on 'Western equine encephalitis virus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment for muscular weakness should be performed several weeks after the symptoms of viral meningitis have improved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/20,29,32\">",
"     20,29,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Long-term follow-up of young infants should include regular developmental surveillance, particularly during the early school years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/9,20,29\">",
"     9,20,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H18501566#H18501566\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'When to perform developmental-behavioral screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simple hygienic measures, such as hand washing, particularly after diaper changing, are important to prevent the spread of enteroviruses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41383?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Vaccines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccines are available to prevent poliovirus, influenza, rabies, and some arboviruses (eg, Japanese encephalitis virus, Tick-borne encephalitis). Target groups for these vaccines are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/52/17223?source=see_link\">",
"     \"Poliovirus vaccination\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2394?source=see_link\">",
"     \"Immunizations for travel\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/18/27946?source=see_link&amp;anchor=H7#H7\">",
"     \"Seasonal influenza vaccination in children\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Personal protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Personal protection measures to avoid mosquito and tick exposure are a mainstay of prevention. A variety of insect repellants are available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Infection control",
"    </span>",
"    &nbsp;&mdash;&nbsp;When children are hospitalized with aseptic meningitis, contact precautions are indicated for the duration of illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35640/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19658?source=see_link&amp;anchor=H11#H11\">",
"     \"General principles of infection control\", section on 'Contact precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/43/3763?source=see_link\">",
"       \"Patient information: Meningitis in children (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/34/28194?source=see_link\">",
"       \"Patient information: Viral meningitis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/35/16946?source=see_link\">",
"       \"Patient information: Aseptic meningitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/48/1796?source=see_link\">",
"       \"Patient information: Meningitis in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pending results of CSF cultures and virologic studies, the results of the initial evaluation can be used to make a provisional diagnosis of bacterial meningitis, viral meningitis, or unclear etiology (",
"      <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"       table 1",
"      </a>",
"      ). The provisional diagnosis is one of several considerations in the initial management. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview of approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While awaiting the results of bacterial cultures, empiric antimicrobial therapy for bacterial meningitis should be provided to patients in whom bacterial meningitis is suspected or cannot be excluded. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Empiric therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The decision to treat children with suspected viral meningitis with empiric antibiotics while awaiting bacterial cultures is individualized based on epidemiology and clinical factors. We recommend empiric antibiotic therapy while awaiting bacterial culture results in children who are younger than three months of age, severely ill, or immunocompromised (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Empiric antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children with suspected viral meningitis who improve symptomatically, empiric antibiotic therapy is usually discontinued when the bacterial culture is negative after 24 to 48 hours",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an alternative diagnosis is made. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend empiric therapy with",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"       acyclovir",
"      </a>",
"      for children with CSF pleocytosis who have encephalitis or focal findings on examination, imaging, or electroencephalography (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Empiric antivirals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who improve symptomatically, empiric",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/38/34400?source=see_link\">",
"       acyclovir",
"      </a>",
"      may be discontinued when HSV PCR and cultures are negative",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an alternative diagnosis is made (eg, by enteroviral PCR). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Empiric antivirals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When symptoms persist or worsen, nonviral causes of aseptic meningitis must be considered (",
"      <a class=\"graphic graphic_table graphicRef80651 \" href=\"mobipreview.htm?35/24/36237\">",
"       table 3",
"      </a>",
"      ). Additional evaluation may be necessary (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Persistent symptoms'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Follow-up of children with aseptic meningitis includes assessment for muscular weakness and developmental abnormalities. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/1\">",
"      Logan SA, MacMahon E. Viral meningitis. BMJ 2008; 336:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/2\">",
"      Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000; 105:316.",
"     </a>",
"    </li>",
"    <li>",
"     Abzug MJ. Viral meningitis and encephalitis. In: Current Pediatric Therapy, 18th, Burg FD, Ingelfinger JR, Polin RA, Gershon AA (Eds), Saunders, Philadelphia 2006. p.810.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/4\">",
"      Singer JI, Maur PR, Riley JP, Smith PB. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 1980; 96:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/5\">",
"      Overall JC Jr. Is it bacterial or viral? Laboratory differentiation. Pediatr Rev 1993; 14:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/6\">",
"      Jaffe M, Srugo I, Tirosh E, et al. The ameliorating effect of lumbar puncture in viral meningitis. Am J Dis Child 1989; 143:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/7\">",
"      Feigin RD, Shackelford PG. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med 1973; 289:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/8\">",
"      Amir J, Harel L, Frydman M, et al. Shift of cerebrospinal polymorphonuclear cell percentage in the early stage of aseptic meningitis. J Pediatr 1991; 119:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/9\">",
"      Wilfert CM, Lehrman SN, Katz SL. Enteroviruses and meningitis. Pediatr Infect Dis 1983; 2:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/10\">",
"      Waagner DC, Kennedy WA, Hoyt MJ, McCracken GH Jr. Lack of adverse effects of dexamethasone therapy in aseptic meningitis. Pediatr Infect Dis J 1990; 9:922.",
"     </a>",
"    </li>",
"    <li>",
"     Current Drug Shortages. US Food and Drug Administration. www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm (Accessed on November 28, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/12\">",
"      Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/13\">",
"      Long SS. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008; 153:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/14\">",
"      Kimberlin DW. When should you initiate acyclovir therapy in a neonate? J Pediatr 2008; 153:155.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Herpes simplex. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.398.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/16\">",
"      Long SS, Pool TE, Vodzak J, et al. Herpes simplex virus infection in young infants during 2 decades of empiric acyclovir therapy. Pediatr Infect Dis J 2011; 30:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/17\">",
"      Shah SS, Volk J, Mohamad Z, et al. Herpes simplex virus testing and hospital length of stay in neonates and young infants. J Pediatr 2010; 156:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/18\">",
"      Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998; 26:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/19\">",
"      Malcom BS, Eiden JJ, Hendley JO. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics 1980; 65:725.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Bronstein DE. Aseptic meningitis and viral meningitis. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.494.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/21\">",
"      Rorabaugh ML, Berlin LE, Heldrich F, et al. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 1993; 92:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/22\">",
"      Rotbart HA. Viral meningitis. Semin Neurol 2000; 20:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/23\">",
"      Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/24\">",
"      Modlin JF. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 1986; 8:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/25\">",
"      Sawyer MH. Enterovirus infections: diagnosis and treatment. Semin Pediatr Infect Dis 2002; 13:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/26\">",
"      Wilfert CM, Thompson RJ Jr, Sunder TR, et al. Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics 1981; 67:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/27\">",
"      Sells CJ, Carpenter RL, Ray CG. Sequelae of central-nervous-system enterovirus infections. N Engl J Med 1975; 293:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/28\">",
"      Bergman I, Painter MJ, Wald ER, et al. Outcome in children with enteroviral meningitis during the first year of life. J Pediatr 1987; 110:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/29\">",
"      Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007; 356:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/30\">",
"      McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987; 9:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/31\">",
"      Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994; 7:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35640/abstract/32\">",
"      Bao X, Wong V. Brainstem auditory-evoked potential evaluation in children with meningitis. Pediatr Neurol 1998; 19:109.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Enterovirus (nonpoliovirus) and parechovirus infections (group A and B coxsackieviruses, echoviruses, numbered enteroviruses, and human parechoviruses). In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.315.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6028 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-189.2.19.178-DF24B1B659-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35640=[""].join("\n");
var outline_f34_51_35640=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW OF APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Suspected bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Suspected viral meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Unclear etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Repeat LP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUPPORTIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EMPIRIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Empiric antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Choice of agent",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Empiric antivirals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Duration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SPECIFIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PERSISTENT SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Vaccines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Personal protection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6028\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6028|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?34/44/35521\" title=\"algorithm 1\">",
"      Management of suspected meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6028|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/3/4159\" title=\"picture 1A\">",
"      Neonatal HSV neck vesicles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/29/39382\" title=\"picture 1B\">",
"      Neonatal HSV scalp vesicles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/44/28367\" title=\"picture 1C\">",
"      Neonatal HSV eye vesicles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6028|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/55/14204\" title=\"table 1\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/59/956\" title=\"table 2\">",
"      Prevalence of HSV vs bacterial meningitis in neonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/24/36237\" title=\"table 3\">",
"      Etiology aseptic meningitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=related_link\">",
"      Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21769?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/60/10183?source=related_link\">",
"      Acyclovir: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26746?source=related_link\">",
"      Antiviral drugs for the prevention and treatment of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=related_link\">",
"      Arthropod-borne encephalitides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/51/14135?source=related_link\">",
"      Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/36/28232?source=related_link\">",
"      Clinical manifestations and diagnosis of cysticercosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/55/14202?source=related_link\">",
"      Clinical manifestations and treatment of Epstein-Barr virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36664?source=related_link\">",
"      Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=related_link\">",
"      Developmental-behavioral surveillance and screening in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/21/4442?source=related_link\">",
"      Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/48/28425?source=related_link\">",
"      Diagnosis of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41383?source=related_link\">",
"      Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/5/6234?source=related_link\">",
"      Human ehrlichiosis and anaplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2394?source=related_link\">",
"      Immunizations for travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40713?source=related_link\">",
"      Neonatal herpes simplex virus infection: Management and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/35/16946?source=related_link\">",
"      Patient information: Aseptic meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/48/1796?source=related_link\">",
"      Patient information: Meningitis in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/43/3763?source=related_link\">",
"      Patient information: Meningitis in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/34/28194?source=related_link\">",
"      Patient information: Viral meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/52/17223?source=related_link\">",
"      Poliovirus vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=related_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=related_link\">",
"      Rabies immune globulin and vaccine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/18/27946?source=related_link\">",
"      Seasonal influenza vaccination in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=related_link\">",
"      Toxoplasmosis in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/47/16121?source=related_link\">",
"      Treatment and outcome of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/10/33958?source=related_link\">",
"      Treatment and prevention of West Nile virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15207?source=related_link\">",
"      Trichinellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/21/10586?source=related_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22809?source=related_link\">",
"      Viral meningitis: Epidemiology, pathogenesis, and etiology in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35641="Uncommon causes of congenital adrenal hyperplasia";
var content_f34_51_35641=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Uncommon causes of congenital adrenal hyperplasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     Andre Lacroix, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     John L Kirkland, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/51/35641/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/51/35641/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital adrenal hyperplasia refers to several disorders characterized by various genetic defects in the enzymes involved in cortisol biosynthesis (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"mobipreview.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ). The decrease in cortisol production stimulates the release of corticotropin (ACTH). The clinical manifestations of the different disorders are due to diminished production of cortisol and, depending upon the site of block, decreased or increased production of mineralocorticoids and androgens. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/46/28391?source=see_link\">",
"     \"Adrenal steroid biosynthesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review the clinical characteristics of several rare forms of congenital adrenal hyperplasia: CYP17 (17-alpha-hydroxylase) deficiency, 3-beta-hydroxysteroid dehydrogenase deficiency, lipoid adrenal hyperplasia and CYP11A1 (side-chain-cleavage enzyme) deficiency, as well as 11-beta-hydroxysteroid dehydrogenase type 1 (apparent cortisone reductase) deficiency and familial glucocorticoid resistance. The nomenclature for the different adrenal enzymes is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef55287 \" href=\"mobipreview.htm?19/20/19787\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CYP17 DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of 17-alpha-hydroxylase activity is a rare form of congenital adrenal hyperplasia. Only about 120 cases have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], but the prevalence may be higher, particularly in Brazil, where founder effects account for over 80 percent of mutant alleles caused by only two mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disorder was first described in a 35-year-old woman with sexual infantilism and hypertension with low urinary cortisol metabolites, low urinary pregnanetriol, and high levels of urinary metabolites of corticosterone and deoxycorticosterone (DOC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/5\">",
"     5",
"    </a>",
"    ]. It can also cause male pseudohermaphroditism&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef76865 \" href=\"mobipreview.htm?39/0/39949\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Clinical presentation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CYP17 gene encodes an enzyme that has both 17-hydroxylase and 17,20-lyase (desmolase, or side-chain cleavage) activities (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"mobipreview.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ). The hydroxylation of C17 of progesterone is required for cortisol production as well as for synthesis of androgens and estrogens. Lyase activity is required for synthesis of androgens and their derivatives, the estrogenic C18 steroids. Although CYP17 has both activities in vitro, human CYP17 deficiency syndromes have been observed in which patients apparently lack only 17-hydroxylase deficiency or only 17,20-lyase deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Most patients, however, have a combined defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     17-hydroxylase defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduction of cortisol production by the 17-hydroxylase defect results in increased ACTH secretion and, therefore, increased production of 11-deoxysteroids, including corticosterone, and the mineralocorticoids 11-deoxycorticosterone and 18-hydroxy-deoxycorticosterone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Thus, one consequence of 17-alpha-hydroxylase deficiency is mineralocorticoid excess. The ensuing volume expansion inhibits renin release and therefore the synthesis of aldosterone (",
"    <a class=\"graphic graphic_table graphicRef76865 \" href=\"mobipreview.htm?39/0/39949\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     17,20-lyase defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduction of androgen production by impairment of 17,20-lyase activity leads to combined androgen and estrogen deficiency because only androgens can be aromatized to form estrogens. CYP17 is also expressed in the gonads, so that gonadal steroidogenesis is also decreased in patients with this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;CYP17 deficiency, like other forms of congenital adrenal hyperplasia, appears to be inherited as an autosomal recessive trait. Several reported patients were offspring of consanguineous marriages, and obligate heterozygotes have mild defects in CYP17 activity that can be revealed by ACTH stimulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/9,13,14\">",
"     9,13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nearly 40 different mutations in the CYP17 gene, which is located on chromosome 10, have been defined at the molecular level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/4\">",
"     4",
"    </a>",
"    ]. These include small insertions that disrupt the normal reading frame of the gene and lead to premature termination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], deletions of single codons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/17\">",
"     17",
"    </a>",
"    ], deletions of several codons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/18\">",
"     18",
"    </a>",
"    ], large deletions with insertions of foreign DNA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/19\">",
"     19",
"    </a>",
"    ], and a variety of nonsense or missense mutations of CYP17 that produce stop codons, impair CYP17 enzyme activity, or alter splice sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/20-28\">",
"     20-28",
"    </a>",
"    ]. Two mutations have been described in splice acceptor sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There may be factors other than the CYP17 genotype that determine the phenotype of individuals with CYP17 deficiency. In a study of 24 patients from 19 families in Brazil, the majority (20 of 24) had one of two mutations (both of which were completely inactive in vitro) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/4\">",
"     4",
"    </a>",
"    ]. However, for patients with the same mutation, the phenotype was sometimes variable. As an example, of three XY patients with an R362C mutation, one presented at birth with ambiguous genitalia, a second had female external genitalia and normokalemia, and a third had the classical presentation (hypertension, hypokalemia, and pubertal delay).",
"   </p>",
"   <p>",
"    A rare variant, apparent combined CYP21A2 and CYP17 deficiency, has been described in both boys and girls and appears to be due to mutations in the gene encoding P450 oxidoreductase, not the CYP17 and CYP21A2 genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11034?source=see_link\">",
"     \"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CYP17 deficiency usually present at about the time of expected puberty because of hypertension, hypokalemia, and hypogonadism. Most patients with CYP17 deficiency are hypertensive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/5,32,33\">",
"     5,32,33",
"    </a>",
"    ], but 10 to 15 percent are normotensive at the time of diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/3\">",
"     3",
"    </a>",
"    ]. Some also have hypokalemia, but it is rarely symptomatic. There may or may not be adrenal insufficiency, depending upon the degree of the cortisol secretory defect. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/1/37911?source=see_link\">",
"     \"Clinical features of primary aldosteronism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Female patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Female (46,XX) patients have primary amenorrhea and absent secondary sexual characteristics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Male patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Male (46,XY) patients usually have complete male pseudohermaphroditism, with female external genitalia, a blind vagina, no uterus or fallopian tubes, and intraabdominal testes. Affected males have usually been raised as girls, with the underlying disorder being recognized only when the patients are evaluated for lack of pubertal development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum concentrations of progesterone, the substrate for CYP17, are increased in CYP17 deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/34\">",
"     34",
"    </a>",
"    ]. On the other hand, there are reduced concentrations of hormones dependent upon 17-hydroxylase (cortisol, 11-deoxycortisol and 17-alpha-hydroxyprogesterone) and 17,20-lyase (dehydroepiandrosterone [DHEA], dehydroepiandrosterone sulfate [DHEA sulfate], androstenedione, testosterone and estradiol) (",
"    <a class=\"graphic graphic_figure graphicRef73682 \" href=\"mobipreview.htm?4/52/4942\">",
"     figure 2",
"    </a>",
"    ). Because very little androgen or estrogen is produced, serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) concentrations are elevated.",
"   </p>",
"   <p>",
"    Mineralocorticoids, on the other hand, can be synthesized in the absence of CYP17 activity. As a result of the increase in ACTH secretion, increased substrate flux along the mineralocorticoid pathway results in increased production and serum concentrations of 11-deoxycorticosterone and corticosterone. As noted above, serum aldosterone concentrations are generally low due to suppression of renin release, although some subjects have been noted to have elevated aldosterone levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/13,35\">",
"     13,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is based on providing glucocorticoid in doses sufficient to decrease ACTH secretion and therefore the production of 11-deoxycorticosterone to normal, while avoiding glucocorticoid excess. Suppression of the renin-angiotensin-aldosterone axis can be reversed by glucocorticoid administration in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/12\">",
"     12",
"    </a>",
"    ], but persists for years despite glucocorticoid therapy in others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients are reared as females, regardless of genotypic sex. At the time of diagnosis in pubertal-age patients, or the expected time of puberty in patients diagnosed earlier, estrogen therapy should be given, with progesterone in genotypic females but not in genotypic males who do not have a uterus. An alternative for males is androgen therapy combined with extensive reconstructive surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;3-Beta-hydroxysteroid dehydrogenase deficiency is a rare form of congenital adrenal hyperplasia in which synthesis of all steroid hormones is impaired (",
"    <a class=\"graphic graphic_table graphicRef76865 \" href=\"mobipreview.htm?39/0/39949\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;3-Beta-hydroxysteroid dehydrogenase (HSD3B2) catalyzes the rearrangement of the double bond in ring A of steroids and conversion of a hydroxyl group at the 3 position to a keto group. Deficiency of this enzyme results in decreased synthesis of cortisol, aldosterone, androgens, and estrogens. Cortisol deficiency leads to increased ACTH secretion and, therefore, accumulation of excessive amounts of steroid precursors with the delta-5, 3-hydroxy configuration (eg, delta-5-pregnenolone, 17-alpha-hydroxypregnenolone, DHEA and DHEA sulfate) (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"mobipreview.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decreased enzyme activity in this disorder is caused by mutations in the 3-beta-hydroxysteroid dehydrogenase II gene. In patients with the severe, salt-wasting form, nonsense mutations introducing stop codons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/37\">",
"     37",
"    </a>",
"    ], insertion and deletion mutations causing frameshifts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/37-39\">",
"     37-39",
"    </a>",
"    ], and point mutations that alter enzyme function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/40-44\">",
"     40-44",
"    </a>",
"    ] have all been described. On the other hand, all patients without salt-wasting have had missense mutations causing single amino acid substitutions that reduced the affinity of the enzyme for substrates or cofactors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/44-48\">",
"     44-48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 3-beta-hydroxysteroid dehydrogenase type I gene, which is normally expressed in placenta and peripheral tissues, is intact in these patients, providing an explanation for the nearly normal or even elevated serum concentrations of delta-4 steroids (such as 17-alpha-hydroxyprogesterone and androstenedione) in many patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/49\">",
"     49",
"    </a>",
"    ]. The substrates for the peripheral enzyme (delta-5-pregnenolone, 17-alpha-hydroxypregnenolone and DHEA sulfate) are increased because of the defect in the type II enzyme in steroidogenic tissues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients present as neonates or in early infancy with clinical manifestations of both cortisol and aldosterone deficiency, with feeding difficulties, vomiting, volume depletion, hyponatremia, and hyperkalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Females may have mild virilization of their external genitalia, presumably due to excess DHEA, a little of which is converted peripherally to testosterone.",
"   </p>",
"   <p>",
"    Males have varying degrees of failure of normal genital development, ranging from hypospadias to male pseudohermaphroditism with nearly normal female external genitalia. However, 3-beta-hydroxysteroid dehydrogenase deficiency is not a common finding in patients who present with apparent idiopathic hypospadias. In one study, only 2 of 90 boys with hypospadias had evidence of subtle molecular abnormalities in the 3-beta-hydroxysteroid dehydrogenase gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rare patients with severe 3-beta-hydroxysteroid dehydrogenase deficiency have few symptoms and may not be diagnosed until they seek care for delayed puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Premature pubarche with exaggerated serum 17-alpha-hydroxypregnenolone responses to ACTH has been described in three girls with missense mutations of the gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A late-onset or",
"    <strong>",
"     nonclassic",
"    </strong>",
"    form of 3-beta-hydroxysteroid dehydrogenase deficiency that causes hirsutism, menstrual irregularity, or both in adolescent or young adult women has also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. The basis for the diagnosis was exaggerated serum delta-5-pregnenolone responses to ACTH, but the validity of these results has been questioned [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary abnormalities are greatly increased ratios of delta-5 to delta-4 steroids in serum or urine, eg, a high ratio of delta-5-pregnenolone to progesterone in serum or a high ratio of pregnanetriol to pregnanediol in urine. Serum DHEA and DHEA sulfate concentrations tend to be high, and those of androstenedione are low. As noted above, some patients have serum 17-alpha-hydroxyprogesterone concentrations that are normal or elevated. By contrast, the hormonal responses to ACTH as well as the ratio of delta-5 to delta-4 steroids in serum were similar in healthy volunteers and known genotype-proven carriers of a HSD3B2 mutation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    New hormonal criteria based upon genotype have been proposed for the diagnosis of 3-beta-hydroxysteroid dehydrogenase deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/60\">",
"     60",
"    </a>",
"    ]. In this study of 55 adolescent and adult patients whose phenotype was consistent with 3-beta-hydroxysteroid dehydrogenase deficiency, 15 genotypically normal women had ACTH-stimulated serum delta-5-pregnenolone concentrations as high as 5000",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (150",
"    <span class=\"nowrap\">",
"     nmol/L).",
"    </span>",
"    Based upon these results, as well as those from a similar study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/61\">",
"     61",
"    </a>",
"    ], most women previously considered to have a late-onset or",
"    <strong>",
"     nonclassic",
"    </strong>",
"    form of 3-beta-hydroxysteroid dehydrogenase deficiency would in fact",
"    <strong>",
"     not",
"    </strong>",
"    have that disorder.",
"   </p>",
"   <p>",
"    The diagnosis of 3-beta-hydroxysteroid dehydrogenase deficiency should include a standard",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/20/24902?source=see_link\">",
"     ACTH stimulation test",
"    </a>",
"    . Responses vary with age. The authors of the study noted above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/60\">",
"     60",
"    </a>",
"    ] have proposed the following diagnostic criteria based upon peak ACTH-stimulated serum concentrations of delta-5-17-hydroxypregnenolone (in patients with genetically proven 3-beta-hydroxysteroid dehydrogenase deficiency):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neonates &ge;12,600",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (378",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Tanner stage I children &ge;5490",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (165",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Children with premature pubarche &ge;9790",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (294",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Adults &ge;9620",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (289",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24905?source=see_link&amp;anchor=H21#H21\">",
"       \"Evaluation of the response to ACTH in adrenal insufficiency\", section on 'Congenital adrenal hyperplasia'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy is directed at replacing the deficient hormones, which may include cortisol, aldosterone and, at the time of puberty, estrogen or androgen. The goals are provide replacement doses of glucocorticoid and mineralocorticoid and to avoid overtreatment with its risks of growth failure and Cushing's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/16/7433?source=see_link\">",
"     \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     CONGENITAL LIPOID ADRENAL HYPERPLASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital lipoid adrenal hyperplasia is the rarest and usually the most severe form of adrenal steroidogenic defect (",
"    <a class=\"graphic graphic_table graphicRef76865 \" href=\"mobipreview.htm?39/0/39949\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pathophysiology and genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital lipoid adrenal hyperplasia is characterized by deficiency of all adrenal and gonadal steroid hormones, increased ACTH secretion, and marked adrenal hyperplasia with progressive accumulation of cholesterol esters. It is transmitted as an autosomal recessive trait. It had been thought that the defect in this disorder would reside in the CYP11A1 (side chain cleavage) gene. However, CYP11A1 is required for biosynthesis of progesterone, and placental progesterone synthesis is required to maintain pregnancy. Therefore, complete CYP11A1 deficiency was thought to be lethal, and no homozygous mutation has been identified in any patient with congenital lipoid adrenal hyperplasia (see below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. Subsequently, two patients with congenital lipoid adrenal hyperplasia have been shown to have heterozygous mutations of CYP11A1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. One had apparent haploinsufficiency of CYP11A1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64\">",
"     64",
"    </a>",
"    ] and the other was a compound heterozygote with partial inactivation of the gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The defect in the majority of patients with in congenital lipoid adrenal hyperplasia resides in a gene on chromosome 8 that codes for a protein called the steroidogenic acute regulatory protein (StAR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. StAR is a mitochondrial phosphoprotein that mediates the acute response to steroidogenic stimuli by increasing cholesterol transport from the outer to the inner mitochondrial membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/66,68-70\">",
"     66,68-70",
"    </a>",
"    ]. StAR is expressed in the adrenal cortex and gonads but not in the placenta, and placental synthesis of progesterone, which requires CYP11A1, is unaffected in congenital lipoid adrenal hyperplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of StAR has been studied by sequencing the gene in patients with congenital lipoid adrenal hyperplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/67,71-74\">",
"     67,71-74",
"    </a>",
"    ]. More than 35 different mutations have been described; the mutated StAR proteins were inactive in functional assays. Most of the mutations reduce activity of the lipid transfer domain of the StAR protein. Steroidogenic cells that lacked StAR were initially capable of low levels of steroidogenesis; this explains why some steroid hormones may be secreted until after puberty. The authors concluded that the congenital lipoid adrenal hyperplasia phenotype is the result of two separate events:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An initial defect in steroidogenesis due to the StAR mutation",
"     </li>",
"     <li>",
"      A subsequent further defect in steroidogenesis due to cellular damage from accumulated cholesterol esters",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The \"two hit\" hypothesis is supported by data from a girl with a homozygous StAR mutation who underwent spontaneous puberty at age 13 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In mice in which both the StAR and apolipoprotein A-I genes have been knocked out, the lipid deposits are composed mostly of HDL-derived cholesterol esters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/76\">",
"     76",
"    </a>",
"    ]. The mitochondrial structure of StAR knockout mice is less abnormal than that of CYP11A1 knockout mice, perhaps because CYP11A1 plays an important role in determining the morphology of steroidogenic mitochondria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A patient with male pseudohermaphroditism and adrenal insufficiency who was phenotypically similar to patients with StAR deficiency had a mutation of the SF-1 gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with congenital lipoid hyperplasia caused by StAR mutations typically have severe adrenal insufficiency very soon after birth, although they occasionally present later in infancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/78\">",
"     78",
"    </a>",
"    ] with vomiting, diarrhea, volume depletion, hyponatremia, and hyperkalemia. Male infants usually have female external genitalia due to lack of testicular androgen production. In comparison, female infants are normally developed at birth and occasional patients undergo spontaneous puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A possible explanation for the relative sparing of ovarian steroid synthesis may be the dormancy of the ovary until puberty, thereby preventing the excess cholesterol accumulation that damages the adrenal glands and testes. The same explanation may account for the detectable, if very low, serum aldosterone concentrations with high plasma renin activity in these patients; the adrenocortical cells destined to become glomerulosa cells are minimally stimulated in utero [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This condition should be considered in a neonate with any symptoms or signs of adrenal insufficiency and (in genotypic males) pseudohermaphroditism. The diagnosis is confirmed by the absence of demonstrable steroid biosynthetic activity by either the adrenals or the gonads.",
"   </p>",
"   <p>",
"    The two patients with CYP11A1 deficiency presented with adrenal insufficiency at a later age and did not have enlarged adrenal glands. One was incompletely virilized at birth with an XY karyotype and low levels of all measured steroids when diagnosed at age four years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64\">",
"     64",
"    </a>",
"    ]. The other patient, with an XX karyotype, presented with adrenal insufficiency at age nine months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with congenital lipoid adrenal hyperplasia have very low serum cortisol and aldosterone concentrations and very high plasma ACTH concentrations and plasma renin activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64,77,80\">",
"     64,77,80",
"    </a>",
"    ]. Production of gonadal steroids is also impaired, and serum gonadotropin concentrations are high (for age) in children as young as 4.5 years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital lipoid adrenal hyperplasia has proved fatal in infancy in two-thirds of reported patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/80\">",
"     80",
"    </a>",
"    ], but some patients survive to go through puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/75,81\">",
"     75,81",
"    </a>",
"    ]. Glucocorticoid and mineralocorticoid deficiency has been managed by replacement therapy in a few cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/80\">",
"     80",
"    </a>",
"    ]. For reasons that are not clear, serum ACTH concentrations and plasma renin activity may remain elevated during treatment with supraphysiologic doses of glucocorticoid and mineralocorticoid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CYP11A1 (P450SCC, SIDE-CHAIN-CLEAVAGE ENZYME) DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;This very rare disorder has been reported in only three patients. All had adrenal insufficiency, but there were important differences from the usual presentation of congenital lipoid adrenal hyperplasia. One XY patient presented with complete sex reversal and severe adrenal insufficiency at birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/82\">",
"     82",
"    </a>",
"    ]. No adrenal glands were visualized by ultrasound at two years of age. Adrenal insufficiency occurred later, at nine months and at four years, in two other patients. One patient had male pseudohermaphroditism, but the adrenal glands were not enlarged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pathophysiology and genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;CYP11A1 catalyzes the conversion of cholesterol to pregnenolone in mitochondria in steroidogenic cells. Theoretically, complete deficiency of the enzyme should be lethal because of placental insufficiency, as described above. However, one patient with homozygous disruption of CYP11A1 and a resultant predicted non-functional protein was born prematurely with adrenal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/82\">",
"     82",
"    </a>",
"    ]. The other two patients had heterozygous mutations. The female patient had both a mutation resulting in a single amino acid substitution and an alternate splice mutation causing a 61-nucleotide deletion, both of which partially inactivated CYP11A1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/65\">",
"     65",
"    </a>",
"    ]. One patient with male pseudohermaphroditism had a heterozygous CYP11A1 mutation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64\">",
"     64",
"    </a>",
"    ]. The mutation did not exert a dominant negative effect, so haploinsufficiency appears to be sufficient to cause the syndrome.",
"   </p>",
"   <p>",
"    The \"two hit\" hypothesis is likely to account for this syndrome also. The greater steroidogenic capacity of patients with partial CYP11A1 deficiency than of most patients with StAR mutations would result in slower adrenal damage from accumulated cholesterol esters and a lesser increase in adrenal size.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Clinical presentation and laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female infant with a heterozygous mutation of CYP11A1 had hyperpigmentation at birth that subsequently increased until she was seven months old, when she had a very high plasma ACTH concentration. At nine months of age, she had normal serum concentrations of all adrenal and gonadal steroids and gonadotropins, but plasma ACTH concentrations and plasma renin activity were increased, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    replacement therapy was started [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/65\">",
"     65",
"    </a>",
"    ]. Neither heterozygote parent had adrenal insufficiency or sexual dysfunction. The patient with male pseudohermaphroditism developed hyperpigmentation and severe adrenal insufficiency at four years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid and mineralocorticoid deficiency is treated by replacement therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     HEXOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY (APPARENT CORTISONE REDUCTASE DEFICIENCY)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This rare disorder is not a true congenital adrenal hyperplasia (ie, it does not involve a defect in cortisol biosynthesis), but it is associated with adrenal hyperplasia and changes in cortisol metabolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Pathophysiology and genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;11-Beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) is expressed in tissues such as liver, adipose tissue, brain, and adrenal gland, in which it regulates local availability of glucocorticoid. Six women and one boy have been reported who appear to have deficient expression of this enzyme [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/83-87\">",
"     83-87",
"    </a>",
"    ]. However, no mutation in the coding regions of the gene was found, suggesting either that the defect lies outside the coding region or that some other abnormality results in inhibition of the function of the enzyme. The disorder may result from either an autosomal recessive or an acquired defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/83\">",
"     83",
"    </a>",
"    ]. Additional studies in four patients demonstrated a triallelic digenic pattern of inheritance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/73\">",
"     73",
"    </a>",
"    ]. Each affected individual was homozygous or heterozygous for two mutations in intron 3 of the HSD11B1 gene; the other introns, exons and 1.5 kb of the promoter region were normal. In vitro, transcriptional activation of constructs containing these mutations was 2.5 times lower than that of wild type constructs. However, since 25 percent of unaffected individuals were heterozygotic for these mutations, and 3 percent were homozygous, this mutation alone does not explain the cortisone reductase deficiency. Each of the affected individuals, but none of the unaffected individuals, also had a mutation in exon 5 of the hexose-6-phosphate dehydrogenase (H6PDH) gene. Since HSD11B1 requires NADPH for activity, and H6PDH generates NADPH, it is likely that the combination of mutations led to cortisone reductase deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with this disorder present as adolescent or adult women with truncal obesity, facial plethora, oligomenorrhea, hirsutism, infertility",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acne. One patient had a successful pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/83\">",
"     83",
"    </a>",
"    ]. A six-year-old boy presented with gonadotropin-independent precocious puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/85\">",
"     85",
"    </a>",
"    ]. The adrenal glands are diffusely enlarged on CT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with deficiency in this enzyme have normal serum cortisol concentrations, high serum adrenal androgen (testosterone, androstenedione, and DHEA) concentrations, very high urinary excretion of 5-beta-reduced cortisone metabolites (tetrahydrocortisone and cortolones), and very low urinary excretion of cortisol metabolites (tetrahydrocortisol and cortols), especially the 5-alpha-reduced metabolites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/83\">",
"     83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9240?source=see_link\">",
"     \"Metabolism of adrenal steroids\"",
"    </a>",
"    .) Conversion of orally administered cortisone to cortisol is impaired. Adrenal steroidogenesis is suppressed normally by administration of low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    (0.5 mg every six hours for 48 hours).",
"   </p>",
"   <p>",
"    The mechanism for the altered relative activities of 5-alpha-reductase and 5-beta-reductase is unclear. It is possible that the disorder could be caused by an increase in 5-beta-reductase activity alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/51/35641/abstract/87\">",
"     87",
"    </a>",
"    ], but this would not explain the defect in conversion of cortisone to cortisol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific therapy has been recommended. However,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    administration (0.5 mg at bedtime) may be useful in suppressing adrenal androgen secretion and ameliorating the hirsutism, acne, and menstrual abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/16/7433?source=see_link\">",
"     \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     FAMILIAL GLUCOCORTICOID RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial glucocorticoid resistance is a rare syndrome that is not a true congenital adrenal hyperplasia, but is associated with adrenal hyperplasia and clinical features similar to those of CYP11B1 (11-beta-hydroxylase) deficiency. This disorder is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12408?source=see_link&amp;anchor=H12#H12\">",
"     \"Unusual causes of adrenal insufficiency\", section on 'Familial glucocorticoid resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H173529295\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;21-hydroxylase deficiency is the most frequent cause of congenital adrenal hyperplasia (CAH), but several less common causes of CAH exist and are reviewed here:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       CYP17",
"      </strong>",
"      <strong>",
"       deficiency &ndash;",
"      </strong>",
"      CYP has both 17-hydroxylase and 17,20-lyase activities and its mutations can cause either or both deficiencies. 17-hydroxylase deficiency causes moderate cortisol deficiency and accumulation of mineralocorticoid precursors with hypertension, hypokalemia, and renin suppression (low aldosterone levels), which usually is diagnosed at the time of puberty. The 17,20-lyase defect results in adrenal and gonadal androgen and estrogen deficiency as it is expressed both in gonads and adrenal cortex. Female patients have primary amenorrhea and absent secondary sexual characteristics. Males have complete male pseudohermaphroditism; the majority of patients with CYP17 deficiency are reared as females regardless of genotypic sex. More than 40 mutations in the CYP17 gene, located on chromosome 10, have been defined at the molecular level. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'CYP17 deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       3-Beta-hydroxysteroid dehydrogenase (HSD3B2)",
"      </strong>",
"      deficiency results in decreased synthesis of cortisol, aldosterone, androgens, and estrogens. Cortisol deficiency and increased ACTH secretion causes accumulation of excessive steroid precursors pregnenolone, 17-alpha-hydroxypregnenolone, DHEA and DHEA sulfate. Most patients present as neonates or in early infancy with cortisol and aldosterone deficiency, volume depletion, hyponatremia, and hyperkalemia. Females may have mild virilization of their external genitalia. Males have varying degrees of genital development failure, ranging from hypospadias to male pseudohermaphroditism. (See",
"      <a class=\"local\" href=\"#H12\">",
"       '3-Beta-hydroxysteroid dehydrogenase deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Congenital lipoid adrenal hyperplasia",
"      </strong>",
"      is the rarest type of CAH and can result from heterozygous mutations of",
"      <strong>",
"       CYP11A1 (side chain cleavage enzyme)",
"      </strong>",
"      or more frequently from mutations of the",
"      <strong>",
"       steroidogenic acute regulatory protein (StAR)",
"      </strong>",
"      which increases cholesterol transport from the outer to the inner mitochondrial membrane; StAR is expressed in the adrenal cortex and gonads. Patients typically have severe combined adrenal insufficiency soon after birth, or occasionally later in infancy. Male infants usually have female external genitalia due to lack of testicular androgen production. Female infants are normally developed at birth and occasional patients undergo spontaneous puberty. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Congenital lipoid adrenal hyperplasia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Hexose-6-phosphate-dehydrogenase deficiency",
"      </strong>",
"      (apparent cortisone reductase deficiency) is a rare disorder which is not a true CAH, but it is associated with adrenal hyperplasia and changes in cortisol metabolism. Patients with this disorder present with diffuse adrenal hyperplasia as adolescent or adult women with truncal obesity, facial plethora, oligomenorrhea, hirsutism, infertility",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      acne. They have normal serum cortisol concentrations, high serum adrenal androgens, high urinary excretion of 5-beta-reduced cortisone metabolites (tetrahydrocortisone and cortolones), and very low urinary excretion of cortisol metabolites. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Hexose-6-phosphate-dehydrogenase deficiency (apparent cortisone reductase deficiency)'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/1\">",
"      Yanase T, Simpson ER, Waterman MR. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 1991; 12:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/2\">",
"      Biglieri EG. 17 alpha-Hydroxylase deficiency: 1963-1966. J Clin Endocrinol Metab 1997; 82:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/3\">",
"      Kater CE, Biglieri EG. Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol Metab Clin North Am 1994; 23:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/4\">",
"      Costa-Santos M, Kater CE, Auchus RJ, Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 2004; 89:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/5\">",
"      Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man. J Clin Invest 1966; 45:1946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/6\">",
"      New MI. Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest 1970; 49:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/7\">",
"      Zachmann M, V&ouml;llmin JA, Hamilton W, Prader A. Steroid 17,20-desmolase deficiency: a new cause of male pseudohermaphroditism. Clin Endocrinol (Oxf) 1972; 1:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/8\">",
"      Zachmann M, Werder EA, Prader A. Two types of male pseudohermaphroditism due to 17, 20-desmolase deficiency. J Clin Endocrinol Metab 1982; 55:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/9\">",
"      Winter JS, Couch RM, Muller J, et al. Combined 17-hydroxylase and 17,20-desmolase deficiencies: evidence for synthesis of a defective cytochrome P450c17. J Clin Endocrinol Metab 1989; 68:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/10\">",
"      Kater CE, Biglieri EG, Brust N, et al. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome. J Clin Endocrinol Metab 1982; 55:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/11\">",
"      Griffing GT, Wilson TE, Holbrook MM, et al. Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome. J Clin Endocrinol Metab 1984; 59:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/12\">",
"      Rovner DR, Conn JW, Cohen EL, et al. 17 alpha-Hydroxylase deficiency. A combination of hydroxylation defect and reversible blockade in aldosterone biosynthesis. Acta Endocrinol (Copenh) 1979; 90:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/13\">",
"      D'Armiento M, Reda G, Kater C, et al. 17 alpha-hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family. J Clin Endocrinol Metab 1983; 56:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/14\">",
"      Wit JM, van Roermund HP, Oostdijk W, et al. Heterozygotes for 17 alpha-hydroxylase deficiency can be detected with a short ACTH test. Clin Endocrinol (Oxf) 1988; 28:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/15\">",
"      Kagimoto M, Winter JS, Kagimoto K, et al. Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency. Mol Endocrinol 1988; 2:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/16\">",
"      Yanase T, Sanders D, Shibata A, et al. Combined 17 alpha-hydroxylase/17,20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P45017 alpha (CYP17) gene. J Clin Endocrinol Metab 1990; 70:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/17\">",
"      Yanase T, Kagimoto M, Suzuki S, et al. Deletion of a phenylalanine in the N-terminal region of human cytochrome P-450(17 alpha) results in partial combined 17 alpha-hydroxylase/17,20-lyase deficiency. J Biol Chem 1989; 264:18076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/18\">",
"      Fardella CE, Zhang LH, Mahachoklertwattana P, et al. Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 77:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/19\">",
"      Biason A, Mantero F, Scaroni C, et al. Deletion within the CYP17 gene together with insertion of foreign DNA is the cause of combined complete 17 alpha-hydroxylase/17,20-lyase deficiency in an Italian patient. Mol Endocrinol 1991; 5:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/20\">",
"      Yanase T, Kagimoto M, Matsui N, et al. Combined 17 alpha-hydroxylase/17,20-lyase deficiency due to a stop codon in the N-terminal region of 17 alpha-hydroxylase cytochrome P-450. Mol Cell Endocrinol 1988; 59:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/21\">",
"      Rumsby G, Skinner C, Lee HA, Honour JW. Combined 17 alpha-hydroxylase/17,20-lyase deficiency caused by heterozygous stop codons in the cytochrome P450 17 alpha-hydroxylase gene. Clin Endocrinol (Oxf) 1993; 39:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/22\">",
"      Monno S, Ogawa H, Date T, et al. Mutation of histidine 373 to leucine in cytochrome P450c17 causes 17 alpha-hydroxylase deficiency. J Biol Chem 1993; 268:25811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/23\">",
"      Lin D, Harikrishna JA, Moore CC, et al. Missense mutation serine106----proline causes 17 alpha-hydroxylase deficiency. J Biol Chem 1991; 266:15992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/24\">",
"      Yanase T, Waterman MR, Zachmann M, et al. Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg(496)----Cys, Gln(461)----Stop) actually cause combined 17 alpha-hydroxylase/17,20-lyase deficiency. Biochim Biophys Acta 1992; 1139:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/25\">",
"      Ahlgren R, Yanase T, Simpson ER, et al. Compound heterozygous mutations (Arg 239----stop, Pro 342----Thr) in the CYP17 (P45017 alpha) gene lead to ambiguous external genitalia in a male patient with partial combined 17 alpha-hydroxylase/17,20-lyase deficiency. J Clin Endocrinol Metab 1992; 74:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/26\">",
"      Fardella CE, Hum DW, Homoki J, Miller WL. Point mutation of Arg440 to His in cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 79:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/27\">",
"      Yamaguchi H, Nakazato M, Miyazato M, et al. A 5'-splice site mutation in the cytochrome P450 steroid 17alpha-hydroxylase gene in 17alpha-hydroxylase deficiency. J Clin Endocrinol Metab 1997; 82:1934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/28\">",
"      Brooke AM, Taylor NF, Shepherd JH, et al. A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency. J Clin Endocrinol Metab 2006; 91:2428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/29\">",
"      Costa-Santos M, Kater CE, Dias EP, Auchus RJ. Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells. J Clin Endocrinol Metab 2004; 89:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/30\">",
"      Arlt W, Walker EA, Draper N, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004; 363:2128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/31\">",
"      Fl&uuml;ck CE, Tajima T, Pandey AV, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004; 36:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/32\">",
"      Goldsmith O, Solomon DH, Horton R. Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome. N Engl J Med 1967; 277:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/33\">",
"      Malin, SR. Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency: two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries. Ann Intern Med 1969; 701:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/34\">",
"      Martin RM, Lin CJ, Costa EM, et al. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 2003; 88:5739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/35\">",
"      Miura K, Yasuda K, Yanase T, et al. Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 1996; 81:3797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/36\">",
"      BONGIOVANNI AM, ROOT AW. The adrenogenital syndrome. N Engl J Med 1963; 268:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/37\">",
"      Rh&eacute;aume E, Simard J, Morel Y, et al. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat Genet 1992; 1:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/38\">",
"      Zhang L, Sakkal-Alkaddour H, Chang YT, et al. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996; 81:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/39\">",
"      Simard J, Rh&eacute;aume E, Leblanc JF, et al. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin. Hum Mol Genet 1994; 3:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/40\">",
"      Katsumata N, Tanae A, Yasunaga T, et al. A novel missense mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Hum Mol Genet 1995; 4:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/41\">",
"      Rh&eacute;aume E, Sanchez R, M&eacute;barki F, et al. Identification and characterization of the G15D mutation found in a male patient with 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency: alteration of the putative NAD-binding domain of type II 3 beta-HSD. Biochemistry 1995; 34:2893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/42\">",
"      Sanchez R, M&eacute;barki F, Rh&eacute;aume E, et al. Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Hum Mol Genet 1994; 3:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/43\">",
"      Simard J, Rh&eacute;aume E, Sanchez R, et al. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 1993; 7:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/44\">",
"      Zhang L, Mason JI, Naiki Y, et al. Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder. J Clin Endocrinol Metab 2000; 85:1678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/45\">",
"      Rh&eacute;aume E, Sanchez R, Simard J, et al. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1994; 79:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/46\">",
"      Russell AJ, Wallace AM, Forest MG, et al. Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. J Mol Endocrinol 1994; 12:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/47\">",
"      Sanchez R, Rh&eacute;aume E, Laflamme N, et al. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency. J Clin Endocrinol Metab 1994; 78:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/48\">",
"      Mendon&ccedil;a BB, Russell AJ, Vasconcelos-Leite M, et al. Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol 1994; 12:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/49\">",
"      Cara JF, Moshang T Jr, Bongiovanni AM, Marx BS. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency. N Engl J Med 1985; 313:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/50\">",
"      Simard J, Rheaume E, Mebarki F, et al. Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J Steroid Biochem Mol Biol 1995; 53:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/51\">",
"      Codner E, Okuma C, I&ntilde;iguez G, et al. Molecular study of the 3 beta-hydroxysteroid dehydrogenase gene type II in patients with hypospadias. J Clin Endocrinol Metab 2004; 89:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/52\">",
"      Pang S, Levine LS, Stoner E, et al. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. J Clin Endocrinol Metab 1983; 56:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/53\">",
"      Rosenfield RL, Rich BH, Wolfsdorf JI, et al. Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1980; 51:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/54\">",
"      Marui S, Castro M, Latronico AC, et al. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clin Endocrinol (Oxf) 2000; 52:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/55\">",
"      Lobo RA, Goebelsmann U. Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. J Clin Endocrinol Metab 1981; 53:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/56\">",
"      Pang SY, Lerner AJ, Stoner E, et al. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J Clin Endocrinol Metab 1985; 60:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/57\">",
"      Azziz R, Dewailly D, Owerbach D. Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994; 78:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/58\">",
"      Azziz R, Bradley EL Jr, Potter HD, Boots LR. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am J Obstet Gynecol 1993; 168:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/59\">",
"      Pang S, Carbunaru G, Haider A, et al. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test. Clin Endocrinol (Oxf) 2003; 58:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/60\">",
"      Lutfallah C, Wang W, Mason JI, et al. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 2002; 87:2611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/61\">",
"      Mermejo LM, Elias LL, Marui S, et al. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. J Clin Endocrinol Metab 2005; 90:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/62\">",
"      Sakai Y, Yanase T, Okabe Y, et al. No mutation in cytochrome P450 side chain cleavage in a patient with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 1994; 79:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/63\">",
"      Lin D, Gitelman SE, Saenger P, Miller WL. Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J Clin Invest 1991; 88:1955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/64\">",
"      Tajima T, Fujieda K, Kouda N, et al. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 2001; 86:3820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/65\">",
"      Katsumata N, Ohtake M, Hojo T, et al. Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 2002; 87:3808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/66\">",
"      Sugawara T, Holt JA, Driscoll D, et al. Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci U S A 1995; 92:4778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/67\">",
"      Lin D, Sugawara T, Strauss JF 3rd, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267:1828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/68\">",
"      Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994; 269:28314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/69\">",
"      Stocco DM, Ascoli M. The use of genetic manipulation of MA-10 Leydig tumor cells to demonstrate the role of mitochondrial proteins in the acute regulation of steroidogenesis. Endocrinology 1993; 132:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/70\">",
"      Stocco DM, Sodeman TC. The 30-kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J Biol Chem 1991; 266:19731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/71\">",
"      Bose HS, Sugawara T, Strauss JF 3rd, et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996; 335:1870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/72\">",
"      Katsumata N, Kawada Y, Yamamoto Y, et al. A novel compound heterozygous mutation in the steroidogenic acute regulatory protein gene in a patient with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 1999; 84:3983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/73\">",
"      Gonz&aacute;lez AA, Reyes ML, Carvajal CA, et al. Congenital lipoid adrenal hyperplasia caused by a novel splicing mutation in the gene for the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 2004; 89:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/74\">",
"      Fujieda K, Okuhara K, Abe S, et al. Molecular pathogenesis of lipoid adrenal hyperplasia and adrenal hypoplasia congenita. J Steroid Biochem Mol Biol 2003; 85:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/75\">",
"      Bose HS, Pescovitz OH, Miller WL. Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 1997; 82:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/76\">",
"      Ishii T, Hasegawa T, Pai CI, et al. The roles of circulating high-density lipoproteins and trophic hormones in the phenotype of knockout mice lacking the steroidogenic acute regulatory protein. Mol Endocrinol 2002; 16:2297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/77\">",
"      Achermann JC, Ito M, Ito M, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999; 22:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/78\">",
"      Gassner HL, Toppari J, Quinteiro Gonz&aacute;lez S, Miller WL. Near-miss apparent SIDS from adrenal crisis. J Pediatr 2004; 145:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/79\">",
"      Fujieda K, Tajima T, Nakae J, et al. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest 1997; 99:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/80\">",
"      Hauffa BP, Miller WL, Grumbach MM, et al. Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol (Oxf) 1985; 23:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/81\">",
"      Nakae J, Tajima T, Sugawara T, et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet 1997; 6:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/82\">",
"      Hiort O, Holterhus PM, Werner R, et al. Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab 2005; 90:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/83\">",
"      Jamieson A, Wallace AM, Andrew R, et al. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab 1999; 84:3570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/84\">",
"      Draper N, Walker EA, Bujalska IJ, et al. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 2003; 34:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/85\">",
"      Maunowicz EM, Romer TE, Urban M, Bossowski A. 11beta-hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy. Horm Res 2003; 59:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/86\">",
"      Biason-Lauber A, Suter SL, Shackleton CH, Zachmann M. Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolism. Horm Res 2000; 53:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/51/35641/abstract/87\">",
"      Phillipov G, Palermo M, Shackleton CH. Apparent cortisone reductase deficiency: a unique form of hypercortisolism. J Clin Endocrinol Metab 1996; 81:3855.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 127 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-125.39.66.147-2DA2A50332-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35641=[""].join("\n");
var outline_f34_51_35641=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H173529295\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CYP17 DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - 17-hydroxylase defect",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - 17,20-lyase defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Female patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Male patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      CONGENITAL LIPOID ADRENAL HYPERPLASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pathophysiology and genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CYP11A1 (P450SCC, SIDE-CHAIN-CLEAVAGE ENZYME) DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pathophysiology and genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Clinical presentation and laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      HEXOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY (APPARENT CORTISONE REDUCTASE DEFICIENCY)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Pathophysiology and genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      FAMILIAL GLUCOCORTICOID RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H173529295\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/127\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/127|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/7/123\" title=\"figure 1\">",
"      Adrenal steroid synthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/52/4942\" title=\"figure 2\">",
"      17 alpha hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/127|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/20/19787\" title=\"table 1\">",
"      Steroidogenic enzymes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/0/39949\" title=\"table 2\">",
"      Different forms of CAH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/46/28391?source=related_link\">",
"      Adrenal steroid biosynthesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24905?source=related_link\">",
"      Evaluation of the response to ACTH in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11034?source=related_link\">",
"      Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9240?source=related_link\">",
"      Metabolism of adrenal steroids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/16/7433?source=related_link\">",
"      Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12408?source=related_link\">",
"      Unusual causes of adrenal insufficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_51_35642="CT traumatic SDH";
var content_f34_51_35642=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68102%7ENEURO%2F67573%7ENEURO%2F53951%7ENEURO%2F56200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68102%7ENEURO%2F67573%7ENEURO%2F53951%7ENEURO%2F56200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    TBI subdural hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 424px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGoAXwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACinCN2+6jH6CpjZXQTcbeUKe5QigCvRVyDTLucAxxZz0ywH8zUy6FqT52WrNj+6Qf60AZtFXW0nUFbabK4z6eWTVVopEJDxupHBypFADKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACnxKjE+ZIEA9iSaREZzhFZj6AZr0HwZ8G/G/i0o9ho01taN/y83o8lMeozyfwFAHCRyQRnPkmQ5/jbA/IVbi1mWAf6Nb2sR7ERAkfnX1t4S/Ze8PWltG/iS9nvrrA3LA2xAe/ua9Q0L4T+B9EZWsfDtkZFGA8yeYf/Hs0Afnz9v1W6GyOS4cA5xGv+Ap8mna5ckeZZalLxkZic8flX6W2ei6XZAi006zgz18uFV/kKuLDGvIjQfRRQB+d/hn4U+JvEOlTXdnp12sittSOSBl3/iaevwc+IizvGnhfUsqcbgAAfoc1+iAGBxRQB+e6fCz4nadKkkPh3V1Ycgx/Nj8jRDp3j/TrwR3vhzUXIbcwmsmx784xX6EUUAfmtq2swfbZ4r/AEK2WRWwy4MZB/CsaWXTZuVt57c+iOHH61+kev8Agzw34hGNa0TT7w4wGkgUsP8AgXWvN/Ff7OngjWLWQadbS6TdFcJLbuSqn1KnrQB8LsqlyI2+XPBYYzSeW+zftOz+9jivZfGH7OXjjQnZ9Ot4datQeHtHw+PdGwfyzXleo2GreHr17TUrW6sLkfeinjKEj6HqKAMyirEsqTuC6KjE8sgx+lE9q0al0ZZYf+eicj8fSgCvRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFPSMsGbICjuTTRt53Z6cYrpfDnhS71aD7XIki2udkYRcyTv2VB1JoA5ttuPlBx6nqa9P8Ahl8E/FPji4hm+ytp2jtgte3AwCP9gdWP6e9ezfCD4ALK1trPj6zSJIvmtdHU5A7hpj3P+z+fpX0xFGkUaxxIqRoAFVRgKOwA7UAeffDf4Q+FvAlujWNmLvUMfNe3QDSE/wCyOij6V6JjjFFRzTxQoXmkSNR1LHFAElFZMniTR41UvqNuNzbB83JNOt/EGlXLulvexSMnUKelAGpRXPy+LdNSfyt0hc9ML1rB1v4o6Jpc3lBZp377RjHtQB31FcToHxG0jWLmOBFlhZ0Lgv047V0em65p+oyFLWcM4z8pGCaANOiiigAooooAMVh+KfCmheK7L7L4i0u1v4f4fOT5l91Ycqfoa3KKAPl74j/su28iS3ngO9aGQAt9gvG3KfZJOo/4Fn61806/oOueENUNpren3WnXY6LMmA49j0YfTIr9N8VjeK/DOjeK9KfTvEGnwXtq3RZF5Q+qnqp9xQB+awihv1zbhYroDmH+GT/d9D7VQZSrFWBBHBB7V778Zf2etS8LCXVvCHn6po65eSDGZ7cDvx99fccj0714a0ou1VJcC5HyiQ8b/Zvf3oAp0U51ZGKupVgcEHtTaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKmixHtklQsDnaOgP8A9auq8FeG7vUr60n+xSXck8my1tlHzTyev+6O59qALXw88KLq2rWkd1byXVzOw+zafH9+X/ab0Uepr7b+Hfw6sPDCRXl1HHPq2zaGA+S3X+5GO3uepqp8HvhjZ+BbCS7uljuPEN4M3Nz18sf88k9FH6mvRz0oAWqOr6rZ6Rame/nWJO2epPsK4rxd4+ht5rnTtLbE6qQbjsG9F9T715L4h1WfVEkjv7udptuULtnn2oA9E1v4hvq1tcW+kMbUA7TIThwPX2ryZ9cvn1PZeXkskD5wzMTn3rNtZ5EnlZR8r4UnPpVR4wzlPNJfkgHtQBcvJ5ZJBLI52xsdoz6U7w7qd1Zaqs1vI+yQ7myapQM89u/yjC5Jz37Gqklx5ETogwkY+Vh70Ad/qvi+9njiz5UcsZOSvVh61x+oXQdrhwS8jneCe2azzeLJaiPnegJJ7tntVc3GbVperRgZI6AelAHT+HL82l5DInzEDjngGrl7rd75mLKWSO55GV6GuaWRbaXZGMgqCorYsZPntjuzMSQR60AdR4O1rWPCl7HrOvand3VoyNm28wlT+BrZT4zS+ILW5t7ENp96H3QMvO5R2bNcj47ZoNBsbJV/ez5fJP3R6V5bdzywy209vlHTKErxz70Ae7H4m69c2bx3btDcRNtJhG3PvW3a+M9Tj+wMt9JNIwJkU4II7V5Npl6txBCh5kK/O4raFvcWtwrWjfK65GexoA+gbPxbbvavJKrN5e1SVGNxNdBZ3kN3GGhkBz2zyPwrwDwtqj/28lpfyYVYSX9AexqaTUb+1upzHO0KRsTG+cZoA+gaK8f8HfFCb7R9k8Qx5Tok6jkn3r1myuoL22S4tZFkicZVlNAE5r5u+PvwCh1kXPiLwVAkOp8yXFggwlx6sg7N7dD9a+kaDQB+ZKQf2iHs7lfI1WDKr5nBlxxsb0YdvyrEdWRirAqwOCCOQa+rv2qPhI8zS+NfDNv+9QbtRgjGCQP+Wyj19fz9a+bdUli1m2+3R8X8Sj7SmP8AWAceYP6/nQBhUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFWLSFJCzzErAnLEdT6Ae5p+mWMuo3iW8JRSeS7nCqO5J9Kl+yTXWoppumq9yzS+XCsYyZGPGRQBq+EfDmoeMfEFvZ2NtI6u4Q7FyEX0r7x+G/w+sfC1vb3U0Ub6qIRFvxkQr3VPT3Pes34FfDiLwJ4StReRIdZmTfO3Xyyf4R/WvTqACuM+JesNYaULSFmSW6ypdeqj/wCvXYTSJFE8krBUQFmY9ABXzt468ZRarrsl3Gx+zxHyokPT60AYEjiWdo5CSxJ5zWfdyblYZ3tANo55NQxTBi5lBYeaTnP61RvPnuWiIZWzlWH8QoAjMrROY92Y2beAO1SQEidJhgrP8qseq4qvduJ0eQMEEIwMdSamik36ZatHj92SXx6UAWrkhI5UXiQfMSPT0rEnl3NHEmCjsSVPpVrULxAuEDDeQAT6Gs6Li4ZmUlYk+Rh2NAEywk3MiBCuzB+lWRBHM0kBRQGIJxwDT4pEntYpB/rmOZR7Us0hXm3I653EfpQA/YUCXGdzCPaQfTpW74HsxJqO+43eTGN+cdKxZgptJVD52LnI/PFdx4XhSbwdq00M3lzQ2nnuduSRuAC+3WgDifEmoS3mpzF2LKCVjJ/hA9K529ibcyDPl/KwrZ2NNbBQm8QOSzE8kVmXTtMk0mBsX5io9KALeh3G29MEuQvXj1r1TwzdWIZmvyr7V4XvjtivKmkiaJNpzM4BAHFXoLyVdUyTglQOvA9qAO1u7H/T4tQhl2jzgWGedueldXeS29+sgjiJJ5jB7151ZXruLwTMQVG7OeBXSaLa3l4Vlt5AsQQbXz0PegBzWKR6lFGyF1ClyM9TW14M1670TU1lkZ2smUqYt3DfT3rO1yMQR/aFkMmweWMd2NVopCLa3jAJZXHHo1AH0Rp95Df2kdxA2UcZweo9j71Zry7TtebQb5GkjzaMiq6qecnv9a9OglSaJJYzlHUMp9jQAsiLLG0ciqyMCrKwyCD1BFfEX7RHwul+H/iNdd8PQN/YF25YKBkW8h+9Gf8AZPb8u1fb9Z+v6PZa9pFzpuqQJPaXCFHRhn8frQB+Y19HGsiyQH9zINyj+6e6n6VWrrviX4SvPAvi/UNCvl/do3mQPjh4z91h+HBrkSKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKfDE00qxxjLMcAUxQSQAMk9AK1p4fsMa2cYLX82BLj+AHog9/WgCvYWV1f3a2OnRNLM5xiPnd/wDWr7J/Zv8Ag9B4VsI/EOuxJNrU43QAjIt0Pp/tH1rlv2dvAn2SeOSa1jN0yBpZmX/Voeo+p6V9RqoVQFAAAwAO1AC0UnSvJvi58SF0cz6NpDn7ft/eyr/Bn+Ee9AGD8UPiHNqGrz+HtNRorSGQpcS7uZcdh7V5TIC/nW5XABzuNVJpHmuUnnlYSSsWDZ5BrRju0WAvOT5jjapA60AUJy0KJArBsKSp9TVX7ZLNIhJ5QYc/3aeXzBJB/EPmUnqKjtIcrIpJAkAA7ZNACs++5tkGfLXJbI4aiGVoZblAODwB7U0NJHLBwcK21/zpyqDfzKGARW6+ooArzTqsqJKdyjGfpSwP5O5Hb5GbgmpNqCV9yKSfmX1pnlmacIRhZhnB6AigB0krJHiCPDA/eHenmSWeCWAgBF+YnvUrIIsFj+9PyhT/ADqQQkROpXDKcnA6igBlpkWhdeXTGQ3GRW7Bqlzpej3UFjteDUkWOfcpJUBs8HtXOQkrPKkmW3LgAdq7DQrm3j+HWqafLcx/bLi+tyISw3tGgLFgOuM0Ac9e7YLl1iKiKRcH3zVGSJIZGhQkoY8Yx96rdz5dzcxEIREjkMDVa8kW4ugM5SHjcO9AGdayGMPHKoEqHI9hWpHjzk3DLH5jWV8qzT5B3MQvzVcjzgEuVdGwfpQBpRXJmljtYnABJMhP8q2/D2vzQW5Nsdyxny2B6ema5uOOKB5Qrcb+o69Ku2fkxoqR8lwcgfzoA9Nj09b61jCyhpRiTaD196iFlJYz+XtyRmUnrk1y3h/Wrm2ugYznZHtIHdTXUG6+zwh3YM8ilkG6gB8Uqh/NuZWEucup5HsK9J+GGrXV1DdWd6eI2zBn+76V5RJqBvLeaeVESdv4P5V0vgrUntdR0eSd1WJ2KM2e/vQB7dRQOeQeKKAPD/2qfh8vinwW2t2MO7V9IUyZA5kg6uvvj7w/GvihYVmsGljAEkBAceqnofwPH5V+oksaTRvHKoeNwVZTyCD1Br8/fjp4F/4V34/ntLbc2lXime2yOkbHlP8AgJ4/KgDzKilddrEA5HY+tJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVd021WZnlnO21hG6RvX0Ue5oAnt4v7Ps1vZlHnS5Fup7f7f+Fep/A/4fP4g1e3ub+NneZ8rv6qvdj71xnhPSLnxfrsU1xtEKMqBcYUAdFHtX2v8KfBkehKb/zdxePy0QDoPWgDttB0e10TT0tLJcKo5Y/eY+pNaNAoNAHOfEDxAnhrwveX5dVmC7YQe7n/ADmvkK71H+1NSnup3dnYFgx7n3r0f4/eK01jxMui2spWOxyp54aTv/hXmekQERYmCltxyf6UAOkCtbRZOWAOCOxpDcSfZoMkMCccevrU7rEsarDhXZ/nz2FVyht7rYACAMgdcUAPvsLdblI8zbkVMjCSzkZWIZB1PrVGWQRM29d0xbKkcjFKrboLksxDk5BPSgCQSGS5jVj+9PyknoajljIuArZXynyxB4xSO4kcbcbI03Fh60kcoMMUobcd2COxB9aAJnlWa7LAqpBCp7itJIg1vnb84bBB68VjyxFLsoWXJIdeOh9K1HuYwisrfvY8mUHvQArzxTTsHG6UAFMDgVLZzyS6fcl9q3O75R6islgzGS5IwTH8oHQGr2nAxQp5w3SOB0oArSZit5WQEXA4I659cVvHRltfDmn699o5nuGtlh28/KoYtuz6nGMVz107SXLMjHz48j2wfWtMa1LceF7PRSqeTaTySK4B3Fnxkk+nHHFABcNidp1A2BTx36VlwIy2yuOdzFv92tVVjhVM7mbZjisVpTBMY2YnkqPbNADNQGPKuDyJHHA7Ee1aiwPNvm2gwtzgdeKzo1CyLPMwdEzj0zWzDiHTkxwSTIX9PagCK9VIWjdiAbiPdtHY0xLlRBFKgxkeXgdTWeHW5mmcH/Vj5ea0lsyliVmwHADp/wDWoAv6Q4tvkfJLkAnuBnpXU38fmzJGocBMSBuxHpXF2K+ZuZiTtA+X1NdjqryzWVg6h0gBDEr3Udc0ALhp5madcIpHC9QvrU+p3KtbK0TMFiYKoHfHes+WcxbJVDAXAI57jtVJJNyEglpEOCOzH0oA+ofCeoDU/DtjdAglowGx6jitevHvhh4pFpOtjfyLDayYVAeiuewr2EUAFeLftU+B38VeADqNjEX1LR2M6BRy0R++v5YP4V7TTJY0ljeORQyOpVlPcHtQB+YUVs99pcskUeZLFQ0mOpjJxn8Cf1rNr1P4k+F5Phl8ULqzIJ0e7Ztm7o1u/Ufhn9K861uwbTNVurNznynIVv7y9QfxGKAKNFFFABRRRQAUUUUAFFFFABRRRQAUUUUAT2FrLfXcNtbrullYKorZewlvNVh0LT/nVJNrOvO9u7H2HaprGL+xtAN+xxqF6PLtkxysfdx9egr2/wCCPgeC3msL66hYyTkM0jdvrQB1/wALvhvbWGnIZ5AsNmQ75HMx64r6B0ZETT4vLUorDcAa4OyspV8QJHHIJLWSTay9ABXpCqFUADAHAoAWuf8AHfiO38K+GLzVbk/6tdsa/wB5zwBXQV8+/tO6081zpugR5ChftUmO/UD+VAHiTO97q1xqM7lnnZn5Oe/WrESGBDGSGMnzBs/dNQRRMLNXjwzbipP91asSKEs8ZLK3Vj1oAsRFIraNWKuXOWY/wmq8iq8kzROfMKkgfSjToGnWdiuFUgrnvT4IJYpgWXLHoR6GgCCCNfLi3SGRtpzikiYtayRgqfNB+opyL5DyBzhQx28dDTI1QTRYf5HGD9aACUKlmjJuB2lW460IEESxhlACjA/xqWMsokjfDYO3A7VUni8kbW2SP1IHVaALyyrNeRHZ8wwox3IpUQvPe/u/lHJP9Kr3Escd9bPb7sAZbPrUjSvHbTCIgCU7m9qALMcfm2rKHCg4zHjtVmYG3gjcMwK4QgDpTNO8pgpIbzgvOO1JfXP2h0VSVVgck9iKAI9ZVEaM28TxmY/O9dB4tnt7fwz4OtrSWGaSOydplRhuDPIThsdDx3rIDtJpa7/nES55/nR4v0ZtAntUklSWa5tY7sFVxs3jO360AUzdoCihtj+nbPpVBR5V4HnYnJy2abFGkVxatNh4/vu3vS3L74GwmZHcshB7UAAXzJZYxkwfeGKurdebbSQAho+Bu9faq8ICXihjgGPABPFFhHgxvHj5XIKHvQBds7b7NfwxKu9XGZBjpWilwsl/dyyKrxwrt5P6CkaZbOTzRIGkdCpUjpWZpCq8IaUsVLMzDP3jQBp28ii1aSb92sik8fwntW94P1lTZxw6tiSBgVjP16VyW0iGR7g7oAcFRVq3XMKvKCiIv7tV/SgDuNasJDb2gjGRb5BK+/NY106W1vLNEody4CnPT1rpPB+rCbw9crMN8hGAcZIPrXOXFvI2ofOhWFG+Vf79ACapDcRwwSwsRIWViV5C1718OPFw1mIafdY+0xRgo/8Az1A4P414LHcmTTrlpg0W1yqrnqewqTQtbl0ea2uIXYXcTjocAc9KAPrCiqOialDq2lW17bsCkyA8Hoe4/A1eoA8G/a38HjWvBC61bw77vTT8xA58snn/AD718ka1Gb/w7p2rglpEJsrj6qMoT9V4/Cv0g8QaZFrOh3+m3AzFdQvE34jFfnta6LJZ6l4p8LXQY3ESu0K5x+8iOQcepXNAHDUUUUAFFFFABRRRQAUUUUAFFFFABWp4b01dT1NY5m8u1jBlnc/woOv59Ky663UYX0HQodJRFbUdRCTTbeWRT91Pr/jQBo+D7MeIfEkt7KStraECBD0AB4UfhX1b4PKjT4lGPMc53AcBQOleN+CfDC6Xo1naXZCzAiWdQOdx7V6ppszaVpxaRvLiYMU3fwqeKAPQfDkSz6wpiIaKL5z6g121cf8ADOFm0V72RcG4c7c/3R3rsKACvmL42M0nxHuLj7+xEgVfQYz/ADNfTU8qQQvLKwSNAWZj0AFfKvjzU477xVqV6reZG8hMYzzt9RQBxs4EcTwAKuWLbj/KkT/niqhlbkgmp5YxOqPD+8jJ+YY5FOeFZCAuAythWzjPtQBHYyNaq4b5hycVII3lKyHdHu5Xd2pqweZDJI2QoYg9sEVLZyF5I/OJeJlNAEVyqCWYSKuCoAb/AGu5rNlt9tyqIdwAzu6bq0onMk7JIgJwdv0rNu0aYKsxMflnhh6e9AEqx+ZBIykx4+VsnnNZl1cLayyT+WzRHCknsfWtW3iczt5iqFAyNp6+9Ld2itZzxOg8pmBGOuKAIYlWCGbawk85Q4fryagkZhDs4LdGGeCacF+zXMcLH9xswO+KLOLzWnBjciPlW7GgBY5TbSiJyzS7OTSwxStHI+4LuBIqv5fmEvOzbkOFb2qbc4EozhtuIx7etAEscsu5YSSsTfIzDrg1q+Odbl1rXokmSKN47aOJQhJUKigDr3rJtfMmuI0TBJlQFvQbhmui+KptD8SL/wCyiHyI5NoMQAXCgDtx2oA5j76IpAZFyNo9ahkKRIwmUrGOBjrWkVVJdkY+R/mEh7nFZkxEjx+YGMTfKwx3HegCe4QTPbFMx7F2qT3o02TzWYIrB4gSR60lwyy3ChCdoTGc9KhdvJt/3LHYH5x1bPagCxJPLPCjnO4sS/0q9Z7YbeaLcMTEMh9KhuSkUcTRo2FUBwPf1qtbssjlWYqgJAI7UAabSeTppgI3iRiQaY0rSW6xRtg7cEd/woG2QbpVKsnyIM8fWo2YR3bTHh+BgjoO2KAOk0m+ksrJLWM/MoCqO7E1uXEp221m/E+C7sexA4ri45JLdxKgOR+856j6V19xE8lrDqUIaQuoDjr81AGJdyG5hUMhBWTcyjtjvRLEsksEo+ZA/RetdHpeiTXdrDKV/wBfuaTHYitG08N/ZY5gIwbjG8E9Fx3oA6z4M+J4oWn0if8Adw5MiFz91j1H417GK+RfD+qtb6tdTSMC8koX249K+n/B+oHUdCt5X++o2n8OlAG3XxD+0dYN4U+Oi6rEhWC88q7B7Mfuv/Kvt6vmr9tXw89z4e0XX4lyLOZraU+ivyv6j9aAPl/xvp0emeJ76CDP2dmE0J/2HG4fzrCrotemfVdEsNSc5lgH2OX8BlT+Vc7QAUUUUAFFFFABRRRQAUUUUAdB4K0oahqclxOoNjYRm5uCem0dB+JxXT/C/S38W/EA314GNvAxuHY9Bj7oqndxroXgO2sUydS1kiaRR1Ef8C/lz+NejfDjRLnw3pNukg23FyfNmVeuD0FAHdpDDLfNcEMm2Xcc9HA9KnsptQ8U+L7XTbaHFqx/e7uioDzUsUSSW8TRuH8o/vF6H6V6N8JdEEFlJq06YmmLRx/7gPWgDv7WCO1t44IECRRqFVR2AqWig9KAPPvjR4gGj+Fnto5As94dg/3e9fNAna5uQyFXbkbvb0rr/jXr7a34ueC3cvHbkrGB0KiuNso0gKrgoQC2c9KAJtPljSfyYBiTGXz05qx5UaWJ/wCe4fcB6iqGPLlWSBtyOCB9aktpwtupmfe+/gDqKAJInM0PmlWZd3zL2pl2wSOOJOEBOT6A1M7mNgAojjZsOPWmXpDpEmxVK52/7QoAz4ndnYqf4sAegp0ih5JY1IbBABbvSbdkuyMfMq7mbtn0pDO0GRGoaUD5gBQAkcDy3EgLbWVcBQfSp7F2uIiy5Lk7AvvUYiMsDu+ElZcmTOKmtZYxc2/k/I+OQfX1oA674c2en32szw6lp1vczvaz+S02SIysbHcF6E5xyc4xxzU0iWt34Eay06BLPUbLShe3Ul1pUatcqXJZo7gnf0wBgYO3APXHL2d3dwP5lpK8NwNwEkbFTtIwRkeorG8T6vqZ8NjSZNUuxpKOpNuJT5fDZxt+vNAHe6V4T8O3Hhe3vdQfVzcS6Vcao6QTRrHiGYRhBlCQWyOSTjHQ5wNg/Dzw3FqdtbXdxq7PPczwwSRyRAJGlqs43gp8zfNt4wO/HSvCNY8UavHZrBb388cMcDWojWQgeSxDMmP7pIBI7mslvGfiSa6jkXW9Sb7OWkaQztkbkEbEc90AX6DFAHrWsaHZ2viTQNK0a4nV9bt7eeH7U6u0fm8YZlUBuQeQBXFa3eW+m6xqWmySq91ZyPbkoPlcgkZHtWLoni28svEWha1LO+of2XNC8cUznIjjOVjB52qKqMkus+JbrUGjO+edps54XcScfrQB2Nrerc2UAcE+WMk+vtUEjPEsoyFkPY+nbFPtIglm/nL82ccfdqWVvtE6ScbkGzaBQACIA2zYCvt5B6saXY0UigrujTJLeh9KWIoYVmmyJQ+35j3odW+0oVy25umaAJEuAsP7wEkfOSBwQfWoFTy52YDdG/OD0X3qZnBWayTDMx49xUDuZba4UEBGwAOhBFAG0rJNOoA/dBcAnrn1qvF5XnbnIl2kAj6VVt5ikTCRsrswG9DT4DtxDBHl9nzk/wA6ALlzK3295Gb5goXap4rd0zU5NPheAN5lvLjlv4TXIJM0UqqIwzt0PpWjHu8uRpCzRAgLjuaAPZdP1K3js7SCJNkP3Sccn1NVdd1mJjI0EhDQoYiF/iB7muZ0W+llt4trqY1+XJ/h4qlqeIo3Fl/CSW3dzQBhQqpimco24OWUkd6+gPg5razab9nuJP3kmCgPbArwn5zA0wOA3BX3rqPh5qzWep26FSxRsgD+tAH09XIfFvQY/E3w517TJI97PbO8YHUOo3KR+IrqLK5W7to5k6MAfpUzAMCCMgjBoA/NnwaIbm11nRrtSJrmHdACORKnIH17VyrAgkEYI4Ir0f4t6JN4E+Kt0YgQv2g3MXGBgsSQK4zxNCsWsTSRD9xcfv4yBwVbnj8c0AZVFFFABRRRQAUUUUAFafhnS21nXbSxXhZHG89lUcsfyrMFd54Cii03Qda1u6OzMZtbc4/iPLEfoKALOm2M/i74lrFHt+zWjgFv4VROgr2S3aO51uSG3cboQu1s+nauC+EVrHpfhG+1mWQR3FxJsRmPau78IW6x2UupFDLPKpVB/eOetAHX6RpI8RaqLC2YxyIcyyDoR3Ne7WdtFZ2sVvbrtiiUKo9hXL/Dvw3FoelfaHQfbbwCSVvQY4WuuoAK5j4ka9H4d8IX147YcoY48H+Jq6evnn9oTxN9qvv7IgIkhtxhwD/Gep/DpQB5iWN15VxIN7OSc96rTsY0jKIySu21lYdRT9OQraL5b7gvY8c1Msq3ASR2y6nG0+tACIqSchGjKADb60ahGv2eN2CIwfAcdce9Nt5HCvKOZSxwP61LFIl0skcgUyBckepoAlu7Z4ljwVaKUZJzz9ap+RsjVppPMjDHBB+6Ka10qwIZo2CRHjB5HtTWASALnME3zqP7poAWMfaLSZoxnyzgHofrUSXCiWKBfmkkUhmxzTkkMCNIm0HIDJ2OO9O2eQ3nxhGWQ7gT2zQAt3GjwFJS2R8qge1LCr3Cq0SqJYk5z3HenXNs0MCnzNzyH5e/4VWtJHS/bIx5EfIB657UASl2MUU0ZxblirKDyKo6m8UXkm5tRcxxurvAWKiRAclSw5GRxketW4ZI1STz48IBuCqe/vWTr1zH9nnSLLBk49QaAOfi1bSLqa0E+kySCOW4aZYbggsjL+6QZ6BDgk/xCsl5tCWKVYLXUxLJYlAyyKVa6353YxxHtyMdc96oW0UqSQ4ZUjAO5s9z1zVjSrFJL9khaR0Q7Vz0J9aAPXfg3o3hm58ZxORNJbwW5aOK7iRlkIt3Mm/tw4G3171gaPYFrqS42ARMOQO2ehq94O8LT6xPdx27xqLW0ku5WckDauMge/IrQj8qARSQxkqMA54xQBmNHLEoQ8LGScHv70y3G2JSnKSEsXPUU8v5+qXPm54GAM0kcaMEDZDcrweMUAMmRJpbS3gyYpJCzM3r61LcMjAlVy0DEZ6ZqK1bzZJWK48niLtRLlYfMGMsckZ7+9AEexpZraUsqyR88elPbbPdNmPCn5iBUMoP2AxsoHQ7l9DVuRkS0823KkwHkn+MYoAGjCW21Vy27KA9xU2nK8t/NNg8ptb0pbaVbxoQgBkC9R0ApVnKSRRRHZE0hVz60ANksjPuWCTajjapHUGrNurpbwocqqEhie59adI0a36pBtWAsU3Z5yasQRPIlwiyAtEdh3dDjnNAG54ajEOnXkPV2fefUVc1SV55lgjRUBQDjqTVHwa4vUvdgBkjUsCDjpV64JiuPOj2nCgnI6UAZ93A1tZoGPmPKpJA/hxVWya4sRHdRvg45C9efWtSBWv7PzuhTKs3qKh0/a0YBUm3c+Xu96APqTw5Kk2g6fIgwrwocfhWjXPeArVrTwtZxtIX4LcnoPSuhoA+YP20NBibTdK1mJR5ySGOQ46qelfNN1i88KW0+WaezlMLeyNyv619ufHq1tdY0s6LfKSJ7d3hKjJ3g/8A6q+IfD8bSalNpUrlI7jdGVP98fd/UUAYhop0iNHI0bgh1JBB7Gm0AFFFFABRRRQADJPHWu51azxbaHoPmeRkBpgT/GeSf1rnvCNj/aHiGziZS0Sv5sgH91eTXSaQF8R/FGNCSySTEID2x2oA9KsvDcE+jWWnlz5CHd8vY17D8MfD4ne3gmTNtatkKw7da4rSNHR/Ej6fNK1vEpGWXoPSvc/h7ZG3tLqRuSXEavjGQB1oA6wAAAAYA4FLRRQBg+OdaOgeF76/TmZExGP9o8A/h1r4+1C+e8uZDdylpS27zTzuPevXvj9rcsmriyt7hhFAgDRg8MTya8XLRzJtWL5kBJ2nmgCWJWjCSCUgSnGO1X54UMStA5UxffTHLe9UrQHyNzqoUHG0/wANaELgJDLLgXGMHPcUANs51unLouwjjmqjDN2zBGQ9Qf7xqSKNn1Ayp8sadQOxNXbpg5hEuTs5XA5NAFK6RprQzQqMs+1g38NVYP3cXk3IBG4BW3damZlFqwAbynkyVPUGo1V4J3ubiNZIV4Re9AE0NruzllKM/Legp8gLyyJlUhiGVY+npSxOIo492GjbJz6E06SO3+zzMFb5+gPQkUAVzOqMDGxC78qG7nFVMbGmmkbDkfc9fepp2nZGjKrlV3Yx0+lUnXKifksBtNAGhp+x5RhkYFDuB71ysTi+1K7ixhFJQgd66ExRy2btBKqMRkD3rlbRJUvmYIY3WTGCfvjuaAOUe0xJcR+YT5ch/dn0z1Nb/h8Ot5b3UTZgDHIx0qrrSPbeJZpJIQoeMsEH8XFaHhR4ZbuFZykKlDJtz/SgD1LRdWbQLLUvkE0WqWMlmrg7Sm4qS3v06Vm2zLe287lWVg3CjuBXTeHrO3l+HfiS7u4Ynmtxai3LclC0hyV9OBXI6ZLOqyFQh3EkAcUAVEulW4KsgBBO5scmnLsaQgv8ijcn19KgmVnu5dvCH5i49R2qxIiv9k2YZVbezdMetAENsrSuTsKNHnBJ4NSSiKSSWIcxgDp3NLD5lwZXzhEyFA/iHrTIf3d8ghIHbnoaAG2+6O4EbrsiYbMHniizhRI54JQx3uWj9xS5YyyPLIMpJlU7nNT2yy3t6khXYMgBPQetAAsZjCGPCuWC7V9O9SoqpHcuNuAeuema1/DcCP4j0p7lAsMd/AcvjDKZFzn2xX1gIfDeOI9Hwf8AZi5oA+MEURCJndWycnnr6V1q6Hf6VY2d7Mu+11eHzYJFHAJ6qfcV9RfZ/DZx+50c+nyRVn+OpPD0HgycauYk00riEQ4B3/w+Xj+LPp/KgD5c0OT+z9Q8qBsOxw2PT3rtPsElwLYoeS3IA+8PSuGs41W7nuYi7k/MA3Bxn+deg+FNfS5tz8hSSDOFI/CgCp4f0ea7XUkUybLYE4A45qG0tQk0dsiMUkGR7MDW/oeqG1vLq1Gdlz8zMPX3qq0SRXsU4UkbvmI/hz6UAe5eDpWOiQQyArLGoyrdQD0rdri/Bd9E+pS25kMkvkqA3+yvQfrXaUAcH8WbDzNMs9TT79jLlvdG4I/PFfB/jKD+yfG908I2J5/npjsCc1+jXiOyXUNCvrZ/+WkLAfXGR+tfn38W7YR6pbThPvqysw6Eg0AYPja28nXpJ0XEV2ouE99w5/XNYNdFeu2peE7WdstLYSeSxx/A3IrnaACiiigAooooA7PwYRpmha1qzplmiNtCehBPJI/SrXwRsZb/AOIVk0Z5gVpmPsBz/OqniGdbDwfpOklcSyJ9oYjqCxzzXafs16a9zrWp3CoTiDy0YdQepoA9m0W4t7jxbLM7EQKuQSOMj3r3Xw+hXSLYnOWXeSe+ef5Yr5k1O5ksdV021tSZBPOIWPqWbB/nX1TbxiGCOJfuooUfgKAH1n+INRXSdEvb9xkW8RfHv2rQrgvjRqC2ngue3LFTdHZnHYcn+lAHzf4svptWv3vy6mSRjnnrnvWULfawNqVD8CQnjmmtIQEaOPlCBg+nrUjgMWjjbIdt3HUUANgVkZ3mHqCoPT3qS2laZANhaQjCnsBUP2g5dJ4jvzxIv9at6eogRlllBkbgj2NAEwKW1wiLl1cASt7+gpbsywtFDbZkVH3fMOee1ME2ZIw4A8sknP8AF6Uy9cSSxtucYXd0x83pQBbkigklSFFAkc/O390+9Zt67w6myKcISAq9mxVuFzsWWUbZXIywqmzu16CxJSJvlO3k59aAJryGLeSAQEIJQcZNOuXie1EolKSI2HiI7H0pl8skiSSRsGkDj5u9DMTLvdEdVT5x60AUJJCbm2kjckL8rg/1qK4RpJvskJIl+95nbHpUMTb5rkqcc/KfUVbcrCsUy/NNkE+4oAbGjQw+WQBJ1x/eqBNPEzrOcIysWbPatKQW100zmR1ZFxGg9aWQqukBJPkmdsk+w6UAcf4uVDB9qnAWRFKow7isPwu8cd3FOWEsrjaUPUV1Os2yahaNFNhliBc47ntXG6EHtpp3YACM4Ix83NAHstlpdzP4Vm1ZSDZiZbMruwTIV3AY7jHescsbctEsTAjGVHY1t6br8beAIdHSBxi8+3PLnr+72Bcfjmsc3CtdSvMdhcZDE9RQAso8i3h2Lnzckt7+lUhujtnhON7kN/u+1TyuvlKI5SbborHqTUFyVmsdkPLK+A2etAD4GZZXiBZERMnjiq5DgbQdxQ7iwHQVYsEeSOVLgscD5jnt7VKLhLawKMilnJGPUUAMmSFkXdlvNZWL9yK0LSVdhjix5rPhM9hWQu7y4y/+rX5t3p7Vdu5EitkeEfOwwCO9AGhcyCdmVD9wbFBHWkKRj7F5QT5iRIu37tNu5IJbJYreVVcKGPHOaLa8RoIizjeVIzQACFmlyHXaM4GB0rSuNTuNR0mzjvJ2EOnxeRbQdFQDvj1PrWNBeh2G9BGsQKjPJNNa6ZxO8al9xK4I6CgCY3TRxsQvyg4496u6bdSWDgSs4LMC+30NYiuyxIGzs34yK1S5bcil/LIBcn2oA7S3gaLUvPV2cSRjbGvcetdFPbxyfZ0kySVyAtYnh9mM9i+CIFUrkclhjpXSrNHNasWcQyrnH0oAv/DLUGk8VTebKv8AzzQdtvevZq+WtPnuNKmuZonAWNt5IPPWvp3T5hc2NtODkSxq+fqM0ATsAQQeh4NfCHx60DUNL1S+XUI/LSG6YwY6GNjwfyxX3hXh37SmgRaraWpaLJeGRS/uoyKAPk7wNENS0/WdJX/WzQGSMepUZH8q4/2Nb3gu7ew8UWbKOWfyjk461R8QWpsdcv7Y/wDLOZ1H0zxQBn0UUUAFTWMJuLyCBRkySKg/E4qGtHw4GPiDTAgy32mPH13CgDp/G9i9547SxcCNtqRnHTgdvyr3T4b6daeF/CV2BGY7hv8AVzDrzXz98QrmdPGlzKzkTRsCD3Fe8+Ebz+1PCYa4JYvAGQ54DUAaXhbTZtX8deH2VxPBDdCSTjpjJyfyr6crxj4B6MsRur6Q5kHC5969nFABXinx91CU3VtYpgpHCZSvqScf0r2uvAPjx8/iZFgYLceUiliei9eKAPHbiNgwYbhkdAO9LEx2rNGMyldrg9QasJOXuBbTMVYAkOO9VrcOjyzyv8qnBHc0AQyRkSGSOUsp+/ilWRUSW5TGwHbyeg9anSNnJuIoyC2QQehX1pl7aq8PlxIV53PGe4oAtwsCtu8saSIQWXnnNSQg3kJPmlUcnAI5BrKiuDHCEbAiXlOOfpVzzROqQp8pA3RknHNADLzfFIsGN7RgOStOhlH2h2iYsXAbYfX3qyPlAMhX7URs2g85qnfxS2d1ulKFhFuLDp9KALjucpE0YRipkLA/pWTHPLN9ohtRiQcsT2FWrGT7TZSS3A2HbtWs5EWCd5o2YTFcdeGoASOMbYoYzvZQWlwOfpWoyiK4hCorK6YG7qtZttuaOURYjkY/M571qXMccSQpGCSqnLep/wAKAI0jVZJFUgTkfKT0pL5Xbb5cTSSpgEH7o9ajldz9mlSMAg/N+FXwqTo0ETMG2fPKfWgDm9TKIwikUAldxK9K5CO3+037ujNG2djKRwwHeus1hCHjiDq0h+TdnrWIAIn8uRj5gYxjjqaAPVLjT7W3+GvhW4ghRby7a6aWTHLqrqEB9hzXNwhJ3uGmgzGi8N7+1SRaXqWl6Np39oSHZeW32u2XfuxGWI6fwnINQrMsmnzwjcyY3Kw4waAFMi26lWUeW4+6eefUVCsSJE1uq+W4+c5NR224Wn+kKD5pCqxP3atTGNUD7FLIfnycsRQBFB/pNskGGBXOT0OKYMSXGAMqn3s9BTVupdxuJ4vvHAC8ArUgIVH2KVWRcl/T2oAZGQlxKJsGJzlfargZIrUtjcI+gx39qqfZt9sd0mIowNzMPyqxAWfTVdU3+S/y8/eoAhEflTx8Ykcbj9D2p6qzsiKQuCdpXoKSASPqDXdyMNtwFHQ0W7uzy/8ALOIDeFHPIoAuWlqrt5LsHcc5x2qa2tGtvnWRWRpMeyn3pbSQpGkiABSpJYd/rTp2C2yJu2wzHdtHf3oAbIiGYuSWfzPlC/cHvSyxv+8EZI8wlG56iknfyGs4rc4XcMoe49aS8uc3rSyYZt3Ea8DFAHTeA797e5FrdOWljOFxyMV2sC2xw0pC7WJG7o1eZaddlrxLkAKxYLtHevQtOuGudInW4EassuYs9h3oAyfEdqRpF1LbkFScMB3+lfQPw/na48FaLI+dxtUBz7DH9K8WnQkTQuglgZgyhO4r174aybfDUVmxHm2xKMv90HkUAdXXIfErTFv9HikKljC56ehGK6+orqFZ7d4mVWDDGG6UAfmVrcLaZ4rvIVBQwXTAA9QN3+FT+OEP9vvLj5Zo0cHrnjH9K6D46aFLoHxL1eCUqwmk89SvTmsTxGTcaBot0dpKo0LMOpxzzQBzdFFFABWr4Ux/wk+k56faov8A0IVlVa0qUwapZygkFJkb8mFAHWfGGMR+N7r5dpKjPGOea9U+Fhmn8E2ItiGfO07vY44ryv4v3Mdz4wlkhYlTGOG6g16V8CJnuPDiqSqxWsxznuSaAPpH4W4jjlhKeVMo+dSPve9eg15x4JmWTxKrL8uYWUgHOe9ej0AFfPHx8KnxQwiVjMIU3N2UV9D18+/HlxF4mcshw9ui5Hf3oA8mjETMXcD5ExvJ6mqpkmltGiwFkibg46/WrkEhjtipi3pu3KCM5qfUJXlhjVo1VpD2HSgCkLxnt0QgKBwwqSD5Zbjed/mL8h7qPSkMCTx7FMauvBJPU1XuYpLWXEgMm/8AiXopoAn8txAgiCmV+I8jr6024XyLlH8sl0Ufu29fUUtoWgYYRnCjeoY9PpSGdbq7aRgw3LtU/wB31oAdLue5guIsEA7pH/un0p08ZupRJcAsr5JGe3qKrzulsSm8vC5AYjv7VfglG5ZEYv5KFQpHAoAzxO0TMFRSEB2jrke9UbXZIUBGc5fIPf0q1OFd0nUEOM+YQcAGqtu0apKyqMY4kJ6fSgC1axxpMrkeYwXLLnkVblR2shI3/LR9gyfuiqVtCou0nXfICuDgdasyBPtM0bbvKBBA9TQA9gIhBDuXbgpvoLiBHVUYofmwvfFRTrC6bULEId+w9z6UuoXFvI6eSzpCwAMackUAcvqjIurxyM4MmzeIz2yajZ/NuC1xtDN8ycc1Z1y2M0320wFlI2LIvXHpVfUtMzY2t1p0xaVh5YRvvKaAOu1zxHDrsmjLbxyW8Gmaali6yEfOQSSwx2y1VLVXaIjYRHsJZjwCPQ1c+LOlQaR4t+x6VAsSRWltvRO7mJSx/EmqNhOzWn2ZiP3wGcnhTQAyWT93FIEyiAbgeBmo/LN1cIsJHmKCze4pzAI9xHdbpZE+4FPyjHeiBxLKrofLkKYJUd6AIrgyvfpub/Rh29xUkGHMEEuBC7EHB6elEKuxbIHk9N3vUtoAAYvlDhwq7hwBQBPMBLFNAEUQLw5z2FNjVoLdZIB+7xhQP5mpArwyT2+Ubc4H+8aqvPKVaGLhc4f29qAJYnKruQqWZd7AjpSTjbtdExuIDZ6YqJBl7mAK+1dpP0qW6RZTCq5yrDOTjigCaWbYJOQqk7Vx/KnQRzSxwggAgMMt/CKqEq1+kAY4Rsla0RJGxKqNpz69R70AMSA/aoC75UptMnp70l1ZrHeSpanfBKAEYnn3qw7AwQiNhwDv44IHpUk91bwwRx24I3KMSEZ2k0APsE+yXgUYSMtjJ5zXothbxvpsMlwqRI7EDPXHrXlGjSXf9otJL80aOBgjOR6ivYNP1azvdLa1k2MwUvkjlVoA1Le1srqOCO0lOAcbyMAn0rf+ElzOuva/Y3WdybHQ+q5IrMtVgtoNKuFQMyR7YoBxknua2/h7BLH4z1h7gBZDAnAPHWgD0ig0U2UExsB1INAHxl+2LozWfjHT79ctFcQkFsdDmvHFkM/guSNgf9HuAwOOx4x+tew/tYXl5fXXh64mDR28kDL5RPRlOMn3ryjTp0k8Eajb+X86Mrbsf7QoA5WiiigAoBKkEdQc0UUAdr8SwJptMvjtLXFshLKODwK7/wDZ2YPo2uRq+ZRIrCP2x1rgfErm98CaDPHGcQJ5Tt9CRWx+z7qi2fjiOxk+7fL5a+m4cjNAH1x8L7dfOEu5V27gATy1emV5RpKGw8V6d5BUNJJtdM4474r1egAr54+OhdPGTncXRoEGw9Bx2r6Hr5q+NitdeNrrJJSFVIB+lAHCWMssc/mIo2ckB+lKk73DSuhVnB+cgfdpts6+Wu7p1Cn0qxDHBBKzROGjlOCPQe9AEaCKWJm4YgHGRjmqb7nRSpIjY4K+pq9cxqqs0amUFcqOn1qndzh4Izbo0UgBwT0zQBTvPMhDqjM6jr/eH/1qYtwgtvs+4BM7g/cZq6IZEUusyyzTcSY/grOMBRS7eW0a5BUHk0AWg8U0KQXG1oE+ZSg5/OqNxeSwxzyW0jKjnbtK9aSJkMHloHVk+YkDoKdD5kzMgbEKpndj7x9qAHPKnKbG8/ywcg9D9KikiBMcMwZABuwRgGlgKrdfMCrbc7j1IqS+vlhR3vSNvVFJ7UAWLCUQPJKzbHK/u/T8azjqCNdmQvunZuV6CucfXhqMzw2o2huSDxx7VMbuCK3jnmbasZOMjlqAOguNVeSNlg8sByQSRWdoiSfZZPtQKGViq7TnAqhY3H9qXLIYsRSn5dvRa14xJYtJBCo8rII3c4xQBaW2kS2CE+ZGfuoeDxU21WmVI40Nw7KqqD0Y8CmIplCPuZrgqShHQfWpNPaKy1zTr69jfZBMkku3+IBgSP0oAnvbO7ttdubDW3J1G1kaO5d33kMBxhu4rDMrxCcwuCIX4yPvVt+LNVOs+LtS1iKCQR3kxljUjoCe/vVCOFDI+5lLk7sHjFAFsSILVriIBmZRvWq7rvhgeGPESt07g1XlLKgO4pbk5YEdcGrcsplutsKbYFAcE8ZoAjjR3vkjXEMeP4jwTSqDLIzzYZDJgbeDxTzmNZPPYSO/zLgZ49KiLCJYljRnd23fSgBkkypesEQhlf5Af61auopBbkEIrk/MemRUFtCsly8ssZLuScD0FOmVpANrMeCwxzgUAJGWa+l/fbVZQMjrV22jSQMqgvJ0Vj0yKp27QS3qGUgEDccDqamtW8lsp84LEKo6Ke9ADdPtyb93umwCCpQdc1ZCPIJbdUXg4BU84pm+Oa5aUsBI3y5Tov1pYmaOdYVBQCTAbuSf6UASxRtbYQS7kUYIPvTo9kahXyUc8lhwB7UrpG4khMm6VWJJ7cU6W5SeFjCEZVX5c9aAC2ZBqFww3nCYXHStLTLyWTzRApEjRlTnsKxdNnkkmnEIyoUcdvzro/DQll1KXyURUXAZj3PpQB33gK5+0+V9s3SxqQAc8rjtXp3gjT5IdX1G7m3bnAVQewz0rzrSI47N3uiqxRswXZnp74r1LwdKbk3NyzfNJgbe+B0NAHTUGiigD4+/a3u4ymmWijDx3MucjBHJP9a8T8NATaFrcAbDiHeAfQdf5V6h+1xdbvHqWvmhwqmQj+7ngCvMPB9vJLaaxIpIRbZ8nt0NAHM0UlLQAUUUUAd94eH234carCwybZ2K+wIB/nmuZ8Hak2keKdKv0O0w3CMT7Zwa6P4VTCS41TTnXetxBvC+6n/A1xuoQNa6hcQkbTHIy8duaAPu7TBnXLW7EnmxSskiM3bPavW6+ffgT4kHiTwhpzSbZ5LYiK6B+8hHQ/lX0BEVaNShypHH0oAdXzT8Yy8Pj69DgvG6KcDr0FfS1fPPxntXk8Yy7HDHYGK9xxQB5pFmW7K4+ZRtTjj8akt9hjuVuxhhwMdzUKwMRsjkbIkyWB6D0qxt81cyL91jyDkUAI32iS1MkRXH3Fzw2O4qkUngty6qq5YgJJzV52SWBFic7xzv7CrNgqtAzXCCQZ+8e3vQBhShrd/MJMfHYZBNZv2fbDl2ZblzvTuMVvgEvKkbI8TPlVIqgq7rmYy/63GwIP4aAKTBhho23FuP8anuCyWy8hscHYf6U2CNPMjSVt38IZf4T71FfBrQv5JEo3cHGPrQBT1a/Sy0/d5e99uT/erhLq5vb2RJDMdmOh6itbXDHdXEiK8zqTlgh7+lSaFY+Vb/AGvUEEcJOPLYYJoAowrAZFuUQqYzgEjBJoCz6reRyTY8mNsKy9D9asahcPdRSW9la+VCXAQnqR3rofD1hBY2aqEG8tuOaAJ9KtIrVPLQYZuf94+lWB5MIm84j7Q7D5WPCj0pFkBZpLdXZlk3Krcfl7U8QpPLJLIrOXBLLjO00AKs1xFMIfKClvmBH92vQvBfhSC/1HSEvbcz2l5OouFJOCvUj1HArjLS1YwRlnCTR4IDcnZ6V3+kyXWp6RJHoJnE8YMqNG+1gVUkkHtxmgDz24MOn6vcpbg+QHdVjJ4VdxwPyqjDEFUvK6ttDMgbrVx97zwXXlAgnlD1NQXGy4vN9wFT5c7F4x6CgCniS5MbSNtRR0x1NO00NcCQPJ+8VSQPb0ovWnaRvIwImX05FOj22FozIPNKplyOuTQA9XLWcZy0cyMflI4YVYEMEHn3DSO+EBEQ7e9NMzXWnxs6JE6gMGPQigMssoWYmNGj2lx0JoATE5gt9rrHCoyf7zA9qitJRHOUVikYygOM9aeI0+zAxFm2Z5b+I06NPsiYlZdkn3jnJWgCCZgkMkkS4MR276IN1zEfIk8t2+dm7Cku4jbJKqx7o5ANmT1PrTFBjgRhgK7che3tQA6ZYLZgY3bax/M1LNcsD5wDcrliBzTrmEvsjkG09VB7VoRsqolvGmUIHnORzQBSg8x40Y7dp+8o+8feiSOGScB1EXynAzx+NTkNBeOrAE7CFwOnpStG7W0rhAV2bt3egBsStHh4AFijIyAfvV0Hh1i2qotruMki5YH+H3rnrRHzmSMsrgEFe9bHh55f7exCm0thWIOSBQB6hIbdrWWNQ0kkQBLn/lr34r1L4fFZNOaVRkOFOfTjpmvH2RnnuoYOigfM3H5V7j4NsV0/w1YW69owx+p5oA2qKKbM/lxO/wDdBNAHwj+1OyyfE+4lWQNuUrgDpjiuU8I7IPCGuzliXaNgF9sYzUfxd1CfU/G97dXBGZGLgDtkmnaUDZ/DrVJjGC1yyxqx7AsM/wAqAOKooooAKKKKAOh8AaqNH8W6fdPnyi/lSAd1YYP86u/E7Szp/iN5kTbDc/vErklYowZThgcg+hr1TxksWveB7PV4kZpSisxznaw4YfmDQB2n7Hmv2dtres+H74hf7RjV4mJ/iXqP1r6h8C3NxJDqNvcyrJ9muSsZHZT2/nX5yaDqlxo2r2uoWcjRzQOHDKecZ5FfoH8PdT065hstRtLhJF1eFWyDwXA/n1oA9ArxH47aVJDqlvqsRIWaPyi3ow/+tXt1cr8S9NbUvCd0Igpkg/fAEZyB1/SgD5VJeK1YOwWVm2lvWq8JmaMCHcpi5x/eq9qaGSSNEhOepLDgGmsixASxE+axC7c8YHegCtHbXF55zYG1gRheMNVa3e5ZWLZSIfLjPNacV1MzFFRUDNktnke5pzRLvmVnEjOM7lH5UAZzTC2ukEZBXb39feqlvmd2WYnzGJbzAfyFWrt8RKksQMsYwSvQ+9RRQLCI51Jz1NAEUO2FpoEba5YFlI6n2qrdozxszSYKsSqD+I+lWZBFBI0s8rSSztlMnAFLNa7bSIyfMPMLIQen1oA5WTbaXQlZTBO3IyMj8aoa9qt1rbWYt42RImO58cE+tdYYRLLJ9ojEkOSS49B2q35MDWubWJIwqcAigDGstN+wIPtLi5ldVPy9s1fSKPmATkTk4Q44H1qWKVY/LjkVcqOGxTo4fs9yJFO5Q3IPNADpMl2iPzDaFEi8YPerkU0ds8UdtwwGSSfvGs+2K+dM7viMn5T6k9qvqkEdw/2hsHaPLYc4oAsRkkCXaQyZ3E9wa6jwJq8Wjx6jOd777eWOMRjje67VJ9q5m2tXnEjO5jjwQBnljWlbwvN4faOPYqs23jgrjvQBg3kdxFJDI0iuQQr7TxVW4dYZG3K3mBiTIeRViWLy3FnKrsT83J/i9TT5ooSY1lG6EDDCgCljdIskS7olTLE96ZqETf2WjIjCKVsSFeoFaFnEJLWSOIEKvzMR121Uv5HlghEZZRCcvnoV96AGzCIwwooLIAAAOPlqVHiuWJG4wJgBMY5osUTiUkGAAsDnJqleyyQyK8f3QNwoAlcSWwkMQBRj8oJ6U9wq20okz50igqT2pVijN8slxLvxHuVF6ZIpsyPKgEhG4L8rA8UAR3A3eV5s2VTGMjmpIEjUt5aBxu3sc8CoXkWSMRjLPEPlGMAn3NOdZIraTy8J5uFIA70AWm8vz45pJCc87evTtWzaYlG9Wjjll5K+1ZNsq27xLLtlXbg+oapZU8m7b7OwY7ckjmgBIwU1R0kc4cHAXqKszNIW8ichBtKhQM7hWdDueCeRSrTuce4FXra8CkTSqC6r5QbrzQBYto/3DRAs82eAOy+ldB4FhhRbqaVjCUbI3D9KwdMW7a8Vojt+fDPnqK6bR4PJNzmZQu7exbnPpigDtfKXU4opIUKEphUxy+PWvbdJiaHTLSNxhkiUH64rzXwBZ/bNSBupACqiVFHGR6V6rQAVn+Ibj7JoWo3AODHbyMPqFNaFeWftIeI20D4aXywPtubsGFADyRjmgD4O1y8k1HV7y7mbc8srMT+Nb1/cSQfD+xtX4864Mg9wAf8AGuURSzqvcnFdD4weRDY2knHkxZGPf/8AVQBztFFFABRRRQAV6R8KtRS8gvPDt5l4Z8yxL3Jx8wH4c/ga83q1pl7NpuoW95asVmgcOp+nagC74p0h9E1q4tCD5YbMZPda9m/Zj8XSf2nH4Wu5P3bTC5syTyjjqB9RXK+PbSPxJ4ettc04ksF3vHjkDuPwNefeGtWm0LxBp+q2pIms51mXHfBzigD9QAcgH1pk8STQyRSDcjqVYeoNYXgTxRaeMPC9lrWn8Q3C5Kk/dbuK6CgD5k+JOlyaD4lmso2UQyANCGHVT71xUQWG58soxx1Ddj7V9E/G7w/Hqfhd79Y83VnyGA52E8/414EIFdoU8wiRgQAR09yaAKcIQx+cuDuJDA9PpVRrtIYlYL5Thjt78e9XGSZxHaSoDhsCROAfrUGpW8kVuZE+ZpDtYYyABQBXJe4s2lgdXZgcg+tJtCoixgMQoDox6H2qFos2I4XryF4KmoBbyTJGDkspyUXqPc0AJOIxMF8suDypPRT6Cm7BHwN4VAWdOoHvVtljtgSsisMEDPSs4h3gkgjkZZGI6/yzQBOskXkwnBEb5bFKC9vbsMLKrDIiHU/jUyczrbsAVxt3be/pTvs0ltKDcITFI21Nvf8AwoAfZRLOsSlMTBdwVug9qddwCO0WYHa20qygd6nUCKYRw7Dj5Rv6g+lOd288rt8xVYDb296AKklpELaCIoD8m9iP71LbQRXIIYOqrjLDkfSo5rhotVYMjEjJVB021ZMksVkosirFvmlj749aALxu4ILZUk3Z3ZUAdQKsXEMo0eJ4tiW8wLcH5hzWaL6CO1S5Ko+F2lT1BPerV+gltrG2RjsEe5G9zQBRnSMxMAG85mAEjHJFSxApIiBVZHGN2Ohqs0ZN9GiEmQD5yegIq690bfTEEEYMpfLZoAp30htCBaxseDvweMVn3pmd4pZCGs5Fyyjqfar9xK76bcOsAJ3YOOhNUIAoi+UO7leT6fSgB0Fsn2lhECny5Ck8KKq2iLJcSXVw6sqnYsfrUi3h81pvMzPjaMjj8aSGMCNnQYOck46GgCRxHPJ54AKfdCx8fgar24e5gkCoY4oepJrRsYUSKRS2WYZB6KKdPaxwWhAfe0q/Oq9KAKDRufNUsqRgK+Vp8lzIZ2Of3SjcGx0wKtSI1x5KLEoUgLgcUXMLwwFpCAEb5UA6n3oAqW2Li5hmgJLAF2DdzVnSrhIJpfMCedJwU/HtUFo7LeS7wD5o4UDj6U7TrV5JSk6hZFYsu3rj3oAuKdzzRiNdmMggYxUlsgi3nYHEjKQoHB+lJJDJHCYULcsQGUff+tFo93AyRyqhI+VHPAxQBfjdGvDctKEjVgphQda6i0eyudTt0u2aG3dQNqDp71zGjQGS+nI2fu/mKjnd611+jWDapqUDWFuGKSbJC3KqtAHu3grS1tIvNWMCLYFhcnJK11VQWMIt7OCIKF2IFwO3FT0ABr5L/bI8VL/bWm6HZyq0kUDNOMfd3EYH1wBX1fd3EVpazXNw4SGFDI7E8BQMk1+bfxO8St4t8b6rq/PlzTHy8nPyg8fpQBjeH7b7XrNpDgkM4zVjxfP5/iC75yIm8pfovFbHgyOK10nU9VZSZ7dT5Zz0/wAnFcjI7SSM7kl2JJJ7mgBtFFFABRRRQAUUUUAejfCbUopDe6PeOSJEMluhPDN/Ev4jn8K5DxXp66Zrt1bxxukYOVVuuDWfp91LY30F1bttmhcOp9wc16R8TILLVtEtNd08F2cKXb0B6gj2NAHo/wCxz44Fjq934SvXkMd6fPtCT8quB8y+2R/KvryvzD8J65deGvEen6xYsVuLOZZV98HkfiM1+lfh3VoNd0Kw1SzdWgu4VlUqcgZGcfh0oAt3lut1aTW7/dkUofxr5g8a6e2l395C6OjRyFVJHDD1NfUprzv4seGF1HTJtStwRNEhMqAZ3gUAfPlqYwnMqgj51wcgmopx5cPz3A3OSRGOlMls40bzI4iPXBqC/syxjuFdVYj7jdQBQBBezhYYYwmNpy2B0qvck3IaaEldiDLA4q0tn9liEwB3yDlAck/hVaR5EtZ4kCBtwXbjqKAK5j8vYZQGBAOOwFSI0ZuVCRv5e7O4jg+lS2gQzK10+2MrgoanvYsqkKFBCBgYPTPSgCvZMt5MyGQJKjktjtjvVqSWSELK8oMUhOVHOcdxWXaWzWrNI2flyrEc7hWtazQjYzPGSwzHEw6UAKkME7rcQksDn5G6k02dJEx5AwU5Ydcn0FSwQSMRcH5ZS3Q8YH0pbmZbm68yJRtT5WZTgMaAM1oALlZSpZnbDrnkZ9KlMWZGMW7zUOw4OOPerK2uxyxk3I6blx1BpYYS1rI5bEbH5jnkmgCsEt4ZhvO7BAwBkfjWpr8yvqUUaIimNF2FOnTvVCGJVVPKKvKXHyHq30qfW1mhBluYzFKhG4Y5waAIEzOJ4IiTIG+8vJWmyBLucBZNxQBWC8dO9RQl4EU2hXzZMqzg84pVURwTIrJ5zj5mX7wxQBDq9xI0ckUWVtlXAA7mqaKXjiFzN5JVflRByQaJR5oFysnmhPkCdDn1Iq80KeXGYBlto3EjJzQBRtN7s8KW4Cq2WZ+pHrT59qszI7LIpwR/CRTlQw4a53bJCUU5wQfeo4y0aTBQrof4T60ARKzNeFCzbFXcwXkc1biaQuUdHjAOSAOStU92y2UysRL3VR0q9BfNAjGaTcHAw2Mn6UAasERurJp0l2xI/wAq981QuT8mZNwLPk02CScNJJI/lRfe2DuKtXCJNaq5zHExwpc8k/SgCt/Zc1wqyRgLIFLkg8Yq1allkhedvvjaSOM0k8j/ACQRFkwAjStwG+lPuBHtW2iDOyrv3AZ5oAab+dkAgQbFZhwOc0tjARFGbjOV67z096g2y+SsMBLD7z842e+akVXnhZ3JkEbYZs4HFAG74dEMM93dSMGVEKgDoc17F8FNEWSGXU5FKxbsRqD8rH1/CvOvAmj/APCQfZY7aAL5xMcjMOBjuBX0vpNhBpmnQWdqipFEoUBRjPvQBbooooA8b/ai8bxeFvh7Np0Zzf6yGtolBxtTHzt+oH418KRpvyAQCOx7/SvYv2p/GMHin4jtbWTl7TSUNoGzwz5y5H48fhXnXgzR/wC1dVQS7hBGQSw7n0oA2vFclvpfhXT9PtI9r3Sh5G7kD/6/8q4WtvxjqC6hrsxh4t4P3MQ/2V7/AInJrEoAKKKKACiiigAooooAK9F8G/8AE18FahYliz27H5cZ+Vuh/PNedV0vw/1g6Rryh2YW90pglAPXPT9aAOckQxyMjfeUkGvrX9jjxqkukXfhS+mPmwyGa03H+E9VH48/nXzb48sY7bVjPbRNHBPyNw71d+EPiOHwt4/0nUrt2S0SULKV7Ke/4UAfpBSMAVIIyDxiq+n3ttqNnFdWUyTW8q7kkQ5BFWaAPCfjJ4NXTS+r2EDGxY5eKIY8tz3+hrytw0boZwju4G1T1UetfYt3bxXdvJb3EayQyKVdGGQQa+dvip4Ek0HUDfWXOnycITyYz6E0Aeb3rZuGYOTKuNnpipPJjuWjlVlDOeCRjn0qKO2WxlDTuzySZ+8MjHtViTH2i3haE+VjJlB6UAVIomLs8kPJbBDcYx3FWGTdeGNlVldQzSY4Wmy3EsmpKGRpIg20v0IUelWo/KiupNu6WMqeOzfWgDEvbWVhLIHZAh3ADoRUENxHGjFoNzSDbHMf4T7VPqFz5EbxljuY8beQo96bIF8iOZD+7xhVIzz3OKAJ/t0yW6K3zTrhFdec1IPIDxweYrPnewzjH4VnpBMsrmWQFQNylTjn0qXyo/kklAWTP7x1HzAelAFq8kjs95tHklVRtwepPtUwZHk+yzRvagR7tx5yajVs2czIqlc/Ix+8KtQNb3KvLcSBbkgBQ5+9igCTSLUi/s2hjO3JO7qaraoZLm5BnuNyLIS4Y8sPaui8Nx/6bNcwuAscbb1fkBsVytyjyXDeZ8zHLpigBgj8+KQImxVk+Ug9RWfGZIXfdhfmOSDktVuETRSuGXfDgncP4TipdPiDQbZzmQtlSRyaAKl4FcLsjEaqp8wdGJ9a0bS1RNOkeLKgLvLt1FRagrRxyA+WHHO4nJIqRbxrixeBk8qDj5v79AGe6g28skjZEzD5WOWz6ip4rNJbkBXEcO3hT147ms95RDOViiDyKPlB5BraETTTw3E0iRIANyJ1PtQBl6mxCl7eMtuAG89KjZNlrkSB0XnaBzmtHW/KnysZKxRsCB0JFIIj9nE7SIkWMbQOaAKoLyvHJMzJH1QNwWrZYJHC8ELI0qDfluq59Kyrx4fIgmmRmIbEG7/CnRxrJOXk3l/vFhwMelAFyS4zHuuAZNoyg7k9qT/TftEJEqW8hTD9PlqFGWdnjA5bIB7j3qLGJDCf3mMFpO9AFqVAQYoG3Io3Mc8yU/SrZ7tvJVGittw81ievsBVTSiZ52C/M8hKZH8I+lewfB/wdDqd0s1zGxgtWDyOejt2WgD0D4VeEY9Kt11J0eNpFxDE38Cnufc16KKQAAYHAFLQAVyHxT8XweCfBl/qs2GmVCsMecFnI4rrya+IP2qPiB/wk3i86NYybtN0w7MqeHfuaAPE765kvb24upjmWaRpG+pOa7qwR/D/gua7kbZcS/LEO+W6fkOa47QbE6jqkMAIAJyc+gro/iTe/6Xb6ZFKHjtl3OAOA5HT8v50AcYeuTRRRQAUUUUAFFFFABRRRQAUqkqQVOCDkGkooA9Hukbxd4Winh/e30AwyA4IcD+R6151LG8UjRyKVdTgqeoNbng7XjoOrJNIpktZPknjHdfUe4610XxD0aO6ZdZ0cLJZyJuYrwT70Ae6/sqfEXzNNTw5qN1G8iPthQ8MF7H3FfTor8uNK1C50rUIL2xlaOeFgyspx+FffnwH+IFv478HRylz/AGjaYiuEbqD2NAHpdU9Y0221fTZ7G+j8y3mXaw7/AFHvVyigD5r+Jfw61LRbv7ZYu11pcaYBfqg9D/jXnUkMMl95RWUBQCSr9T6V9qXMEVzA8NwiyRONrIwyCK8I+J3w9bRY31LRojLaZJkULloR/UUAeVOojgld3cEEBEHU003MjuWt9sa42hCO/wBaqTGaQpIZDFCxKgAZOfetG3hC2jRFXbn744OO9AGJIn2ySSZN8YV8NkcNV+aFIEaKMM5RclgPXtT0tt8myFibZjnnqKuNK8NzFHuDo4yx7DFAGc1huiKL8rON2GPP5VUYmeeFLSBmbq+f4q2plN5cM8WGcnBJ42D2qGK3Fs8pS4Ei8qnH3aAMKW43MXjf5Eb5kQZxVm1tD5j3ExEpGGRMc1Nd6emnWcc6xSlZWJJX0pLCUz3bwWwaJCOsg69zQBu6BcXNta3oRE8nhWDnnJ7Cs6KRIr9sKqtjYOc49a6PTQ0XhW4gW2h3zyBmkc5P/wBauNmge0ExlfE7NlFXrigCzP5m1wr/ALvfwQOo75qFoFVdsspWQcoVPOKIJJWtAtw/zDny8ctUEMxuGd4ozEEHcdTQBfkkMtuMxp7SMOfpWe4iWdmunaVSB8kYwM02RUCbI5pCy/OWB/TFNMDTIkyOS+PlXpmgCOO4MDiR0yHO1do6fWtSGC3GJ2ci4ydq54qDdCBDJs3IByB/eqXULo3lmsNvFGkxwdwHC0AWLi2Ey/vEyZBnYvT86yZ5GXagdDMGH7peRj61bmSe1MKPMJJgoZ1zw2aguUgS6M0QESqACijvQAOJ5Jo4JWVFPzBl7H0qeFmgW8iXLSnkB+lWNTISCFkQF9vQ+tNtVaWIPLKiFZMcjkg0AV/s8lxcRiMCJyPnZewqdrZpdQSCL5vlxuAxUsDtasdgLszhD67TXe+AfA0+o63FP87xxncATwnufWgCt4H8F3F4UsoR5d7K2Wl25CqOpNfSegaRbaJpcNlZoFRB8xAwXbux9zSaHpFtpFmsFsg3Y+d8csa0hQAUUVW1K+t9Nsprq8lWKCJS7MxxwBmgDiPjV4ytfB/gjULiacxXUsZjgC/eZjxxX543Mz3NxLPMxaSRi7E9ya9T+P3xRk+IWvLDap5Wk2TFYRnlz/eNeeaHpNzqlwBCqbEOSX4B9qAOq8Jx2ej6BLq92m+UDKDpk9hXDXdxJdXUtxM26SVizH3Nb/jG/wB06adbzK9tb4zsGAXx0/CuboAKKKKACiiigAooooAKKKKACiiigArtfAmuRrFJompfNaTkmI90fHT6H+dcVSqSGBUkEHII7UAaGu6bJpt9JG0bLESTGW7iuy+CvxBPw+8Ui+nWaWykG2WKNsZ9zVK0ubHxLpjRak7pqUC/Jt/5a+49/WuUv7KSz2eYCpfOFYYYD3oA/Snwf4q03xXoltqemSgxTjhGPzA+hrer85/hv8R9V8GXcYinmaxDbjGjYI+n+FfbXwo+JOlePNIR7WdFvkUeZCSAfrigDvqRlDKQwBUjBB70tFAHjHxG+F6ecdT8PQZG4vNbg9PdR/SvK9SSe2mdLyFYJ0y3zccV9d1yHivwDpHiB57iVDFeSLjzRyM+u2gD5oj1CGSPNtGqkYAUdWJ71VupGjePKpnptHQmvQtZ+EOr6ZdPc2kSXsa52rAcE+nymuEvrS7srt49ZhkgPICsm3bQBSSCZr0sZVijGNwBzg1be2t57RvOlKSs/wAwHRgO/tTLyzjgEFwJDJGfulD296ZB59lM1yZRscYRCMnHrigAZ5HmOGZhEoAQ9h3qOO1Es015Fuhy2FaQ4/SrVtJLDcNJJGBExyZj1/KtLT9MuNXZ3umRbctgBuAQKALVxZqvg0XLyj7SJtpKn5WHqa426hNxcwGTcrH7xAzx7V6PfGJNNk0uFoZjGu4QqOB9TXAXE9yk7RXDKrryEAztHpQBGbyDzhFHGWUNy5HIPtU0ccksCxwxyKxyd5HBNZ5eQvhVGzGVA7t71Ziv7tbX7MimJgcqzdvWgBYo3jnAjRDg4cn07mjVLWfzcwHfCq5DgcCpkWRAyEb0YfeT+KnQTpHbpgjap2eWTgk+tAFKdGjWGCbZEhGdo6n3p0Btkj8tfMldTkY6H8auPZRmHcZQ9y3BUjJVaiiEVu3lxrLuEmN4HAWgCWeKW6jCGKIEAYcdQPrVCRVjwk21iGwGHc1otuSdJjt8qVvLwexHeoorKR7nzJcM0bMV2dBjpQAxmcWXmJyoGwKR0Oav6Rotxq2oww4JLEAxoM8npXWeFfAOs609oWs5IrdjvZm+VQD35617h4I8DWPhcyzIxnupOrsMBR6AUAcT4U+FKtEjaqGiQNllYZdvp6V6tpGkWekQGGwi8tTyTnJP41fxRQAUUVHcTR28LyzOscaDLMxwAKAC4mjt4XlndY4kG5mY4AFfG37SXxe/4SK6Og6HvitLcsssu7lz7Yrs/j58bre3tH0XQ4hLLKpzI38Pocf0r5LdpLi4LMS8sjZJ7kmgBbW3lup0hgQvIxwAK65bZ/C2kSTTyK1zcDESDsfX8Kz9HuYvD266kKy35X93Bjhc92P9KxL+9uL64aa7laSQ9yenOcD0FAEDEsSSck8k0lFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAElvNJbzxzQuUkRgysOxr07SBa/ELTZbRxbwa9GAUX7vnDuy+/qK8tqS2nltbiOe3keKaMhkdDgqR3BoA0Nd0O80a7kguYyQhxvA4NP8LeI9T8L6vDqWjXLQXMZ4I6MPQivXvBPivTfGulNo2vR20esBcRu4AFz9P9v279q4Hx34NudJummtLeRoGJzsXIWgD7B+BvxgsfiHpxtrzZaa9bgCWAtxKP7yev0r1qvy50rULrSdRgvbKV4rmBgyspIORX1N8O/2kXngtbPXbP7RdsQh2NtY++TwaAPqCis3QdYtdc09LyyYmM8FWGGQ+hFaVABVLUtLsdTiMWoWkFwhGMSIDV2igDynxF8GNIvC0ujXMunzHjaTvT/GsK1+Dl9Fc7Jp7eWDoHydwHrXudFAHnY+FmlmyWKaVpJQu3cy5GPpWDrfwqaOB2sz9pVOY4Q23mvYqKAPnufwVrc8hL6PMjRoNpjIAb2Nch4n0HW7SdbibQrmEA7S4iJHPvX1nTJo0mjaOVQ6MMFSMg0AfF/2YI7rsWN1IJDfep0dsbzNukrKTnLMO3tX1DffDnw3dzTStYCOWRdu5Djb7isiT4R6GYIkimuo2QYL5BJoA+cGsbwY2HZGpEe8Hgj1pTpklxeMtpZyS/LuEmMivpKw+Eug2/8Ar5Lu5Gc7Xkwv5Cuw0zQdM0xQLGyhixxkLk/maAPmfTPBviPUYUl0/SJtwTYzSfKP1rsdK+EGo3qKurMlvGVDFVYcN6cV70OBx0ooA80tPg/oETq073EgHIRTgA10+meCfD2m82+mwls7t0g3HP410lFACKoVQqgAAYAHaloooAKKa7rGjO7BUAyWJwAK8m+Ifxx8MeFfPtYLpLu+VDt8oh1DenHWgD0vWdXsdGtDc6lcxwRjpuPLH0A718rfHD48fbbmLT/C5PlxEmVn5XP4da8l8f8AxS1/xlcSm9uCIW+VQOML6YHA/CuBAzk+nvQBZup7jUr6SaUtLcTNuJHqacWitCBEd9yjff6qv0HeomuCqNHDlIz971b61BQAruzuWdiWY5JPekoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBUZkYMjFWByCDgg+teueEviL/aelf2H4icCaQhEvXONw7Bz6+/515FRQB6F428HG2d7qyGV6nnO734rgdssDK5DxkHKnkY+ldL4S8Wy6PKkN/G17p+NvlM3KD/ZP9K7dLbR/EkXm6fJG4YEyIwwyf8B/woA5XwT8T/FXg6/+06TqcrKeHhnPmRuPcGve/BX7UkExSLxZpohPRprbOPrivnbxB4SudPl3W2ZoGYgMRiuYYFWIYYI4IoA/Srwd468O+LrRZ9D1GKbP/LNjtcfga6fNfltYahd6fKJbK5mt5B0aNyteg6B8bvHeioEi1ua4jAAC3HzgAUAfoRRXxn4d/ai8S20yrrdlZ3cOeTGmxsV3en/tT6KVU6jpVwu7qsPJX65oA+kaK8m0D9oDwDrEsMQ1KWzlkOMXURQA+55r0zT9W0/UollsL22uEIyDHIGoAu0U0OrHCsCfY06gAooooAKKKKACimSzRxKWlkRFHUswFYt54u8P2jsk+sWSuvBUSgkflQBu0Vmw67pc9gb2K+t2tgMlxIMCvE/Gv7Rmm6P4gi0zSLI3algrzu2AOcdKAPfiQOT0rzr4h/F3w14JgkN7M9zdKdoghwWJ9K8v+Jvx/gsfDk9noVwkutO4w4AKqvevlLWdUvdc1Oe/1CVprmZtzsenP8qAPSviX8dPE3jRHtIpP7N04k5hgOCw9GNeXR2V1PF5yQu0ZbG89M/WiNoYM+ZGJpPTd8o/LrST3k0yBGciJeka8KPwoAh+63UNj8qRmLMSe9JRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUkE0lvKskEjRyL0ZTgio6KAOx07x3eKkUOr28WowR/d3fIw/EdfyrT/ALa8L6pEBcQfY5WJzujyAPqK87ooA6mbwxFc+dNpV9BNCPuqGGfpVM+FNVwu2AOzc7VNYQJHQkVNHd3ERzHPKhHdXIoA05vDWpwPEssGDIcDnOKfJ4W1dZFQWrMWOBtPWs5NTvkYMl5OCDkHeetXIfEuswzLKmpXHmL0JbP86ACXw3qscxja0cuBkhecU22utb0iXfbz39q/TKMy1r2nxA1+3YsZ4JWPUywqSfxrQh+Jd/iQXWl6VOH55iK4/I0AY8HjDxRasGj1bUEJOeXbmrzfEfxg0kWdav8AMXRRIwH4gGtiL4oxfZ/KufC+mTAD5TuZcUyD4jadEJD/AMIpZNJJ/EZjkfTigCXwx8W/HOl6gXXU7+5jOS8TOTx+Nd7D+0n4ginib+zZJVTjbIxO76155N8Sbd4vLj8NWUZJyX81tx9ulR2vxLe0iVINC07IYtucljQB6B4n+OXinUdPW9t7ee1xlGXJABPfArz8/F7xvscJq8yAgruGflzTrz4pXk8M6Jo2lxmUAbijMV+nNYb+NtSaFohBp6I2M7bcc0AUr3xb4gvgVu9Zv5ATkgzNWS9xNIxZ5ZGYnJJYnNa7+IDPMXvNPsZQeu1NmfxFX7jXNCltFH9is1yq4UmQBQfw5NAGFDq+owWklrDfXKW0hy8ayEKT9KpMxY5Ykt6k1NdzrO5KQRQqTkKg6fjUFAAaAeKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan showing a left acute subdural hematoma (SDH, arrow). Subdural hematomas are typically crescent-shape. In this case the SDH is causing significant mass effect and shift of midline structures to the right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: J Claude Hemphill III, MD and Nicholas Phan, MD, FRCSC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diffuse axonal injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 417px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan of the brain showing diffuse axonal injury (DAI). Note the deep shearing-type injury in or near the white matter of the left internal capsule (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: J Claude Hemphill II, MD and Nicholas Phan, MD, FRCSC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frontal cerebral contusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan of the brain depicting cerebral contusions. The basal frontal areas (as shown) are particularly susceptible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: J Claude Hemphill III, MD and Nicholas Phan, MD, FRCSC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    TBI epidural hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 450px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan demonstrating a right epidural hematoma (EDH, arrow). Note the lenticular shape.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: J Claude Hemphill III, MD and Nicholas Phan, MD, FRCSC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35642=[""].join("\n");
var outline_f34_51_35642=null;
var title_f34_51_35643="Causes secondary adrenal insufficiency";
var content_f34_51_35643=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of secondary adrenal insufficiency in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pituitary etiology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Congenital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        PROP-1 gene mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pit-1 gene mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T Pit gene mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        POMC gene mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Idiopathic isolated ACTH deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Acquired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Brain tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Brain hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Brain surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cranial radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        End organ unresponsiveness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Cortisol resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Familial glucocorticoid resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Aldosterone resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pseudohypoaldosteronism 1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     POMC: pro-opiomelanocortin (the precursor molecule for ACTH, melanocortin, and &beta;-endorphin); ACTH: adrenocorticotropic hormone.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35643=[""].join("\n");
var outline_f34_51_35643=null;
var title_f34_51_35644="NTCTCSG staging";
var content_f34_51_35644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Registry staging classification",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Papillary carcinoma",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Follicular carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Age &lt;45",
"       </td>",
"       <td class=\"subtitle2\">",
"        Age &ge;45",
"       </td>",
"       <td class=\"subtitle2\">",
"        Age &lt;45",
"       </td>",
"       <td class=\"subtitle2\">",
"        Age &ge;45",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"3\">",
"        Primary tumor size, cm",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1-4",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;4",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"5\">",
"        Primary tumor description",
"       </td>",
"       <td>",
"        Microscopic multifocal",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macroscopic multifocal or macroscopic tumor capsule invasion",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Microscopic extraglandular invasion",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macroscopic extraglandular invasion",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poor differentiation",
"       </td>",
"       <td>",
"        N/A",
"       </td>",
"       <td>",
"        N/A",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        Metastases",
"       </td>",
"       <td>",
"        Cervical lymph node metastases",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extracervical metastases",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jonklaas, J, Sarlis, NJ, Litofsky, D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006; 16:1229. Copyright &copy;2006 Mary Ann Liebert Publishers.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35644=[""].join("\n");
var outline_f34_51_35644=null;
var title_f34_51_35645="TWAR equation";
var content_f34_51_35645=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59117&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59117&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Equation for computing T wave alternans ratio",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 280px; height: 91px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35645=[""].join("\n");
var outline_f34_51_35645=null;
var title_f34_51_35646="ACC AHA ETT diagnosis CHD";
var content_f34_51_35646=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74054%7ECARD%2F52995%7ECARD%2F61603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74054%7ECARD%2F52995%7ECARD%2F61603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Exercise ECG testing without an imaging modality for the diagnosis of obstructive coronary heart disease (CHD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that exercise ECG testing for the diagnosis of CHD is indicated in patients with:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; An intermediate pretest probability of CHD based upon age, gender, and symptoms, including patients with complete right bundle branch block or less than 1 mm ST depression, in the absence of the exceptions listed in class IIb and class III.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence or opinion is in favor of the usefulness of exercise ECG testing for the diagnosis of CHD in patients with:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Suspected variant (vasospastic) angina.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIb - The usefulness of exercise ECG testing for the diagnosis of CHD is less well established in patients with:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; A high or low pretest probability of CHD.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Digoxin therapy and less then 1 mm of ST segment depression at baseline.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Electrocardiographic evidence of left ventricular hypertrophy and and less then 1 mm of ST segment depression at baseline.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III - There is evidence and/or general agreement that exercise testing for risk assessment and prognosis in patients at intermediate or high probability of CHD is not useful in the following settings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull;&nbsp; Patients with the following baseline ECG abnormalities:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Preexcitation (Wolff-Parkinson-White) syndrome.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Electronically paced ventricular rhythm.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. More than 1 mm of ST segment depression at rest.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4. Complete left bundle branch block.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; An established diagnosis of CHD due to prior myocardial infarction or coronary angiography. However, testing may be warranted in such patients to assess functional capacity and prognosis.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for cardiac stress imaging as the initial test for diagnosis of coronary heart disease (CHD) in patients with chronic stable angina who are able to exercise",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Class I",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       1. Exercise myocardial perfusion imaging or exercise echocardiography in patients with an intermediate pretest probability of CAD who have one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Pre-excitation (Wolff-Parkinson-White) syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. More than 1 mm of ST depression at rest",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       2. Exercise myocardial perfusion imaging or exercise echocardiography in patients with prior revascularization (either PTCA or CABG).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       3. Adenosine or dipyridamole myocardial perfusion imaging in patients with an intermediate pretest probability of CAD and one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Electronically paced ventricular rhythm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. Left bundle-branch block",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       4. Dobutamine stress echocardiography in patients with an intermediate pretest probability of CAD and left bundle branch block.*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Class IIb",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       1. Exercise myocardial perfusion imaging and exercise echocardiography in patients with a low or high probability of CAD who have one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Pre-excitation (Wolff-Parkinson-White) syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. More than 1 mm of ST depression",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       2. Adenosine or dipyridamole myocardial perfusion imaging in patients with a low or high probability of CAD and one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Electronically paced ventricular rhythm b. Left bundle-branch block",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       3. Exercise myocardial perfusion imaging or exercise echocardiography in patients with an intermediate probability of CAD who have one of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Digoxin use with &lt;1 mm ST depression on the baseline ECG",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. LVH with &lt;1 mm ST depression on the baseline ECG",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       4. Exercise myocardial perfusion imaging, exercise echocardiography, adenosine or dipyridamole myocardial perfusion imaging or dobutamine echocardiography as the initial stress test in a patient with a normal rest ECG who is not taking digoxin.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       5. Exercise in patients with left bundle-branch block.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       ACC/AHA classification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Class I:",
"       </strong>",
"       Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       <strong>",
"        Class II:",
"       </strong>",
"       Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Class IIa:",
"       </strong>",
"       Weight of evidence/opinion is in favor of usefulness/efficacy.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Class IIb:",
"       </strong>",
"       Usefulness/efficacy less well established by evidence/opinion.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Class III:",
"       </strong>",
"       Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful and in some cases may be harmful.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Modified from: Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418.",
"    </div>",
"    <div class=\"reference\">",
"     Data modified from: Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for cardiac stress imaging as the initial test for diagnosis of coronary heart disease (CHD) in patients with chronic stable angina who are unable to exercise",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Class I",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1. Adenosine or dipyridamole myocardial perfusion imaging or dobutamine echocardiography in patients with an intermediate pretest probability of CAD.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       2. Adenosine or dipyridamole stress myocardial perfusion imaging or dobutamine echocardiography in patients with prior revascularization (either PTCA or CABG).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Class IIb",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       1. Adenosine or dipyridamole stress myocardial perfusion imaging or dobutamine echocardiography in patients with a low or high probability of CAD in the absence of electronically paced ventricular rhythm or left bundle-branch block.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       2. Adenosine or dipyridamole myocardial perfusion imaging in patients with a low or a high probability of CAD and one of the following baseline ECG abnormalities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Electronically paced ventricular rhythm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. Left bundle-branch block",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       ACC/AHA classification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Class I:",
"       </strong>",
"       Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       <strong>",
"        Class II:",
"       </strong>",
"       Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Class IIa:",
"       </strong>",
"       Weight of evidence/opinion is in favor of usefulness/efficacy.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Class IIb:",
"       </strong>",
"       Usefulness/efficacy less well established by evidence/opinion.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Class III:",
"       </strong>",
"       Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful and in some cases may be harmful.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data modified from: Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35646=[""].join("\n");
var outline_f34_51_35646=null;
var title_f34_51_35647="Superior mesenteric artery stent";
var content_f34_51_35647=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superior mesenteric artery stent",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 251px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Aortogram in the lateral projection. The arrow head shows the superior mesenteric artery (SMA) which contains a deployed stent and no evidence of stenosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Uflacker R. Mesenteric Ischemia. In: Peripheral Vascular Interventions, Kandarpa K (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_51_35647=[""].join("\n");
var outline_f34_51_35647=null;
